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ABSTRACT 
Acinetobacter species, especially GDG 3, are important nosocomial pathogens in 
Hong Kong. The therapy oiAcinetobacter infections can be complicated by multidrug 
resistance to a range of antimicrobial agents. Resistance-Nodulation-Cell Division 
(RND) type efflux pumps can be responsible for a wide substrate specificity in 
Gram-negative bacteria. AdeABC is the only published efflux system \n Acinetobacter 
(Magnet et aL, 2001). To study longitudinally the emergence of multidrug resistance, 
8 sets of epidemiologically and clonally related serial isolates from clinical specimens 
with different resistance patterns, belonging to GDG 2, 3, 13TU and other GDGs 
were found. Two sets of GDG 2 and one of GDG 13TU were adeE\ They were used 
to study the expression of adeABC by real time reverse transcription (RT)-PCR and 
expression was found in only one set of GDG2. AdeB was closely associated with 
GDG 2 Acinetobacter (70% in 56 GDG 2 isolates). 
Two RND-type efflux proteins, AdeE (1037 aa) and the putative AdeY (1054 aa) were 
identified in a GDG 3 Acinetobacter (isolate 4365). Target disruption of adeE revealed 
that it was a multidrug efflux protein and its substrates included quinolones, 
ceftazidime, carbapenem, aminoglycosides, tetracycline, rifampin and ethidium 
bromide. 
A total of 271 isolates from blood culture were screened for the presence of adeB, 
adeE and/or adeY. Of the 56 GDG 2 isolates, 70% were adeB". Of the 83 GDG 3 
isolates, 82% were adeE" and adet, 8% adeKadet, 2% adeE^adeT, and 7% 
adeKadeY. Isolates from clinical specimens were significantly more likely to be 
adeE" than those from the environment (45%) (p = 0.001 Fisher Exact test, Odds Ratio: 
� i 
5.41 (95% confidence limit, 1.79 < OR < 16.56)), suggesting AdeE may be a 
contributing factor to the multidrug resistance seen in clinical isolates. Expression of 
blam?-A was also studied by real time RT-PCR in 19 GDG 3 isolates and a general 
correlation (coefficient of correlation = 0.58) between the transcript levels and 
meropenem MIC was found. 
Although adeB’ adeE and adeY mo, likely to behave as functional efflux pumps, over 
70% of the adeB+, adeE^ and adeY^ had low MIC of amikacin, netilmicin, imipenem, 
ciprofloxacin and rifampin. Their contribution to clinically significant resistance is 




不動桿菌卿e t o b a c t e r species)在香港是一種重要的院內感染細菌，特別是那 
脫氧核糖核酸基因組別三(Genomic DNA group 3)尤其重要。治療不動桿菌時失 
敗的原因往往可能是由於細胞產生了多重抗藥性（multidrug resistance)� 
Resistance-Nodulation-CeU Division (RND) type 的排藥幫浦(efflux pump)可以使 
革藍氏陰性（gram negative)細菌對多種藥物產生抗藥性。在不動桿菌內， 
AdeABC是唯一發表過的排藥幫浦(Magnet et al.’ 2001)�本硏究在威爾斯親王 
醫院的臨床樣本內搜集了八組同源細胞（來自同一病人），彳_有不同抗藥性的 
表型的樣本，用來硏究多重抗藥性的演變。這些樣本包括脫氧核糖核酸基因組 
別二（Genomic DNA group 2 / A baumannii),三及其他組別。其中，兩組脫氧核 
糖核酸基因組別二及一組組別13TU (Genomic DNA group 13TU)在聚合晦連鎖 
隨(Polymerase chain reaction)裏對ac/eB產生陽ft反應，這些樣本都用作硏究 
AdeB的表態量(expression level)�這硏究會用即時定量反轉錄聚合晦連鎖反應 
(real-time reverse transcription PCR)來量度表態量。結果發現只有一組樣本有 
AdeB的表態。在不同的脫氧核糖核酸基因組別中，AdeB與細(1 二最有關連（在 
厂 五十六個ffiSfJ二的樣本裏，七成樣本對AdeB產生陽性SJg) 0 
本硏究更在一株（4365)不動桿菌脫氧核糖核酸基因組別三內發現了兩種 















.. amikacin, netilmicin, imipenem, ciprofloxacin 及 rifampin 只有低的最少抑菌濃 
度因此，不動桿菌的臨床抗藥性的主要原因可能是因爲其他的抗藥性的機制 
(resistance mechanisms) ’而排藥幫浦的幫助則不大。 
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Definitions are given below the most common terms used in this thesis (Struelens et 
al., 1996) 
Clone: The word clone will be used to denote bacterial cultures isolates 
independently from different sources, in different locations, and perhaps at different 
times, but showing so many identical phenotypic and genotypic traits that the most 
likely explanation for this identity is a common origin 
Epidemiologically related isolates: Epidemiologically related isolates are those 
cultured from specimens collected from patients, fomites, or the environment during 
a discrete time frame or from a well-defined area as part of an epidemiologic 
investigation that suggests the isolates may be derived form a common source. 
Genomic species: here called DNA groups. The division of genomic species (DNA 
groups) of Acinetobacter isolates should be based on DNA-DNA relatedness. 
Isolate: Isolate is general term for a pure culture of bacteria obtained by subculture 
“ of a single colony from a primary isolation plate, presumed to be derived from a 
single organism, for which no information is available aside from its genus and 
‘species. 
J ‘ 
Strain: A strain is an isolate or group of isolates that can be distinguished from other 
isolates of the same genus and species by phenotypic characteristics or genotypic 
characteristics or both. A strain is a descriptive subdivision of a species. 
� xxi 
CHAPTER 1 
CHAPTER 1 INTRODUCTION (PART A) 
1.1 Acinetobacter spp. 
The genus Acinetobacter is generally identified as: Gram-negative coccobacilli, 
oxidase-negative, non-fermenting in Huge and Leifson medium, non-motile in 
hanging drop preparation, demonstrating aerobic growth, catalase positive, nitrate 
reduction mostly negative, and hydrolysis of Tween mostly positive (Cowan, Barrow 
and Feltham, 1993; Dijkshoorn et al, 1996). Identification to the genus level can also 
be performed by a transformation assay (Juni, 1972). 
The division of Acinetobacter isolates into genomic species (DNA groups) is based 
on DNA-DNA" relatedness. The present phylogenetic definition of species is based on 
70% or greater DNA-DNA relatedness of strains. However, no name has been 
assigned to the phenotypically undifferentiable genomic DNA groups (GDGs) 
(Wayne et al., 1987). Until recently, 19-21 DNA groups have been recognized by 
-d i f f e ren t researchers (Bouvet and Grimont, 1986; Bouvet and Jeanjean, 1989; 
Tjernberg and Ursing, 1989). An overview of the currently delineated GDGs is 
depicted in Table 1.1. 
i " 
Confusion in the genomic DNA group classification 
Bouvet and Grimont (1986) delineated 12 GDGs fox Acinetobacter, using DNA-DNA 
hybridization. Later, five more proteolytic GDGs, numbered as 13 to 17, were 
reported by Bouvet and Jeanjean (1989). Independently, Tjernberg and Ursing (1989) 
used DNA-DNA hybridization to demonstrate three more new GDGs and numbered 
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them as 13 to 15 (now prefixed as TU13 to TU15). It was found that TU14 
corresponded to Bouvet and Jeanjean's 13 (Tjernberg and Ursing, 1989). However, 
they could not reproduce the results of GDGs 8 and 9 reported by Bouvet and Grimont 
in 1986. GDGs 1, 2, 3 and TU13 are phenotypically very similar and often referred to 
as A. calcoaceticus - A. baumannii (Acb) complex (Gerner-Smidt, Tjernberg and 
Ursing, 1991). The confusion in DNA group classification and intensive labour 
required for DNA-DNA hybridization have prompted the development of new 
methods of identification. 
Table 1.1 Current delineation of Acinetobacter genomic DNA groups by different 
researchers. 
DNA groups according to : 
� . Bouvet and Grimont (1986) & Tjernberg and Ursing (1989) Species name- „ ^ , , � ,  Bouvet and Jeanjean (1989) 
A. calcoaceticus 1 1 
A. baumannii 2 2 
3 3 
ug 13TU 
A. haemolyticus 4 4 
A. jimii 5 5 
6 6 
A. johmonii 7 7 




• A. radioresistens 12 12 
• 13BJ 14TU 
• 14BJ nt 




A. venetianus* nn nn 
ug: ungrouped; nt: not tested; 
nn: not numbered in the systems of Bouvet & Jeanjean , Tjernberg & Ursing; 
* identified as a new distinctive DNA group by DNA-DNA hybridization (Vaneechoutte et a/.，1999) 
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PCR based methods 
Amplified rDNA Restriction Analysis of the 16S rRNA gene (ARDRA-16S) was the 
first PCR method reported for genospeciation and used to classify mostly clinical 
isolates to the 18 described GDGs (Vaneechoutte et al., 1995). The internal region 
(�1500 bp) of 16S rRNA gene was amplified and was restricted independently with 
five restriction enzymes (Cfol, AM, Mbol, Rsal and Mspl) to obtain the restriction 
patterns for analysis. 
PCR amplifying the intergenic spacer between the 16S and 23S rRNA genes without 
restriction analysis was shown to identify only 15 of the 17 reference strains tested 
(Nowak, Burkiewiez and Kur., 1995). The result of another study, using the same 
PCR method coupled with two restriction enzyme analysis (ARDRA-spacer) was 
difficult to evaluate because only clinical isolates of Ach complex were used and 87% 
of them belonged to GDG 2 (Dolzani et al, 1995). PCR of the locus recA followed by 
restriction analysis was able to differentiate 17 genomic DNA groups but only 
reference strains were used in the study (Nowak and Kur, 1995). 
Recently, PCR of the tDNA gene sequence was found to be reproducible, rapid and 
capable of differentiating most of the GDGs, although some Acb complex were 
indistinguishable (Wiedmann-Al-Ahmad, Tichy and Schon., 1994; Ehrenstein et al, 
1996). The rRNA spacer length polymorphism (tDNA fingerprinting) and selective 
restriction fragment analysis by amplified fragment length polymorphism (AFLP™) 
have also been validated against a certain number of reference strains and reported to 
be reliable and reproducible in the identification of Acinetohacter species 
(Wiedmann-Al-Almad, Tichy and Schon, 1994; Ehrenstein et al, 1996). 
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Among the methods described above, ARDRA-16S is capable of differentiating most 
DNA groups, and those of the Acb complex. The ARDRA profiles obtained were 
highly reproducible in different laboratories. Since ARDRA-16S provides acceptable 
GDGs identification according to recent taxonomy, well established in our laboratory 
and relatively easy to perform, acinetobacters were therefore identified to GDGs by 
ARDRA in this project. 
Other methods 
Other methods such as phenotypic identification, commercial systems (API 20NE or 
Biolog system), SDS-PAGE of cellular components are limited because of their 
difficulty or inability to differentiate GDG adequately (Dijkshoorn, 1996). 
1.2 Clinical importance of Acinetohacter 
Acinetohacter can be found widely in the environment, for example in soil, water and 
sewage (Baumann, 1968; Henriksen, 1973; Houang et al., 2001), raw food such as 
‘vegetables, fish and meat (Gennari and Lombardi, 1993; Hounag et al, 2001) and on 
human skin as parts of the normal flora (Berlau et al, 1999; Chu et al., 1999). They 
are ubiquitous in the hospital environment and carried on superficial sites of hospital 
‘ s ta f f and patients (Bergogne-Berezin and Towner, 1996; Chu et al., 1999). 
J 
Nosocomial infection and its particular relevance in Hong Kong 
Acinetohacter causes opportunistic infections in patients with high risk factors such as 
immuno-suppression, ventilator-assisted respiration and the elderly or critically ill, 
particularly in ICU (Buxton et al., 1978; Hoffmann, Mabeck and Vejisgaard, 1982). It 
has been isolated from different types of opportunistic infection, including septicemia, 
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pneumonia, endocarditis, meningitis, urinary tract infections and skin and wound 
infections (Levi and Rubinstein, 1996). The increasing use of invasive operative 
procedures, the wide use of antibiotics in ICU and the weakened immunity in patients 
of advanced age or with chronic severe diseases (Bergogne-Berezin and Towner, 1996; 
Towner, 1997) are thought to contribute to the increasing incidence of Acineobacter 
infections in ICU. 
In Europe, Acinetobacter infections are usually nosocomial in origin and outbreaks 
have been mainly associated with single strains (Allen and Green, 1987; Koeleman et 
al., 1997). In Hong Kong, Acinetobacter is associated with endemic infections and is 
mostly caused by heterogeneous strains (Chu et al., 1999). The number of 
Acinetobacter bacteremic episodes per 1000 hospital admissions to our Hospital, the 
Prince of Wales Hospital, from 1987 to 1994 ranged from 0.3 to 0.6 (Ng et al, 1996). 
In another hospital, Queen Mary's Hospital, Hong Kong, the average annual 
incidence of isolation of Acinetobacter spp. from all clinical specimens was 29.8 per 
1000 hospital admissions and accounted for 5.5 to 6.2% of all positive blood cultures 
- a n d 14.8% of those from ICU (Siau et al, 1996). These figures are higher than those 
reported elsewhere (Struelens et al., 1993; Tilley and Roberts, 1994; Cisneros et al., 
1996; Christie et al., 1995). 
For many years, it has been difficult to assess the clinical significance of 
Acinetobacter infection as changes and improvements in identification procedures 
and taxonomic methods took place at different times. For example, different 
identification methods were used to study hospital outbreaks of infection by Allen and 
Green (1987) and Gerner-Smidt (1987) and they gave different results. Identification 
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of acinetobacters is often based on the database of commercial kits, such as API 20NE 
(BioMerieux, France) or Vitek - GNI (BioMerieux, France) systems but these 
systems can only differentiate a limited number of GDGs. It is therefore difficult to 
compare isolation or infection rates obtained in different centers which use different 
methods of identification. 
Many studies have showed that A. baumannii (GDG 2) is the main GDG associated 
with outbreaks of nosocomial infection (Bouvet and Grimont, 1987). There is little 
information about the clinical significance of Acinetobacter species other than A. 
baumannii. Acinetobacter GDG 3 was reported in Sweden as causing an outbreak of 
infection in a neonatal ICU (Dijshoorn et al, 1993). Seifert et al. (1993) described A. 
johnsonii being associated with catheter-related bacteraemia. 
In Hong Kong, Chu et al. (1999) showed that Acinetobacter GDG 3 was the most 
common species among blood culture isolates (41%) and was commonly found on 
superficial carriage sites of the healthy and the sick. The finding was different from 
‘ those reported in Europe and North America where work has been focused mainly on 
GDG 2. Since GDG 3 is an important Acinetobacter species in Hong Kong, the work 
. i n this thesis is focused on this GDG. 
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1.3 Resistance mechanisms 
It is of great concern to the medical community and the pharmaceutical industry that 
the development of multidrug resistance in clinically important bacteria causes 
difficulties in antimicrobial therapy. It is therefore important to understand the 
mechanism of resistance, as the first step towards preventing the development of 
antimicrobial resistance. The mechanism may be intrinsic or acquired. Intrinsic 
resistance is often attributed to chromosomal transcripted mechanisms, such as the 
impermeability of the membrane, and the lack of transport systems for antibiotics 
(0'Grady et al. p 26-32). Acquired resistance is achieved by acquisition of resistance 
genes or alternations in the chromosome (mutation) (O,Grady et al. p 26-32). Genes 
can be acquired through plasmid, transposon and/or integron. Resistance can also be 
due to a combination of the above mechanisms (O, Grady et al. p 26-32). 
1.3.1 Intrinsic resistance 
Impermeability of the cell membrane 
“ Resistance due to impermeability of membrane is a non-specific mechanism. In 
Gram-positive bacteria, the thick peptidoglycan cell wall offers little resistance 
(Nikaido, 1994). Gram-negative bacteria are surrounded by an outer membrane which 
acts as an effective barrier. The barrier is composed of a lipopolysaccharide bilayer 
which physically blocks hydrophobic antibiotics from passing through the lipid 
bilayer. Therefore, changes of the composition of the lipopolysaccharide may change 
the permeability and susceptibility to an agent (Cox and Wilkinson, 1991; 0，Grady et 




Impermeability of membrane, to some extent, usually affects hydrophilic antibiotics. 
However, most hydrophilic antibiotics pass through the outer membrane by porin. 
Porins on the outer membrane are non-specific channels for diffusion of some 
essential nutrients from the external medium into the cell (Figure 1.1) and this is an 
energy independent process. It allows the diffusion of small and hydrophilic 
antimicrobial agents, such as chloramphenicol, trimethoprim, tetracycline, 
quinolones and P-lactams (Nikaido, 1994). The population of porins on the outer 
membrane may therefore affect the susceptibility of the bacterium. In Pseudomonas 
aeruginosa, the porin channel, OprD, allows the penetration of basic amino acids and 
small molecules like carbapenems (Perez et aL, 1996). The lack of or reduced 
expression of OprD results in a significantly diminished susceptibility to carbapenems 
(Margaret, Drusano and Mobley, 1987; Perez et al., 1996). 
The active efflux mechanisms 
The active efflux mechanism is an energy-requiring process and is responsible for the 
" p a s s a g e of a wide variety of unrelated substrates. It can be chromosome- or 
plasmid-coded (Nikaido, 1994). The active efflux system can be divided into four 
-families -ATP-binding cassette (ABC) (Konings and Poelarends, 2002); major 
facilitator superfamily (MFS) (Marger and Saier Jr., 1993); small multidurg resistance 
J 
family (SMR) (Grinius et al., 1992) and resistance-nodulation cell division (RND) 
family (Saier Jr., et al, 1994). Only ATP-binding cassette is ATP-dependent, while 
the others are proton-dependent. 
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ATP-binding cassette (ABC) 
Most bacterial multidrug transporters utilize the proton motive force (PMF) for 
extrusion of compounds but ABC is driven by the free energy of ATP hydrolysis. The 
best-characterized multidrug efflux pump is P-glycoprotein, encoded by the human or 
rodent mdrl gene (Endicott and Ling, 1989). Membrane fusion protein (MFP) and 
outer membrane protein (OMP) (also known as outer membrane factor, OMF) (Dinh, 
Paulsen and Saier Jr., 1994; Dong and Mergeay, 1994) are thought to function with 
ABC (Paulsen, Brown and Skurray, 1996). • 
Major facilitator superfamily (MFS) 
Membrane transport proteins in the MFS can be found in bacteria and higher 
eukaryotes, involving transportation of one specific substrate (e.g. TetB in E.coli, 
Nguyen, Postle and Bertrand, 1983) or various substrates (e.g. Bit in Bacillus subtilis, 
Ahmed et al., 1995). It is involved in drug resistance and uptake of sugar, Krebs cycle 
intermediates, phosphate antiport and oligosaccharides (Marger and Saier Jr., 1993). 
Two families, 12-transmembrane segments (TMS) and 14-TMS, under the MFS are 
‘ considered as multidrug efflux proteins (Paulsen and Skurray, 1993). The 12- and 
14-TMS families contain a variety of drug resistance proteins, and proteins of 
unknown functions. MFP and in some cases OMP are found to function with the MFS, 
such as EmrA (OMP) cooperating with the EmrB (MFP) in E. coli (Lomovskaya and 
Lewis, 1992). 
Small multidrug resistance family (SMR) 
SMR is the smallest transporter among the three proton dependent efflux mechanisms, 
with 4 TMS. The smr gene is typically located on both the conjugative and 
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nonconjugative plasmids (Leelaporn et aL, 1995). It confers resistance to a variety of 
organic cations, including quaternary ammonium compounds, and dyes, such as 
ethidium bromide (Littlejohn et aL, 1992). 
Resistance-nodulation cell division (RND) family 
RND family transporters can easily be found in Gram-negative bacteria. Such 
transporters are always associated with MFP and OMP. The AcrAB efflux system in 
Escherichia coli (Ma et al, 1993; Ma et aL, 1995) and the MexAB-OprM system mP. 
aeruginosa (Poole, Heinrichs and Neshat, 1993 ； Poole et al., 1993 ； Gotoh et al., 1995) 
are well-described efflux systems of the RND type. The proposed structure of a RND 
transporter consists of 12 TMS with two large loops between TMS 1 and 2 and TMS 7 
and 8 (Saier Jr. et aL, 1994). The RND protein displays a much wider range of 
substrate specificity, including antibiotics, toxic compounds, and dyes (Paulsen, 
Brown and Skurray, 1996) than those of the MFS or SMR. 
It appears that the efflux of toxins by bacteria is a universal phenomenon. The 
“ substrates include nitrogenous based organic and heterocyclic compounds such as 
dyes and DNA synthesis inhibitors (e.g. fluoroquinolones), other chemically 
‘unrelated nitrogenous bases such as ethidium bromide and the quaternary ammonium 
compound such as antiseptics and detergents. The wide substrate specificity allows 
i ’ 
the bacteria to defend itself against chemical damages (Silver and Misra, 1984; Silver, 
1996). There are compounds which have been shown to inhibit efflux systems, such 
as indoles (Silvia et al, 1999), reserpine (Neyfakh, 1992) and the de-energization 
agents such as carbonyl cyanide m — chlorophenylhydrazone (CCCP) (Li, Livermore 
and Nikaido, 1994). Using these agents, the functional role of the efflux system can be 
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determined by inhibiting the efflux and then studying the accumulation of the 
substrate. 
Among the transporters, the RND efflux system is responsible for the widest substrate 
specificity, and to date, the best characterized, particularly in P. aeruginosa. My work 
would be focused on the RND efflux system (objective ii). 
RND efflux systems in Pseudomonas aeruginosa and other species • 
The high level of intrinsic resistance in P. aeruginosa is partly due to the outer 
membrane composition (Nikaido, 1989) and the presence of multidrug efflux systems 
(Poole, Heinrichs and Neshat, 1993; Poole et al., 1993; Gotoh et al, 1995). There are 
at least five efflux systems that have been identified in P. aeruginosa — MexAB-OprM 
(Poole et al.’ '1993);. MexCD-OprJ (Hamzephour et al., 1995; Poole et al., 1996b); 
MexEF-OprN (Kohler, 1997b), MexXY (Mine et al, 1999) and MexJK (Chuanchuen, 
Narasaki and Schweizer, 2002). 
“ MexAB-OprM is a well characterized efflux system, MexA and MexB are members 
of MFP and RND transporter respectively. OprM is the outer membrane protein 
(OMP). The organization of the three components is shown in Figure 1.1. The 
membrane fusion protein (MexA) links the RND transporter (MexB) which is on the 
J ' 
cytoplasmic membrane, to the channel protein (OprM) on the outer membrane. The 
efflux transporter (MexB) captures molecules, including some antimicrobial agents, 
in the cell to the periplasmic space through the cytoplasmic membrane. Molecules in 
the periplasmic space are then pumped out by the outer membrane protein (OprM). 
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MexAB/OprM is a constitutively expressed system. Expression of MexAB/OprM is 
regulated by the repressor - MexR, which is located upstream to the operon of the 
efflux system (Poole et al, 1996a). Overexpression of MexAB/OprM may lead to 
multidrug resistance, as a result of mutation in nalB located in mexR, leading to a 
decreased accumulation of some antimicrobial agents such as tetracycline, 
chloramphenicol quinolones and a range of p-lactam compounds (Poole et al, 1993; 
GoXohetal, 1995; Li, Nikaido and Poole, 1995;Masuda, Sakagawa and Ohya, 1995). 
The significance of efflux pumps in multidrug resistance 
Proton-dependent multidrug pumps are widespread in both eukaryotic and 
prokaryotic cells. They are usually chromosomally coded but some are found to be 
plasmid-encoded (Leelaporn et al., 1995), indicating the ability to horizontally 
transfer multidrug resistance between organisms. A variety of multidrug systems with 
overlapping substrate specificities can be located in a single organism. For example, 
different multidrug efflux systems were identified in E.coli (for review, Paulsen, 
Brown and Skurray, 1996). The coexistence of efflux systems and overlapping of 
" substrate specificities seems to allow a minimal level of protection to the cell 
(Pumbwe and Piddock, 2000). 
Intrinsic and acquired multidrug resistance in P. aeruginosa is, to a certain extent, 
i 
attributed to the efflux pumps. They play a role in multidrug resistance for a wide 
range of substrates as shown in Table 1.2. MexAB-OprM is expressed in wild-type 
cells and contributes to intrinsic multidrug resistance (Poole et al, 1993; Li, Nikaido 
and Poole, 1995). Mutation in nalB, njxB or nficC was associated with a multidrug 
resistant phenotype and an overexpressed efflux system: MexAB-OprM (Gotoh et al, 
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1995), MexCD-OprJ (Poole et al., 1996b) or MexEF-OprN (Masuda, Sakagawa and 
Ohya, 1995). 
Several mechanisms of resistance may be present to account for the resistant 
phenotype. Srikumar, Tsang and Poole (1999) observed that quinolone resistance 
might be attributed to the co-operation between gyrase mutations and an efflux system 
(MexAB-OprM) in P. aeruginosa. In another study, MexAB-OprM and the outer 
membrane barrier were found to be the main mechanisms involved in the high 
intrinsic penem resistance (Okamoto, Gotoh and Nishino, 2001). 
In E. coli and Neisseria gonorrhoeae, other multidrug efflux systems, AcrAB-TolC 
and MltCDE respectively, are found to play a role in multidrug resistance. Table 11 
shows examples of some common RND efflux systems and their substrate specificity 
in different organisms. 
Table 1.2 Some common RND efflux systems and their substrate specificity in 
different organisms. 
‘ R N D efflux 
system Organism Substrates^ Reference(s)  
A c r A B - T o l C E . coli TET, CHL, fluoroquinolone, (3-lactams, Ma et al., 1995; 
NOV, ERY, FUA, RIF Ma et al., 1993 
.MexAB-OprM P. aeruginosa TET, CHL, fluoroquinolone, P-lactams Gotoh et al., 1995; 
. (except carbapenems), NOV, ERY, FUA, Li, Livermore and 
RIF Nikaido, 1994; 
Li, Nikaido and Poole, 
‘ 1995; 
Poole et al., 1993. 
MexCD-OprJ P. aeruginosa TET, CHL, fluoroquinolone, fourth Masuda, Sakagawa and 
generation cephems Ohya, 1995; 
Poole et al., 1996b 
MexEF-OprN P. aeruginosa CHL, fluoroquinolone, carbapenems Masuda, Sakagawa and 
Ohya, 1995 
MtrCDE N. gonorrhoeae TET, CHL, p-lactams, ERY, FUA, RIF Hagman et al., 1997 
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,Figure 1.1 Diagram showing the efflux system MexAB/OprM and porin in P. 
aeruginosa. MexB and OprM are situated in the cytoplasmic membrane 
, and outer membrane respectively. MexA is the membrane fusion protein 
that links MexB and OprM and facilitates the efflux process. The efflux 
process is driven by the transmembrane proton gradient. Porin is situated 
in the outer membrane that allows small molecules as well as some drugs 




1.3.2 Acquired resistance 
Acquired resistance is seen in a population of bacteria that have become less 
susceptible to an antimicrobial agent than prior to the exposure. The resistance is 
developed as a result of changes in the bacterial genome. Mutation and selection are 
described as vertical evolution and exchange of genes between strains and species as 
horizontal evolution (Twyman and Wisden, 1998, Chapter 10 and 15). 
Vertical evolution 
Spontaneous mutation in the bacterial chromosome may allow the bacteria to become 
less susceptible to an antimicrobial agent. In the selective environment of the 
antibiotic, bacteria of the sensitive wild type are killed whereas the resistant mutant is 
able to flourish. The mechanisms of resistance acquired by mutation include the 
following: . 
- C h a n g i n g the conformation of the target protein, so that the antibiotic can no 
longer bind to the target site, such as in the case of Methicillin-resistant 
Staphylococcus aureus (MRSA). 
- C h a n g i n g the arrangement of the membrane resulting in a decrease in the 
permeability of antibiotics. For example in Pseudomonas cepacia, accumulation 
of quinolones is shown to be affected by changes in the lipopolysaccharide moiety 
. of the outer membrane (Cox and Wilkinson, 1991). 
- Changing the outer membrane permeability in the way of reducing or losing 
porins, leading to a reduction in the entry rate of antibiotics. For example, the loss 
of porin (OprD) in P. aeruginosa led to imipenem resistance (Quinn et al., 1986). 
- C h a n g i n g the expression level of some resistance genes and porins, as a result of 
mutation occurring in the regulatory genes, as in the case of overexpression of the 




Horizontal evolution is the acquisition of genes of resistance from another organism. 
Bacteria develop genetic resistance through mutation and selection (vertical evolution) 
and then transfer the resistant gene(s) to some other bacteria by means of one of the 
genetic exchange processes: conjugation, transduction and transformation. Exchange 
of genes is facilitated by the mobile genetic elements, such as plasmids, transposon 
and integron. 
Plasmids 
Plasmids are independently replicating molecules of DNA that can exist outside the 
bacterial chromosome. Plasmids have their own origin of replication and contain few 
genes. They carry a range of different genes, such as resistance genes. Plasmids can 
acquire resistance genes from transposons and gene cassettes (Hall, 1997) 
Plasmids are transmissible by conjugation, transduction via bacteriophage, or 
transformation (uptake of naked DNA). The acquistion of resistance by transduction 
is rare in nature. Tranformation of resistance factors is relatively uncommon but 
organisms such as Staphylococcus, Acinetobacter, Neisseria etc. are readily 
transformable (O,Grady et al., p 32). Conjugation is the most common method for 
J ‘ 
plasmid transfer in clinically important bacteria and the plasmids are called 
conjugative plasmids. They can be transferred within and across species, thus 
spreading resistance at a rapid rate. (Twyman and Wisden, 1998, Chapter 20). 
Several resistance genes have been identified as plasmid-coded in Acinetobacter, 
such as P-lactamases, OXA-23 (ARI-1) (Paton et a!., 1993; Scaife et al., 1995) and 
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TEM-1 (Philippon, Paul and Nevot, 1980) which hydrolyze carbapenem and 
penicillin respectively. Plasmid-coded aminoglycoside resistance genes in 
Acinetobacter have also been reported. As early as 1980, Gomez-Lus et al., reported a 
plasmid-located aac(3) responsible for gentamicin resistance and aac(6') responsible 
for amikacin and tobramycin resistance in Acinetobacter clinical isolates. 
Chloramphenicol resistance by chloramphenoicol acetyl transferase I (CAT 1) 
(Rosenthal et al., 1983) and trimethoprim resistance by dihydrofolate reductase 
(DHFR) (Amyes and Towner, 1990; Amyes, Towner and Young, 1992) can also be 
plasmid-borne. 
Transposons 
Transposons are genetic elements capable of moving themselves within the genome 
without sequence homology. They encode a protein, transposase, that catalyzes the 
transposition process. Bacterial transposons include the following types (1) simple 
transposons consisting of short inverted repeats at their ends and gene codes for 
transposase. (2) More complex transposons containing other genes in addition to the 
structure indicated for simple transposons. These additional genes may be antibiotic 
resistance genes and beneficial to the bacterial host. 
There is no special requirement at the target DNA site for inserting the transposon. 
J ‘ 
Since insertion of transposon is a random event in bacteria, it leads to rapid 
rearrangement of useful genes that are acquired as a set. More than one resistance 




Transposons can be found on plasmids, integrons and/or chromosomes and carry 
different resistance genes. The presence of inverted repeat sequences flanking the 
resistance gene suggests the resistance gene is transposable. Transponson-encoded 
aminoglycoside resistance in A. calcoaceticus was first demonstrated by Devaud, 
Kayser and Bachi (1982) and it was proposed that the transposon was chromosomally 
located. In a clinical isolate of A. calcoaceticus, insertion sequence IS 15 was found 
flanking aph(3 ’)-I on a plasmid (Goldstein et aL, 1983). The aph(3 ')-I gene was also 
found in transposons Tn6 (Berg et al., 1975) and Tn903 (Oka, Sugisak and Takanami, 
1981). Trimethoprim resistance gene, dihydrofolate reductase, dhrfla was identified 
with the Tn21-like transposons (Sundstrom and Skold, 1990). 
Integrons 
Integrons are genetip units that include genes of a site-specific recombination system 
capable of capturing and mobilizing gene cassettes. Integron consists of m//regions at 
5'-CS that encode integrase, a sull region at 3'-CS that confers resistance to 
sulphonamides, and a specific recombination site {atti) that is recognized by the 
" in tegrase . The gene cassette(s) is situated between intl and sull. The genes within the 
cassette are promoterless and the genes are co-transcribed from a common promoter, 
P a n t which is located in the 5,-CS. The structure of an integron is shown in Figure 1.2. 
^ ‘ P p • 
「ant 
intl < sull  
g Gene cassette  
5，-CS 3’-CS 
Figure 1.2 General structure of an integron. The hatched box represents the 
specific recombination site {atti site). 
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Each gene cassette includes a single gene and a recombination site known as a 59-
base element (59-be). Although the 59-base elements differ in length from 57 to 141 
bp (Recchia and Hall, 1995), they have a conserved 7 bp sequence (GTTRRRY) 
known as a core site for recombination. The structure of a gene cassette is shown in 
Figure 1.3. A variety of gene cassettes has been found, mostly as antibiotic resistance 
genes，such as different classes of p-lactamases, aminoglycoside modification 
enzymes, chloramphenicol modifying enzymes and exporters. (Recchia and Hall, 
1995). 
f ^ — — ^ 
TTRRRY G 
Figure 1.3 'Structure of a gene cassette (linearized). The black boxes indicate the 
59-be recombination site. The core site (GTTRRRY) is partly located 
at the right hand end of the 59-be and partly at upstream of the ORF. 
The gene cassette can exist in a free circular form and is able to participate in 
integration into integron. Integration occurs between the receptor site atti at integron 
and the 59-be within the cassette. Integrase recognizes the recombination sites {attI 
and the 59-be) and catalyzes the insertion as well as excision of the gene cassette into 
integron. Figure 1.4 shows the integration and excision process. Since the integation 





^ r ^ 







r—7 Gene cassette — 
intl 多 o sull  
Figure 1.4 Insertion and excision of the gene cassette into integron. Integrase 
recognizes the atti site (hatched box) of the integron and the 59-be (black 
box) of the gene cassette, and promotes the insertion and excision. 
Integrons can be found within plasmids and/or transposons. Oh et al. (2002) reported 
" that integrase genes were detected in 96% of A. baumannii studied and the presence of 
integrons was significantly associated with multiple antibiotic resistance. Different 
-resistance genes, such as aminoglycoside-modifying enzymes (Seward, Lambert and 
‘ T o w e r , 1998), p-lactamases (Chu et al, 2001; Da Silva et al., 2002) and dihydrofolate 
reductase (trimethoprim resistance gene) (Petersen et al.，2000) were found to be 
integron-borne 'm Acinetohacter. Recently, two integrons carrying different resistance 
genes have been identified in Hong Kong (Chu et al., 2001; Houang et al, submitted) 
and will be discussed under Aminoglycosides and P-lactams (1.4.2). 
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The significance of acquired resistance 
Transposons and integrons can carry different resistance genes and they have the 
ability to jump from one place to another in the genome. Transposons can also be 
integrated into integrons. Once the transposons or integrons, which contain resistance 
genes, conjunct into a conjugative plasmid (Hall, 1997), the drug resistance can be 
spread rapidly between bacterial species, thus reducing the utility of a range of 
antibiotics. Also, the movement of transposons and integrons provides a source of 
mutation in the genome and changes the function of existing sequences by placing the 
sequence in new regulatory situations. 
The process of mutation and selection (vertical evolution) in bacteria and the ability to 
exchange genes between organisms (horizontal evolution) allow the bacteria to adapt 
readily to the antibiotic environment. As a first-step to prevent the emergence of 
bacterial resistance, we must understand the mechanism(s) of resistance. 
1.4 Resistance in Acinetohacter 
‘The therapy of Acinetohacter infections can be complicated by multidrug resistance 
‘ t o a range of antibacterials, such as aminoglycosides, extended-spectrum 
cephalosporins, and fluoroquinolones (Chu et al., 2001). Resistance in Acinetohacter 
involves both intrinsic and acquired mechanisms. My thesis would be focused on the 
active efflux mechanisms which could be associated with multidrug resistance. 
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1.4.1 The efflux system in Acinetobacter 
To date, Ade ABC is the only published efflux system in Acinetobacter (Magnet et al., 
2001). Like MexAB/OprM in P. aeurginosa, ade ABC is arranged as an operon. AdeA 
is most likely to encode a membrane fusion protein, while AdeC is thought to be the 
outer membrane protein. AdeB gene encodes a protein with 1,035 amino acids and has 
the characteristic of a proton-dependent transporter of the RND type (Magnet et al., 
2001). A wide range of substrates is transported through AdeB, including 
aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol, erythromycin 
and ethidium bromide (Magnet et al., 2001). Thus, AdeB seems to recognize 
structurally unrelated compounds, and may have a role in multidrug resistance in 
Acinetobacter. The adeB gene was found in the six A. baumannii but not in the four A. 
haemolyticus strains (GDG 4) studied (Magnet et al, 2001). No further information 
on other GDGs has been published. 
The role of the efflux system can be studied by different methods, such as: (1) 
complementation study to clone the target to vector and then examination for changes 
. i n susceptibility of the target-containing and deficient vectors (Ma et al, 1993; Moore 
et al., 1999); and (2) disruption study to observe changes in susceptibility of the wild 
.type and target-disrupted strains (Hagman et al., 1997; Magnet et al., 2001). The first 
method requires cloning of the known sequence and is relatively time-consuming. 
J ‘ 
Target-disruption would be used in this project because it required only partial 
sequence and was the method used in characterizing the role of AdeABC by Magnet 
et al. (2001) (objective iii). 
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1.4.2 Other antibiotic resistance mechanisms in Acinetobacter 
In the early 1970s, nosocomial Acinetobacter infection could be treated with 
gentamicin, minocycline, nalidixic acid, ampicillin or carbenicillin but increasing 
rates of resistance to these agents were observed afterwards (Garcia et a!., 1983; 
Obana, Nishino and Tanino, 1985; Bergogne-Berezin and Towner, 1996). Many 
acinetobacters are now resistant to the commonly used antibiotics, such as 
cephalosporins of the first and second generation (Morohoshi and Saito, 1977; 
Bergogne-Berezin and Joly-Guillou, 1991), chloramphenicol and tetracyclines 
(Bergogne-Berezin and Joly-Guillou, 1991). Susceptibility remains for some 
relatively new antibiotics, such as cefotaxime, ceftazidime (third generation 
cephalosporins), imipenem (carbapenem), tobramycin, amikacin (aminoglycosides) 
and ciprofloxacin (fluoroquinolones) (Vila et al., 1993; Bergogne-Berezin and 
Towner, 1996). A summary of the major mechanisms of resistance for 
fluoroquinolones, aminoglycosides and P-lactams (cephalosporins and carbapenems) 
is given below as these agents have been described in multidrug resistance involving 
the efflux system (Table 1.2). 
Fluoroquinolones 
The mechanism of fluoroquinolone resistance is mainly due to chromosomal mutation 
‘mediating changes in the quinolone target genes: gyrA and ^rB encoding the DNA 
J ‘ 
topoisomerase II (gyrase) and parC and parE encoding the DNA topoisomerase FV. A 
decreased level of drug accumulation has also been described to lead to increased 
resistance (Piddock, 1995; Piddock, 1999). Mutations in the gyrA gene, at Ser-83 
and/or Asp-87 have frequently been found in quinolone-resistant E. coli clinical 
isolates and other gram-negative rods. Resistance to nalidixic acid often develops first, 
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before the involvement of fluoroquinolone. (Vila et al, 1994; Piddock, 1995; Houang 
et al.’ 1998). Mutations at residues Ser-80 and Glu-84 of ParC in E. coli can also be 
responsible for the decreased fluoroquinolone susceptibility (Heisig, 1996; Vila et al., 
1996). However, mutation in the gyrB and parE genes occurs infrequently in E. coli 
(Nakamura et al., 1989; Ruiz et al., 1997) and other bacteria (Piddock, 1999). In 
ciprofloxacin resistant isolates of A. baumannii, mutation at codon Ser-83 in gyrA and 
involvement ofparC have been described (Vila et al., 1995; Vila et al” 1997; Houang 
et al, 1998; Vila et <3/., 2002). . 
Quinolone resistance may result from a decrease in its accumulation inside the cell. 
This may be brought about by (1) a decrease in the membrane permeability for 
quinolone passage and/or (2) an efflux of quinolone out of the cell (Piddock, 1999). 
Fluoroquinolones are thought to cross the outer membrane primarily through the outer 
membrane porin, OmpF (Nikaido, 1994). Antibiotic resistance as a result of a loss of 
the porin has been reported in E. coli and other gram-negative species (Nikaido, 1994; 
Ardanuy et al., 1998). Changes in the lipopolysaccharide moiety of the outer 
membrane can also influence the accumulation of quinolones in P. cepacia (Cox and 
Wilkinson, 1991). As shown in Table 1.2, fluoroquinolones are common substrates 
for different efflux systems in different organisms. Srikumar, Tsang and Poole, 1999, 
observed that both the efflux pump MexAB-OprM and gyrase mutations were 
‘ responsible for quinolone resistance in Pseudomonas. 
In Acinetobacter, Magnet et al. (2001) described the efflux pump AdeABC 
responsible for multidrug efflux with a wide substrate specificity including 
fluoroquinolones. They believed that changes in the quinolone target genes were also 
thought to be responsible for the high fluoroquinolone resistance seen in the isolates 
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they studied. However, they did not confirm this by examining for mutation in the 
genes encoding the topoisomerases. 
Aminoglycosides 
Although other mechanisms such as diminished permeability or alteration of the 
binding sites have been suggested (Vila et al., 1993), aminoglycoside-modifying 
enzymes are thought to account for most resistance to gentamicin, tobramycin, 
netilmicin, amikacin and isepamcin (Miller et al., 1997) in clinical isolates of 
Acinetohacter spp. (Shannon and Phillips, 1982; Miller et al, 1995; Seward, Lambert 
and Tower, 1998). Three classes of aminoglycoside-modifying enzymes have been 
described: ^-phosphotransferases (APH), O-nucleotidyltransferases (ANT) and 
A^-acetyltransferases (AAC). APH and ANT catalyze phosphorylation and 
nucleotidylation of hydroxyl groups respectively, and AAC catalyses acetylation of 
the amino groups of the aminoglycoside. Four enzymes are commonly found in 
aminoglycoside-resistant acinetobacters: AAC(3)-I, AAC(6')-I, ANT(2") and 
APH(3')-VI. AAC(3)-I and ANT(2") tend to be plasmid-mediated in Acinetohacter 
‘ (Towner , 1997). Resistant strains may contain several different modifying enzymes, 
resulting in complex resistance phenotypes. Magnet et al, 2001, showed that 
-aminoglycosides — kanamycin, gentamicin, tobramycin, netilmicin and amikacin -
‘ w e r e substrates of AdeABC in A. baumannii. 
J. ' 
Amikacin remains an active aminoglycoside in the treatment of infections caused by 
Acinetohacter spp (Vila et al., 1999). The AAC(6')-I (Martin, Jullien and Courvalin, 
1998) and APH(3’)-VI (Lambert, Gerbaud and Courvalin, 1988) inactivate amikacin 
and are the only two enzymes thought to account for amikacin resistance in 
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Acinetobacter (Ploy et al., 1994; Vila et al.’ 1999). The presence of modifying 
enzymes can be studied by immunoblotting and DNA-DNA hybridization (Tran van 
Nhieu, Bordon and Collatz, 1992) but these methods are time-consuming. PGR 
methods of detection of the genes encoding the different modifying enzymes have 
been developed (Vanhoofer al., 1992; Vanhoofe/ al., 1993; Ploy et al., 1994). 
Recently, two new class 1 integrons were found to contain aacA4 genes in 
Acinetobacter isolates obtained from blood cultures at the Prince of Wales Hospital. 
They were bla\M?-4-aacA4 and arr-aacA4 integrons (Houang et al, submitted). In the 
integron bearing arr-aacA4, the arr gene cassette encodes rifampin ADP-ribosylating 
transferase and the aacA4 encodes aac(6')-lh. The arr gene played a significant role 
in rifampin resistance (with rifampin MIC > 32 |ag/ml in all arr positive isolates and < 
8 i^g/ml in all arr negative isolates). As mentioned above, of the 
aminoglycoside-modifying enzymes detected in Acinetobacter so far, only 
APH(3')-VI encoded by aph(3’)-VI and AAC(6,)-I encoded by aacA4 confer 
resistance to amikacin (Ploy et al., 1994; Vila et al, 1999). The aph(3 ')-VI gene was 
detected in all of the 21 isolates with amikacin MIC > 8 ^ig/ml with or without aacA4, 
whereas the presence of aacA4 alone was found in 4 isolates with MIC of 0.5 - 2 
|ig/ml of amikacin, indicating the former may play a greater role than the latter in 
conferring an increased resistance to amikacin in Acinetobacter. 
The integron bearing bla\u?-A-aacA4 will be described under p-Iactams. 
.p-lactams 
The interplay between membrane permeability, active efflux system and the 
production of p-lactamases has been studied in P. aeruginosa (Quinn et al., 1986; 
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Kohler et al., 1999; Srikumar, Tsang and Poole, 1999; Okamoto, Gotoh and Nishino, 
2001). It is thought that, in general, when enzyme-mediated resistance is high, the 
efflux status has little impact on (3-lactam susceptibility (Srikumar, Tsang and Poole, 
1999). Resistance to p-lactams is commonly associated with the production of 
P-lactamases. In Acinetohacter, penicillinase, TEM-1 (Philippon, Paul and Nevot, 
1980) and TEM-2 (Devaud, Kayser and Bachi, 1982) and cephalosporinases, ACE-1, 
ACE-2, ACE-3 and ACE-4, chromosome- and/or plasmid- coded, have been 
described to account for resistance to nitrocephin, cephaloridine, cephradine and 
penicillin G (Hood and Amyes, 1991). Carbapenem remains the most effective 
antimicrobial agent di^ainsi Acinetohacter. Only 2% of clinical isolates were resistant 
to imipenem in 1993 (Pass, Barnishan and Ayers, 1995). However, resistance to 
carbapenem has been emerging. Class D P-lactamases OXA-25, OXA-26 and 
OXA-27 (Afzal-Shah, Woodford and Livermore, 2001) were identified in 
Acinetohacter and shown to be associated with higher imipenem and meropenem 
MICs (Afzal-Shah, Woodford and Livermore, 2001). OXA-23 (ARI-1) (Donald etal., 
2000) and OXA-24 (Bou, Oliver and Martinez-Beltran, 2000) were found to have 
“ imipenem hydrolysis activity (Hornstein et al., 1997; Donald et al., 2000). 
-Besides OXA, a zinc dependent carbapenemase (metallo-{3-lactamase), IMP-2, was 
‘ f i r s t reported in A. baumannii in Italy (Riccio et al., 2000). The b!a體 gene, which 
J ' 
encodes the IMP enzyme, was a part of the gene cassette inserted into chromosome-
or plasmid-borne integrons (Arakawa et al., 1995; lyobe, Yamada and Minami, 1996; 
Laraki et al., 1999). The finding of the blam? on the gene cassettes reveals the 
possibility of dissemination of resistance to carbapenem. The enzyme IMP confers 
resistance to all carbapenems, pencillins and cephalosporins (Livermore, 1997). 
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A new carbapenemase, designated IMP-4 and showing activities against imipenem, 
meropenem and oxyimino-aminothiazolyl cephalosporins was described recently in 
our collection of acinetobacters (Chu et al., 2000; Chu et al, 2001). The blam\>.A gene 
was shown to be a gene cassette on a class I integron (Houang et al., submitted) which 
also contained: qacG encoding a small protein that confers resistance to quaternary 
ammonium compounds (Laraki et al, 1999), aacA4 encoding the aminoglycoside 
acetyltransferase (Ploy et al, 1994), and catB encoding the chloramphenicol 
acetyltransferase (Bunny, Hall and Stokes, 1995). The strain oiE.coli with the cloned 
integron fragment showed > 4 fold increase in MIC of imipenem, tobramycin and 
netilmicin (Houang et al, submitted). Examination of blood culture isolates between 
1997 and 1998 revealed the carbapenem MIC varied from 1 to > 32 |ig/ml in the 19 
blam?-A isolates (Chu et a!., 2001). Only one blaiu?-^' isolate was found to have an 
additional P-lactamase, a class D P-lactamase, indicating that IMP-4 was an important 
mechanism of carbapenem resistance in Hong Kong (Chu et al., 2001). The variation 
in carbapenem susceptibility suggested the possibility of different expression levels of 
“ t h e blaiMp.4 gene. Because of the importance of carbapenem in clinical use, the 





INTRODUCTION (PART B) 
1.5 Methods used in this study 
Study of mRNA expression levels 
Measurement of the gene expression by quantification of transcription levels of 
specific genes is commonly used to study the gene function (Zamorano, Mahesh and 
Brann, 1996; Bustin, 2000). Conventionally, methods to study mRNA expression 
include northern blotting (linger, 1992), ribonuclease protection assays (Hod, 1992) 
and quantitative RT-PCR (Souaze et al, 1996; Freeman, Walker and Vrana, 1999). 
However, the limitation of these methods includes a lack of sensitivity or specificity 
and/or intensive labor (Bustin, 2000). A novel approach to fluorescence-based kinetic 
RT-PCR and real time detection was developed recently. This technology 
significantly 'overcomes the limitations of the conventional methods such as 
reproducibility, low sensitivity and specificity (Bustin, 2000; Schmittgen et al” 2000). 
Zhang et al, (1997) reported that the intra-assay coefficient of variation for 
conventional RT-PCR was 14% while Bustin et al. (2000) reported the variability of 
- r e a l time PCR ranged 0 - 5%. RT-PCR has since been used successfully in a wide 
range of studies (Bustin, 2000) 
‘ T h e r e are basically four chemistries for real time PCR (Bustin, 2000): DNA binding 
i ' 
dyes; molecular beacons; hybridization probes; and hydrolysis probes. Among these 
methods, DNA binding dye is the simplest one, and allows generation of a melting 
curve of the amplicon to check the specificity of primers. (Lyon, 2001). The 
dissociation curve generated from real time PCR is helpful to evaluate the amplicon 
produced from the reaction (Ririe, Rasmussen and Wittwer, 1997) since the curve is 
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determined by the GC/AT ratio, length and sequence. Dissociation curves have the 
ability to distinguish products of the same length but different GC/AT ratio. It can 
differentiate products with the same length and GC content but differing in the GC 
distribution. It is superior to gel electrophoresis which can only separate products by 
size. These properties allow the dissociation curve to be used to detect different types 
of mutation rapidly (Lyon, 2001). The 5'-nuclease assay using hydrolysis probes 
(Taqman assay) is commonly used, applicable in the ABI P R I S M 7700 Sequence 
Detection System (Perkin-Elmer-Applied Biosystems) which is available in our 
laboratory. 
It is critical to include an internal standard in every RT-PCR run so that the gene 
expression from different samples can be compared. The commonly used internal 
standards include glyceraldehydes-3-phosphate dehydrogenase (GAPDH), p-actin, 
cyclophilin, and ribosomal RNA. Comparison of these internal standards by Bhatia et 
a l (1994) Zhong and Simons (1999) and Schmittgen and Zakrajsek (2000) revealed 
that ribosomal RNA is the most favorable choice. The 16s rRNA gene was applied 
-sat isfactori ly as internal control in studies on P. aeruginosa (Edwards and Saunders, 
2001) and Staphylococcus aureus (Tegmark, Karisson and Arvidson, 2000). 
. C Y B R Green assay 
Figures 1.5 a-d show the strategy of CYBR Green assay. The unbound CYBR Green 
dye produces little fluorescent signal. During the extension step in PGR, the dye binds 
to the double-stranded DNA and is measured in real time. The amount of signals, 
dependent on the initial amount of template, is increased in each extension step along 
with the polymerization reaction. 
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By determining the melting temperature (Tm) of the amplicon, the specificity of the 
reaction can be determined by increasing the temperature slowly after the PGR 
reaction. The amplicons melt markedly when the temperature reaches its Tm and 
causes a dramatic drop of the fluorescence signal. The amplification artifacts can thus 
be distinguished from the target amplicon as different Tm should be obtained from 
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1.6 Rationale of this study 
From the above discussion, it is evident that different resistance mechanisms, such as 
impermeability, efflux pump and enzyme-mediated resistance, can contribute to the 
resistance phenotype of an isolate. Work in this area has been mainly based on 
Pseudomonas spp. 
Similar information is not available for Acinetohacter spp which is an important 
opportunistic pathogen in Hong Kong (Ng et al., 1996; Siau et al, 1996). Magnet ^t 
al., 2001, studied one isolate of A. baumannii (GDG 2) and described adeABC, the 
first efflux system found in Acinetohacter. From previous studies carried out at the 
Department of Microbiology, CUHK, Acinetohacter collections of different GDG 
were available and offered the opportunity to study in cross-section the prevalence of 
adeABC and its expression in isolates of different resistance phenotypes. Sets of 
epidemiologically and clonally related clinical isolates which exhibited different 
resistance patterns would also be sought, as they could present good opportunities to 
study longitudinally the emergence of multidrug resistance. To this end, serial isolates 
“ of individual patients in ICU would be collected and examined for clonality and 
changes in resistance patterns. ICU should offer the best opportunity for the 
.emergence of resistance in bacterial population, as it has the highest consumption of 
.antibiotics per patient and therefore exerts the highest selective pressure within the 
J _ 
hospital environment. 
Since carbapenem remains the most effective antimicrobial agent against 
Acinetohacter and bla\u?-A appears to play an important role in carbapenem resistance 
in Hong Kong, the role of bla\u?-A and the resistance phenotypes would be studied. 
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Expression of blamv-A using real time RT-PCR in bla\u?A isolates with different 
ranges of carbapenem MIC (Chu et al., 2001) would be investigated. Furthermore, the 
experience gained in setting up the real time RT-PCR for bla\u?.A would be useful for 
my work in the study of the much less known gene, adeB. 
Magnet et al. (2001) also noted that AdeABC was not found in strains belonging to 
another GDG, A. haemolyticus (GDG 4), suggesting that different efflux systems 
could be present in different GDG. In Hong Kong, genomic DNA group 3 is the most 
prevalent species in clinical specimens and carriage sites (Chu et al., 2001). 
Homologues of AdeABC would therefore be sought in GDG 3 using degenerative 
primers which were complementary to the conserved motifs of the RND protein 
family. 
It is likely that the resistance phenotype of a multiresistant isolate results from the 
interplay of a number of resistance mechanisms. To validate the role of the efflux 
pump in multidrug resistance, experiments such as the measurement of accumulation 
“ of the particular antimicrobial agent inside the cell should be performed. Facilities for 
these experiments are not available in Hong Kong. Thus, to allow for a better 
• understanding of my data on the expression of AdeABC and resistance phenotypes, 
other established mechanisms of resistance to amikacin, ciprofloxacin and 
meropenem would be examined in the sets of serial isolates which showed a change in 
resistance patterns. The presence of the commonly found aminoglycoside modifying 
enzymes accounting for amikacin resistance, the metallo-p-lactamase IMP-4 for 
capabenem resistance, and the commonly found gyrase mutation accounting for 




(i) To study the correlation of bla\u?-A expression and imipenem resistance 
(a) To study the expression of blamvA in bla\y[?A isolates by real time 
reverse transcription PGR (RT-PCR) 
(b) To correlate meropenem MIC with the expression levels of bla\uvA 
(ii) To study the role of AdeABC in multidrug resistance in Acinetobacter • 
(a.l) To obtain clonally and epidemiological related sets of clinical isolates 
bearing changes in resistance patterns 
(a.2) To determine the presence of the common mechanisms of resistance 
to ciprofloxacin, amikacin and meropenem in the sets of isolates 
‘obtained in (a. 1) 
(b) To determine the presence of adeB in the sets of isolates obtained in 
(a.l) 
(c) To examine the entirety of ade ABC operon in cideB+ isolates obtained 
‘ in (ii b) 
(c) To determine the expression of adeB by real time RT-PCR in sets of 
• adeE^ isolates obtained in (ii b) 
‘ (d) To correlate the change in resistance with ade ABC expression levels in 
sets of adeB^ isolates identified in (ii b) 
(iii) To investigate other pump homologues in Acinetobacter GDG 3 
(a) To obtain homologous pump sequences by degenerate primers 
(b) To study the role of the pump homologue by target disruption 
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(iv) To study the distribution of adeB and the putative pumps in different 
Acinetobacter genomic DNA groups 
(a) To study the distribution of adeABC in different genomic DNA groups in 
Acinetobacter 




CHAPTER 2 MATERIALS AND METHODS 
2.1 Bacterial strains and isolates 
2.1.1 Isolates for studying /^fliivip-4 
Chu et al. (2001) studied 19 blood culture Acinetobacter isolates (1997-1998) 
positive for the metallo-P-lactamase bla\u?A- The MIC for blaiu?^ isolates varied 
from Ito > 32 ^ig/ml. OXA-23 (class D P-lactamase) was found in only 1 of the 19 
bla\u?A isolates and none of them were found to have OXA-24. These isolates were 
used to study the correlation between the expression of bla\u?.^ and meropenem 
MIC. 
2.1.2 Isolates for studying adeB 
To study the transcript levels of adeB, epidemiologically and clonally related isolates 
that exhibited different resistance patterns were sought from the following sources: 
2.1.2a Isolates from existing stock culture 
Blood culture isolates (1999-2000) 
One hundred and ten blood culture isolates of Acinetobacter from 70 patients 
(1999-2000), were obtained from the clinical laboratory, the Prince of Wales 
Hospital (PWH, Hong Kong, People's Republic of China) and the GDG of these 
isolates had already been determined by others using ARDRA. 
Existing sets of serial isolates 
In Dr. Houang's laboratory, there was a collection of serial isolates that were 
identified as epidemiologically and clonally related, showing differences in 
antimicrobial susceptibility (Houang et al., 1998). 
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2.1.2b New isolates for this study 
Intensive care unit (ICU) 
One hundred and forty five Acinetohacter isolates from ICU (7.2000-2.2001) were 
collected from the clinical laboratory, the Prince of Wales Hospital. They were 
identified by standard routine laboratory methods. 
2.1.3 Isolates for investigation of other efflux pump(s) in 
Acinetohacter GDG 3 
2.1.3a Isolate for detection of adeB homologue in GDG 3 isolate 
A GDG 3 Acinetohacter isolate (IN 4365) from a blood culture dating 1997 was 
used in finding adeB homologue. 
« 
2.1.3b Isolate for 它忍-disruption 
Ten ampicillin sensitive isolates from the stock collection in Dr. Houang's laboratory 
were used to select the isolate for adeB-disvupi\on. 
2.1.4 Isolates for studying the distribution of efflux pumps 
, 2 ,1 .4a Blood culture isolates (1997-2000) 
Two hundred and seventy one blood culture isolates of Acinetohacter (1997-2000) 
were obtained from the clinical laboratory at Prince of Wales Hospital. All the 
isolates were identified to GDG by ARDRA and the MIC was determined by others 
(Chu et al., 1999; Houang et al., 2001). The DNA templates from these isolates were 
used to study the distribution of adeB, adeE and adeY. 
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2.1.4b GDG 3 acinetobacters from different sources 
One hundred and eighty six GDG 3 acinetobacters from different sources, including 
surveillance (52)，clinical (114) and environmental samples (20), collected by others, 
were used to study the distribution of adeE. Surveillance isolates included those 
from carriage sites of clinical staff such as nurses and medical students at Prince of 
Wales Hospital (Chu et al., 1999). Clinical isolates included those from all type of 
clinical specimens from patients in ICU and wards, and blood culture isolates (Chu 
et al., 1999; Houang et al., 2001). Environmental isolates were from soil and 
vegetable samples (Houang et al., 2001). 
2.1.5 Reference strains 
A. haumannii strain BM4454 which had been identified as containing the 
resistance-nodulation-cell-division (RND) efflux pump (Magnet et al. 2001) was 
used in this project as a positive control for adeB detection and PGR mapping of the 
operon of AdeABC. This reference strain was a gift from Dr. T. Lambert, Unite des 
Agents Antibacteriens, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, 
France. 
Acinetobacter strain 74510 from Houang and co-workers was used as a positive 
control for bla\u?A gene detection. 
The control strains used for minimum inhibitory concentration (MIC) determination 




2.2.1 Sources of materials 
Table 2.1 List of antimicrobial agents 
Antibiotic name Source 




Ciprofloxzcin Bayer, Elberfeld 
Erythromycin Sigma . 
Gentamicin Sigma 
Meropenem Zeneca pharmaceuticals, Wilmington, USA 
Rifampin Sigma 
Tetracycline Sigma 
Table 2.2 List of antibiotic discs 
Antibiotic Concentration Source 
Methicillin (MET) ^ Oxoid, Basingstoke, Hampshire, UK 
Oxacillin (OXA) l|ig Oxiod 
Peperacillin (PRL) 100|ig Oxiod 
Imipenem (IMP) lOfig Oxiod 
Meropenem (MER) lO^g Oxiod 
" C e f e p i m e (EFP) 30|ig Oxiod 
Cefotaxime (CTX) 30|ig Oxiod 
Cefoperazone (CFP) 75|ig Oxiod 
Ceftazidime (CAZ) 30fig Oxiod 
“Cefuroxime (CXM) 30|ig Oxiod 
, A m i k a c i n (AMK) 30|ig Oxiod 
Gentamicin (GEN) 10|ig Oxiod 
Netilmicin (NET) 30^g Oxiod 
Neomycin (NEO) 30fig Oxiod 
Tetracycline (TET) 30|ig Oxiod 
Ciprofloxacin (CIP) 5|ig Oxiod 
Nalidixic acid (NAL) 30f^g Oxiod 
Ofloxacin (OFX) 30|ig Oxiod 
Chloramphenicol (CHL) 30^g Oxiod 
Rifampin (RIF) Oxiod 
Sulfamethoxazole (SXT) 25|ag Oxiod 
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Table 2.3 List of chemicals 
Chemical Source 
Absolute alcohol Merck,Frankfuther Strasse, Germany 
Acetic acid Merck 
Boric acid Sigma, ST, MO, USA 
Bromophenolblue BDH ChemicalsLtd., Poole, UK 
Calcium chloride Merck 
Choroform Merck 
Dthylenediaminetetraacetic disodium salt (EDTA) Amersham Pharmacia Biotech, Upsala, Sweden 
Ethidium bromide Sigma 
Glycerol Merck 
Hydrochloric acid Sigma 
2-mercaptopropionic acid Sigma ‘ 
Sarkosyl (N-Lauroyl-Sarcosine) Sigma 
Sodium chloride BDH 
Sodium dodecyl sulphate (SDS) Sigma 
Tris-base Sigma 
Table 2.4 List of Enzymes 
Enzyme 
Alu\ Boehringer Mannheim, Mannheim, Germany 
Apal New England, Biolabs, Beverly, USA 
ApaLl New England 
Cfol New England 
- DNasel, RNase-free Roche, Mannheim, Germany 
EcoRI Amersham Pharmacia Biotech, Uppsala, Sweden 
Hhal Amersham Pharmacia 
Hindi New England 
. Hindlll Amersham Pharmacia 
Hinfl New England 
‘ Mbol Boehringer Mannheim 
'M-MLV reverse transcriptase GibcoBRL®, Life Technologies, CA, USA 
Msel New England 
Mspl Boehringer Mannheim 
Poteinase K USB, Cleveland, USA 
Rsal Boehringer Mannheim 
Taq DNA polymerase Amersham Pharmacia 
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Table 2.5 List of commercial media and others materials 
Source 
Media 
Brain heart infusion (BHI) broth Oxoid, Basingstoke, Hampshire, UK 
Lab-Lemco powder Oxoid 
MacConkey agar Oxoid 
Muller-Hinton (MH) Oxoid 
Nutrient agar Oxoid 
Peptone Oxoid 
Markers 
100 base pair ladder Amersham Pharmacia 
A- DNA Amersham Pharmacia 
X DNA-PFGE marker Amersham Pharmacia 
Gels 
EZ Squeeze™ Gene-PAGE-PLUS™ FMC BioProducts, Rockland, Maine, 
Pulse field certified agarose CA, USA 
Seakem(S)LE agarose Amersham Pharmacia 
Other reagents 
DNA Polymerization mix Amersham Pharmacia 
One-Phor-All Buffer PLUS Amersham Pharmacia 
PGR primers Invitrogen™ Life Technologies, CA, 
PCR probes (real time PGR) 0秘 e t , Paris, France 
PGR reaction buffer Amersham Pharmacia 
Random Primers Promega, Madison, USA 
Recombinant RNasin® Ribonuclease Promega 
_ Inhibitor 
.Table 2.6 List of commercial kits 
Kit Source 
‘RNeasy Mini Kit Qiagen, CA, USA 
TaqMan^'^ PCR Core Reagent Kit Applied Biosystems, New Jersey, USA 
CYBR® Green PCR Core Reagents Applied Biosystems 
Universal GenomeWalker^^ Kit Clontech BD Biosciences, CA, USA 
Original TA cloning® Kit Invitrogen, CA, USA 
Nucleo Spin® Macherey-Nagel, Germany 
SequiTherm EXCEL™II Long-Read^'^ Epicentre Technologies, Madison, 
DNA Sequencing Kit-ALF™ Wisconsin 
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2.2.2 Buffers and solutions 
All the buffers and solutions were prepared with ddHsO and stored at room 
temperature after autoclaving at 121°C and 15 psi for 15 min unless otherwise 
stated. 
0.5M EDTA 
0.5M Na2EDTA.2H20 / lOM NaOH (pH8.) 
Lysis buffer 
1% (w/v) N-lauroyl sarcosine / 0.5M EDTA pH9.5 
Proteinase-K stock 
Dissolve 1 OOmg of Proteinase-K powder into 2ml ddHiO then aliquoted and kept at 
-20�C. 
RNase stock 
Ribonuclease I "A" Bovine pancreas was prepared as a 1 Omg/ml stock solution with 
ddH20 and boiled for 15 min, then aliquoted and kept at -20°C. 
Sample buffer (x5) ‘ 
25% (v/v) glycerol, 0.5% SDS, 50mM EDTA,0.05% (w/v) bromophenol blue 
SE buffer 
75 mM NaCl / 25 mM EDTA, pH 7.5 
‘ S o l u t i o n I 
50mM, glucose / 25mM Tris / lOmM EDTA pH8.0 
‘Solution II 
‘ 0 . 2 M NaOH/l%SDS 
Solution III 
3M sodium acetate 
IQx TBE 




lOOmM Tris / lOmM EDTA (pH7.6) 
IM Tris/HCL 
IM Tris / concentrate HCl (pH7.6) 
2.3 Instruments and software 
Table 2.7 List of instruments and softwares 
Manufacturer 
Instruments 
ABI Prism® 7700 Sequence Detection Applied Biosystem, CA, USA 
System 
Automated'laser DNA sequencer Amersham Pharmacia Biotech 
(ALFexpress) ‘ 
Automatic Multiple inoculator Dynatech, Denley, UK 
MIC-2000 
Bio-Rad 500-200V powder supply BioRad, CA, USA 
Biofuge Heraeus Sepatech, Osterode, West 
Germany 
Centrifuge MSE MicroCentaur Sanyo, UK 
“ Gel documentation system Amersham Pharmacia Biotech 
(ImageMaster VDS) 
GNA-100 and 200 gel apparatus Amersham Pharmacia Biotech, Uppsala, 
Sweden 
‘ Pulse field electrophoresis system with Bio-Rad 
CHEF mapper 
Spectrophotometer Lambda Bio-40 PerkinElmer Instruments, CT, USA 
‘ Thermal controller (Gene Amp PCR Perkin Elmer, Boston, USA 
system 9600) 
Software 
BioNumerics version 2.0 Applied Maths, Kortrijk, Belgium 
SPSS, version 11.0 Prentice Hall, New Jersey  
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2.4 General bacteriological techniques 
2.4.1 Bacteriological identification 
Acinetobacters collected from the clinical laboratory at the Prince of Wales Hospital 
were stored on nutrient agar slant at room temperature. The identity of 
acinetobacters was re-checked based on the following criteria: gram-negative 
coccobacilli, non-motile in hanging drop preperation, and oxidase-negative. 
Gram stain 
A fresh colony from MHA was streaked slightly onto the slide and then heat-fixed. 
The prepared slide was flooded with crystal violet for 1 min. After washing the stain 
with distilled water, the slide was flooded with iodine solution for 1 min which was 
then washed away with water. Using 95% alcohol the smear was washed until the 
droplets were no longer purple (about 10-15 sec). After washing the slide with water, 
it was counterstained with Safranin for 2 min. The slide was washed with water, 
blotted dry and then examined under oil immersion lens. Pink (Gram-negative) 
coccobacilli should be observed for Acinetobacter. 
Motility test 
Young broth cultures of the organism (incubated at 30°C for 4 hr) were examined in 
, "hanging drop" preparations. Motile organisms move about in the field, and this is to 
be distinguished from Brownian movement, which is an oscillatory movement 
possessed by all small bodies suspended in fluid (Cowan, Barrow and Feltham, 




Colonies were streaked slightly on filter paper soaked with a drop of oxidase reagent 
(O.lg of tetramethyl-p-phenylene-diamine dihydrochloride in 10 ml distilled water). 
A positive result would be indicated by the color changes to purple. Acinetobacter is 
oxidase negative. 
2.4.2 Stock isolates 
Storage at -70°C 
Acinetobacters for further study were stored at -70°C. Isolate to be stored was 
sub-cultured on MHA and incubated at 37�C overnight. Colonies obtained were 
stored in glycerol broth at -70°C. 
2.4.3 Retrieval of isolates 
Isolate to be studied was retrieved from -70°C stock and was sub-cultured on 
Muller-Hinton agar (MHA), MacConkey agar (MAC) or brain heart infusion (BHI), 
depending on the purpose of the study, and incubated at 37°C overnight. 
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2.5 General molecular biology techniques 
2.5.1 Agarose gel electrophoresis 
2.5.1a Preparation of agarose gel 
Depending on the percentage of the gel, suitable amount of agarose was weighted 
into a conical flask. Appropriate strength and volume of Tris-borate-EDTA (TBE) 
buffer was added. The agarose with buffer was then melted by using a microwave 
oven. The melted agarose was left to cool to about 50°C and then poured into a gel 
casting tray with combs. The gel was left to set at room temperature for about 30 
min. 
2.5.1b Gel electrophoresis 
Samples were mixed with a 5x concentrated sample buffer and loaded into the slots 
of the gel in a TBE buffer with the gel tank GNA-2000 and a 3 00-200V power 
supply. The agarose concentration and time of running were adjusted according to 
the size of the fragments being separated. For higher resolution, a large tray (25 x 25 
cm) was used. Gel of 2% w/v agarose was used to separate fragments with sizes 
under 2 kb running for 2 hr, and 1% for sizes above 2 kb running for 1 to 1.5 hr. 
DNA ladder 100 base-pair were loaded on each gel as size standards. 
, 2.5.1c Gel staining and documentary 
After electrophoresis, the gel was stained with 0.5fil/ml ethidium bromide solution 
for about 15min. For a clearer picture, the gel was destained with distilled water 
(DW) for 10 min or more. Stained gels were UV transilluminated and the images 
were captured by a gel documentation system (ImageMaster VDS) and saved the 
images as .tif files. 
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2.5.2 Polymerase chain reaction (PCR) 
2.5.2a Template preparation for PCR 
Templates used for PCR were prepared by quick boil-lysis method, unless otherwise 
specified. Bacteria were grown on MHA at 37 °C overnight. A loopful of 2-5 
colonies was suspended in 300|al ddH^O, and then boiled at 100°C for 5min. The 
suspension was agitated thoroughly and centrifuged for Imin in a high speed 
(13000xg) microcentrifuge to spin down the cell debris. The supernatant bacterial 
DNA was used as template for PCR. 
2.5.2b PCR 
The amount of reaction mixture and the PCR condition used were depended on the 
need of each assay and specified individually. 
2.5.2c Gel electrophoretic analysis of PCR products 
The following electrophoresis parameter was used for all PCR products analysis, 
unless otherwise stated. PCR products were separated electroporetically on 1% 
agarose gel. Each sample (2.5^1) mixed with l^il 5x sample buffer which was loaded 
and electrophoresed using Ix TBE buffer system at 150 V for a large tray or 75V for 
a small tray for 1.5 hr. Also, DNA size standard markers (100-bp ladder standard 
markers) were loaded into each gel for size comparison. The gel was stained with 
ethidium bromide and photographed by the documentation system (see 2.5.1c). 
50 
CHAPTER 2 
2.5.3 Amplified Ribosomal Restriction DNA Analysis (ARDRA) 
The ARDRA method was performed as described by Vaneechoutte et al. (1995) with 
minor modification. 
Template 
Template preparation for ARDRA was same as described in 2.5.2a. 
PCR 
A pair of primers, derived from conserved regions at the edges of the 16S rDNA 
(Rossau et al, 1991), was used and the sequences were as follows: ARDRA 1, 
5’-TGG CTC AGA TTG AAC GCT GGC GGC-3 ’�and ARDRA2, 5'-TAG CTG 
TTA CGA C f l CAC CCC A-3'. 
Amplification reactions were done in a thermal cycler and a total volume of 50|al 
was used. Reaction mixture contained 0.2U ofTaq DNA polymerase, O.ljaM of each 
primer (ARDRA 1 and ARDRA2), 100|aM of each deoxyribonucleoside triphosphate, 
‘ a n d Ix PCR buffer. 
PCR was performed with an initial denaturation of 5 min at 95°C, followed by 35 
.cycles of 45 sec at 95°C, 45 sec at 65°C, and 2 min at 72�C, and a final extension of 
‘ 6 m i n a t 7 2 ° C . 
For those samples without a desirable PCR product, another amplification reaction 
was performed. The reaction was initially denatured for 5 min at 95°C, followed by 




Agarose gel electrophoresis 
Amplicons were separated electrophoretically on 1% agarose gel. Mixture of 
PCR product and 2fil 5x sample buffer was loaded and electrophoresed using a 0.5x 
TBE buffer system at 150V for 1.5hr. The gel was stained and photographed (see 
2.5.1c). The amplicon size was estimated to be 1500 bp. 
Restriction digestion 
Restriction digestion of the PCR products was carried out at 37°C overnight in a 
total volume of 20^1 of commercially supplied reaction buffer and 5U of one of the 
following enzymes: Alu\ (AGCT), C/oI (GCGC), Rsal (GTAC), Msp\ (GATC)�and 
Mbo\ (GATC), and 3 to lO^il of amplicons. The volume of amplicons used in the 
restriction mixture depended on the visual intensity observed in the gel. Restriction 
digestion was stopped by adding 5|j.l of 5x sample buffer. Each digested sample of 
12.5|LIL was loaded in 2% agarose in 0.5x TBE buffer for electrophoresis for 1.5hr. 
All the gels were stained and photographed (see 2.5.1c). 
Analysis of restriction digestion results 
Restriction patterns generated were coded according to the scheme of Vaneechoutte 
et al (1995), and Dijkshoorn et al (1998) in Appendix 1. The combination of the 
five restriction patterns constituted the ARDRA profile. The GDG was identified by 
matching its profile with the existing database of ARDRA profiles (Dijkshoorn et al., 
1998; Appendix 2). 
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2.5.4 Pulsed field gel electrophoresis (PFGE) 
Embedding of intact genomic DNA into agarose blocks 
5 to 10 fresh colonies from MHA (see 2.4.3) were suspended in 500|il SE buffer. 
The cell was washed by brief centrifuging, discarding the supernatant and 
resuspending the cell in another 500|il SE buffer. The washing step was repeated 
once and the pellet was finally resuspended in 200|il SE buffer. 
Sterilized 2% (w/v) low-melting agarose in SE buffer was boiled to melt. The melted 
agarose was kept at 60°C in a water bath. Equal volumes of melted agarose and 
bacterial suspension were mixed gently and thoroughly. The mixture was transferred 
into the slots of the mold. Two blocks were prepared per isolate. The DNA 
embedded agarose blocks were allowed to set at 4°C for about 10 min. 
Lysis of genomic DNA embedded in agarose blocks 
For each pair of blocks, 500|LI1 lysis buffer plus 500|ag/ml of Proteinase-K were 
prepared in an 1.5ml microfuge tube. The set blocks were pushed into the lysis 
buffer and incubated at 56°C in a water bath overnight. After incubation, the lysis 
buffer was replaced with fresh lysis buffer containing the same amount of 
Proteiriase-K. The blocks were again incubated at 56°C overnight. TE buffer was 
used to wash the lysis buffer after incubation. The washing step took place at 4°C 
‘ and was repeated at least 3 times to ensure the preparations were free of residual 
lysis buffer. 
Restriction digestion of DNA in agarose blocks 
For each reaction, 100|xl of reaction buffer was prepared by diluting the lOx 
commercially supplied reaction buffer to Ix concentration. Two pieces of about 
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1mm thickness were cut from the block and placed into the buffer and stored at 4°C 
for about 3hr. 
The restriction enzyme Apal (GGGCCC) was used for the in situ digestion of the 
intact Acinetobacter genomic DNA embedded in the agarose blocks. For each 
reaction, 20U of Apal in 100|il of reaction buffer was used to replace the reaction 
buffer. The reaction was pre-incubated at 4°C overnight for diffusion and then 
transferred to 37°C water bath for 4 hr or more. 
Agarose gel for PFGE 
Pulsed field certified agarose was used for PFGE. For 200ml 0.5x TBE buffer, 2g of 
agarose was weighed to make up a gel concentration of 1% (w/v) in a 500ml conical 
flask. Agarose was melted in a microwave oven. The melted agarose was left to cool 
down to about 50°C. After assembling the gel tray with a comb, the agarose was 
poured to the gel tray and left about 5ml agarose in the conical flask. The gel was 
allowed to set for at least 30 min. 
The portion of the block to be loaded was tipped with a scalpel blade. The block was 
pushed into the appropriate well and placed carefully flat against the leading edge. 
Beside the samples, 4 pieces (of about 1mm thickness) of molecular weight marker 
were included in each gel for standardization. Two internal controls with known 
, PFGE fingerprints were also included in each gel electrophoresis. The slots were 
then sealed with the remaining agarose. The gel was allowed to set for about 15min. 
PFGE fingerprints were generated using a Contoured-clamped homogeneous electric 
field electrophoresis (CHEF) apparatus. Electrophoresis was undertaken in 0.5x 
TBE buffer at electric field 6 V/cm, included angle 120°, pulse time 5 to 35sec over 
32hr at 14°C. 
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Staining PFGE gel 
After electrophoresis, the gel was stained with 0.5^1/ml ethidium bromide solution 
for about 1 hr. Then it was decolorized with distilled water for Ihr and then UV 
transilluminated and documented as .tif file. 
Interpretation of gels 
Gel pictures were analyzed using BioNumerics version 2.5. Following conversion, 
normalization with molecular weight standard markers, and background subtraction, 
comparison matrices of the Dice coefficient were generated and dendrograms were 
constructed using the Unweighed Pair Group method using Arithmetic Averages. 
2.5.5 Minimal inhibitory concentration (MIC) 
A two-fold dilution'of antibiotics was used for the preliminary MIC determination. 
For those isolates taken for further analysis, a more precise MIC was determined by 
using two series of double dilutions, i.e., one at 2，4, 8 and at 3, 6, 12ug/ml of the 
antimicrobial agent. 
The MIC was determined by agar dilution method according to the National 
Committee for Clinical Laboratory Standards (NCCLS, 1999). Antimicrobial agents 
used for different studies are shown in Table 2.8. Plates with the desired 
concentration were prepared by adding appropriate volumes of antibiotics into MHA 
to give the required final concentrations. 
Fresh colonies from MHA (see 2.4.3) were adjusted to a turbidity matching that of a 
MacFarland 0.5 standard using sterile 0.9% saline. The bacterial suspensions were 
then diluted to 1 in 10 dilution, 20|il of bacterial suspension were diluted with 180|il 
sterile 0.9% saline, as the inoculum. MIC-2000 inoculator was used to deliver 
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approximately lO^ colony forming unit (cfu) onto antibiotic-containing plates. The 
agar plates were incubated at 37®C for 18 hr. 
The lowest concentration of antibiotic that inhibited growth of the strain was taken 
as the minimal inhibitory concentration. 
Table 2.8 Antimicrobial agents used in the study of adeB in sets of isolates 
and the role of adeE in target disrupted mutant. 
Antimicrobial agents used 
Study of adeB in sets of Study the role of adeE • 
Antimicrobial agents isolates (see 2.6) (see 2.9.5) 
Amikacin (AMK) 7 7 
Ceftazidime (CAZ) Z 
Chloramphenicol (CHL) / Z 
Ciprofloxacin (CIP) Z Z 
Erythromycin (ERY) Z 
Ethidium bromide (EBR) / V 
Gentamicin (GEN) / 
Meropepem (MER) •/ •/ 
Rifampin (RIF) Z Z 
Tetracycline (TET) •/ •/ 
2.5.6 Antibiotic sensitivity test - disc diffusion test 
Fresh . colonies from MHA (see 2.4.3) were used as inoculum. The bacterial 
‘suspension was adjusted with sterile 0.9% saline to a turbidity matching that of 
MacFarland 0.5 standard. The bacterial suspension was applied evenly on MHA. 
Paper discs impregnated with antibiotic were placed on the surface of the plate. 
Plates were incubated at 37°C overnight. Zone diameters of inhibition were 
measured in mm. Antibiotics used for different studies are shown in Table 2.9. 
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Table 2.9 Antibiotic discs used for the study of adeB in sets of isolates and 
for the study the role of adeE. 
Antibiotics used 
. . Study of adeB in sets of Study the role of adeE 
她 議 c s isolates (see2.6.2) (see 2.9.5) 
Penicillins 
Methicillin (MET) / 
Oxacillin (OXA) Z 
Piperacillin (PRL) / 
Carbapenems 
Imipenem (IMP) / 
Meropenem (MER) / 
Cephalosporins 
Cefepime (EFP) Z • 
Cefotaxime (CTX) ‘ / 
Cefoperazone (CFP) Z 
Ceftazidime (CAZ) 7 
Cefuroxime (CXM) 
Aminoglycosides 
Amikacin (AMK) / / 
Gentamicin (GEN) Y Z 
Netilmicin (NET) 7 
Neomycin (NEO) Z 
Tetracyclines ‘ 
Tetracycline (TET) ^ 
Quinolones 
Ciprofloxacin (CIP) 7 
Nalidixic acid (NAL) / 
Ofloxacin (OFX) / 
Others 
•“ Chloramphenicol (CHL) Z Y 
Rifampin (RIF) Z / 
Sulfamethoxazole (SXT) / 
‘ 
2.5.7 Detection of the presence of the common resistance 
mechanisms 
Common mechanisms of resistance to aminoglycosides {aph(3 ')-VIa and aac(6')-Ib), 
capabenems (^ /fliMP-4), fluoroquinolones (mutation of gyrA and parC) and others 
{integrase I and ^/rr-aac A4) were detected in sets of serial isolates. 
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2.5.7a Detection of aph(3')-VIa, aac(6，)-Ib by PCR 
Primers 5，-ATA CAG AG A CCA CCA TAG AGT-3’ and 5,-GGA CAA TCA ATA 
ATA GCA AT-3’ (Vila et al. 1999) were used to detect the aph(3，)-VIa gene in 
Acinetohacter with amplicon 250 bp. Primers 5'-ATG AAT TAT CAA ATT GTG-3' 
and 5'-TTA CTC TTT GAT TAA ACT-3’ (Ploy et al 1994) were used to detect the 
aac(6')-Ib gene with amplicon of 395 bp. 
Each reaction was carried out in a total volume of 25^1 containing 0.2|iM of each 
primer, lU oiTaq DNA polymerase, lOOjjM of each deoxynucleoside triphosphate, 
Ix PCR buffer and 3|al of DNA template (see 2.5.2a). 
PCR was performed in a thermal cycler, with an initial denaturation at 95°C for 5 
min, followed by 35 cycles of 40 sec at 95°C, 1 min at 58°C and 1 min at 72°, and a 
final extension of 7 min at 11�C. Products obtained were analyzed by gel 
electrophoresis (see 2.5 2c). 
2.5.7b Detection of /^fliMP-4? integrase I and flrr-aacA4 by PCR 
Primers 5'-ATG AGC AAG TTA TCT GTA TTC T-3, (IMPll) and 5'-AGT GTG 
TCC CGG GCC ACC-3' (IMP 12) (Chu et al., 2001) were used for blamp-4 detection. 
Amplicon 474 bp should be obtained from positive isolates 74510 (Chu et al., 2001). 
Primers 5'-TCG TAG AGA CGT CGG AAT GG-3' (Intle) and 5'-CCG AGG CAT 
AG A CTG TAC AA-3' (IntlB) were used for detecting the presence of integrase I 
with amplicon size of 965 bp from positive isolates 74510 (Houang et al., submitted). 
For detection ofarr-aacA4, primers 5，-CAT CCA AGC AGC AAG CGC GTT A-3' 
(intlB) and 5'-TGC TAC GAG AAA GCG GG-3，(aac6IbB) of 1180 bp amplicon 
were used (Houang et al., submitted). 
The reaction was carried out in a total volume of 25\x\ containing 0.2jiM of each 
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primer, lU oiTaq DNA polymerase, lOO i^M of each deoxynucleoside triphosphate, 
Ix PCR buffer and 3|ul of DNA template (see 2.5.2a). 
The reaction was performed in a thermal cycler and the mixtures were heated to 
94�C for 2 min and then subjected to 35 cycles of 94�C for 30 sec, 58°C for 30 sec, 
and 72°C for 30 sec, followed by a final extension for 3 min at 72°C. Products 
obtained were analyzed by gel electrophoresis (see 2.5.2c). 
2.5.7c Detection the mutation of gyrA and parC 
PCR 
Primers 5,-AAA TCT GCC CGT GTC GTT GGT-3' and 5，-GCC ATA CCT ACG 
GCG ATA CC-3’ were used to amplify a 343 bp fragment of the gyrA gene (Vila et 
aL, 1995). For the parC gene, primers 5'-AAA CCT GTT CAG CGC CGC ATT-3’ 
and 5'-AAA GTT GTC TTG CCA TTC ACT-3，were used to produce product with 
327 bp (Vila et al, 1997). 
PCR were carried out in a total volume of 25|j.l containing 0.5|aM of each primer, 
0.5U of Tag DNA polymerase, 200|^M of each deoxynucleoside triphosphate, Ix 
PCR buffer and l|ul of template (see 2.4.2). 
PCR mixtures were heated for 5min at 94°C, followed by 30 cycles of 1 min at 95°C, 
1 min at 50°C and 1 min at 72°C. The reaction was finished with a final extension 
step for 5min at 72°C. The products were analyzed by gel electrophoresis (see 
2.5.2c). 
Restriction Digestion 
PCR products obtained were restriction-digested with Hinfl (GANTC). For the gyrA 




uncut (343 bp). For the parC gene, wildtype strain yielded products 206 and 121 bp, 
while mutant remained uncut (327 bp). The products were analyzed by gel 
electrophoresis (see 2.5.2c). 
2.5.8 TA cloning 
Original TA Cloning Kit was used to clone the PCR products of interest into vector 
pCR®2.1 in this project. Plasmids were extracted from putative clones for further 
characterization. Restriction digestion to release the insert and PCR detection of the 
insert were used to determine the presence and the size of the insert. 
Ligjation 
A ligation reaction was carried out in a total volume of 10|il reaction mixture, 
containing lfj.1 T4 DNA ligase, Ix ligation buffer, 50ng pCR®2.1 vector and fresh 
PCR product. The amount of PCR product added depended on the intensity of 
amplicon visualized in the gel picture, and usually l-2|j.l of fresh PCR product was 
added. The reaction mixture was incubated at 14°C water bath overnight. 
Transformation 
Competent cell TOPI OF' provided by the kit was defrosted on ice. The ligation 
mixture was added and mixed very gently into the competent cell. The reaction 
mixture was placed on ice for 30 min and then heat shocked for exactly 30 sec in 
42°C water bath and kept on ice afterward. The reaction mixture was mixed with 
250|al SOC medium and shake at 37°C for Ihr. 
An appropriate amount (usually 50^1) of the reaction mixture was spread onto LB 
plates, containing 50|ag/ml ampicillin, 40|al of lOOmM IPTG and 40mg/ml X-Gal. 
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Plates were incubated at 37°C overnight. After incubation, plates were placed at 4°C 
for several hr for color development. 
Plasmid Extraction 
Putative clones (white colonies) were picked and inoculated in BHI and shaked at 
37°C overnight. About 1.4ml of culture was poured into a 1.5ml microfuge tube and 
was centrifuged at 12,000xg for 30sec. The medium was decanted as completely as 
possible. The pellet was re-suspended in 100|il of ice-cold Solution I. The dispersed 
bacterial mixture was mixed with 200fil freshly prepared Solution II by inverting the 
tube several times. Then 150|LI1 of ice-cold Solution III was added and mixed gently 
for about lOsec by vortex and the lysate was stored on ice. The bacterial lysate was 
centrifuged at 12,000xg for lOmin at 4°C. Supernatant was transferred to a new 
1.5ml microfuge tube. An equal volume of chloroform, about 400|al, was added and 
mixed by vortex. After centrifuging at 12,000xg for 2min, the upper layer was 
transferred to a new 1.5ml microfuge tube. Two volumes (800|j.l) of ice-cold ethanol 
was mixed with the supernatant by vortex and then placed at 4°C for 15min or more 
to allow DNA precipitation. Precipitated DNA was centrifuged at 12,000xg for 
lOmin at 4°C. Supernatant was removed and 1ml of ice-cold 70% ethanol was used 
to rinse the pellet. After centrifuging at 12,000xg for lOmin at 4°C, supernatant was 
. poured off and the pellet was allowed to air dry. The pellet was re-dissolved in 30|il 
ofddHzO. 
Restriction digestion 
To release the insert out of the plasmid, 1 fil of plasmid was mixed with 5U of £coRI 
(GAATTC) and Ix commercially supplied reaction buffer. The volume was made up 
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to 10|Lil by ddH20. RNase (l|ig) was added to each reaction. The reaction mixture 
was incubated at 37°C for 3hr or more. The digested products were checked by 
electrophoresis (see 2.5.2c) 
PGR 
Apart from size determination of inserts by restriction digestion, the clones, 
especially with small insert size, were also analyzed by PGR using the primers 
specific to the insert. This was done because I found that the small insert released by 
restriction digestion was not obvious in gel picture. 
The conditions for the PGR reaction and parameter used were same as those used to 
amplify the product for cloning. Amplicons were analyzed by gel electrophoresis 
(see 2.5.2c). 
RNA Removal 
Plasmids (obtained from 2.5.8 - Plasmid extraction) of interest were taken to 
remove the RNA from them, by adding 5|ig RNase to the plasmids and incubated at 
room temperature for about 15min. The RNase-treated sample was checked by gel 
electrophoresis (see 2.5.2c) for the absence of smear (RNA) down the plasmid. 
. 2.5.9 DNA sequencing 
Sample to be sequenced was cloned into vector pCR 2.1 using TA cloning Kit (see 
2.5.8) and the RNase treated plasmids were used as template for sequencing using 
ALFexpress™ DNA Sequencer and Sequi/Therm EXCEL™ II Long-Read™ DNA 




Cy-5 labeled Ml3 forward (-20) and Cy-5 labeled Ml3 reverse primers were used 
for two separate sequencing reactions - forward and reverse reactions, to sequence 
both ends of the insert. 
PCR 
For each sample, a total 17|j.l volume of reaction master mix was prepared, which 
contained 7.2|LI1 of sequencing buffer, 3pmoles of Cy-5 labelled primer (either 
forward or reverse) and 5U of SequiTherm EXCEL II DNA polymerase. Depending 
on the intensity of plasmid visualized in the gel picture after electrophoresis, 3 to 9|al 
of plasmid DNA was added to the master mix and then briefly centrifuged. 
For each sample to be sequenced, 4 reactions were included (A, C, G and T), and 
4|j,l of the master rriix was added to 2\x\ of each of termination mix — A, C, G and T. 
Each reaction mixture was mixed gently and then placed on ice. Mineral oil was 
added to cover each reaction mixture. 
The reactions were carried out with an initial denaturation of 5 min at 95°C, then 
followed by 30 cycles of 30sec at 95°C, 15sec at 50°C and Imin at 72�C, and then a 
final extension of 3min at 72°C. 
After PCR reaction, 3\x\ of stop buffer was added and the reaction mixture was 
. briefly centrifuged and then stored at 4°C. 
Sequencing gel electrophoresis 
EZ Squeeze™ Gene-PAGE PLUS™ was used.—The polymerization initiator and 
polymerization catalyst discs were added into the bottle of polyacrylemide gel and 
gently mixed for about 15min. After assembling the sequencing thermal plate, the 
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gel was squeezed into the thermal plate with great care to be sure that no bubbles 
were inside the gel. The gel was allowed to set for at least Ihr. 
The reaction mixtures were denatured at 95°C for 4min and stored on ice 
immediately. Reaction mixture (about 8|il) was added to the corresponding well, 
avoiding the mineral oil on top. 
The sequencing condition was slightly modified from the programmed X-Long read. 
The elctrophoresis conditions were 1500V, 25W, 60mA for 700 min at 55°C and the 
sample interval was Isec. . 
Processing and evaluation of sequencing results 
The raw data were processed by ALFwin (version 1.0) Evaluation. The sequences 
obtained from the processed data were saved and exported in ASCII format for 
computer analysis of sequence data. 
2.5.10 Sequence analysis 
2.5.10a Translation of DNA sequence into aa sequence 
The DNA sequence was translated into aa sequence using program at the web-site of 
the Molecular Toolkit (http://arbl.cvmbs.colostate.edu/molkit/index.html). DNA 
sequence was inputed and the possible translations (6 frames) were obtained. 
2.5.10b Search for matched DNA in GenBank 
The DNA or aa sequence was searched for matched sequences at the web-site of the 




2.5.10c Alignment of sequences 
Alignment of the DNA or aa sequences was performed using the program Clustal W 
at the web-site of the European Molecular Biology Laboratory — European 
Bioinformatics Institute (EMBL — EBI, http://www.ebi.ac.uk/clustalw). 
2.5.10d Topology prediction 
Topology prediction of membrane proteins was preformed using the software 
TopPred (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html, Pasteur Institut, 
Paris, France). 
2.5.11 CYBR Green Assay 
The specificity of the primers planned for Taqman assay was determined by assaying 
the dissociation curve obtained from the CYBR Green Assay using real time PCR. 
In each reaction, a final concentration of 0.3|aM of each primer was used, consisting 
of 200|iM of each dATP, dCTP, dGTP and 400|iM dUTP, 3mM MgCb, Ix buffer 
with CYBR Green, 0.5U of Taq DNA polymerase and l|il of template. The reaction 
volume was made up to 25)il with 1% DEPC water. 
The thermal cycle condition of the CYBR Green Assay was as following: lOmin at 
95°C, then 35 cycles of 20sec at 95°C, 30sec at 58°C and 30sec at 72°. It was 
.. followed by 15sec at 95°C, 15sec at 58°C and 15sec 95°C with ramping time 19min 
59sec from 58°C to 95°C. Data collection was turned on for the programmed ramp. 
Data collected from the programmed ramp was exported as a multicomponent file 
and analyzed using ABI P R I S M ™ Dissociation Curve Analysis software. A 
dissociation curve of a plot of fluorescence signal against temperature was obtained. 
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2.5.12 Complementary DNA (cDNA) preparation 
RNA extraction 
Extraction of RNA was performed by using RNeasy Mini Kit. A fresh colony from 
MHA (see 2.4.3) was inoculated into 10ml of BHI at 37°C for 4hr with shaking. 
About 1ml of culture was taken to measure at OD o^o using spectrophotometer. The 
culture was adjusted to approximately 0.5A at OD o^o by diluting with BHI. Then 
500|LI1 of the culture was used in the subsequence extraction steps. 
The cells were harvested by centrifuging at 5000xg for 5min at 4°C and the 
supernatant was removed. The pellet was re-suspended in 100^1 of TE buffer 
containing 400|ag/ml lysozyme, and incubated at room temperature for 5min. The 
suspension was mixed with 350 RLT buffer using vortex. Then 250faL of absolute 
ethanol was added to the lysate and mixed gently. The lysate with ethanol was 
transferred to a RNeasy mini column placed in a 2ml collection tube. It was 
centrifuged at 12,000xg for 15sec at room temperature. The flow-through was 
discarded. Then 700|j.l of RWl buffer was added to the column and the 
centrifugation step repeated. Flow-through was discarded and a new 2ml collection 
tube was used. Then 500|LI1 of RPE buffer was loaded onto the column. It was 
centrifuged at 12,000xg for 2min. To remove residue buffer, it was centrifuged again 
. at- 12,000xg again for Imin in a new collection tube. Lastly, 40|al of RNase-free 
water was added on the membrane of the column and then centrifuged at 12,000xg 
for Imin to elute the RNA from the column. 
Extracted RNA was protected from RNase degradation by adding 0.4|^L of RNasin 




The reaction mixture was carried out in a total volume of 10|il, containing lU of 
DNase and 2\x\ of RNA sample. RNase-free water was used to make up the volume. 
The reaction mixture was left at room temperature for ISmin. DNase activity was 
inactivated by adding l|al of 25mM EDTA and then incubated at 65°C for ISmin. 
Product (l|Lil) was checked by gel electrophoresis (see 2.5.2c). 
Reverse transcription -
The DNase treated RNA sample was divided into 2 portions, each. One portion 
was treated with 200U of M-MLV reverse transcriptase, of random hexamers 
(0.5|Lig/|Lil), Ix PCR buffer, 1.5mM of deoxynucleoside triphosphate. The reaction 
mixture was made up to 40|il by 1% DEPC treated water. 
For another portion, same amount of hexanucleotide primers, buffer and 
deoxynucleoside triphosphate were added but without M-MLV reverse transcriptase. 
This was regarded as the negative control for reverse transcription. 
The reaction was left at room temperature for lOmin and then incubated at 37°C for 
45min. The activity of the reverse transcriptase was inactivated by incubating at a 
water bath at 95°C for 5min. The cDNA obtained was cooled on ice and frozen. 
2.5.13 Real time RT-PCR 
Real time PCR was performed using the ABI Prism® 7700 Sequence Detection 
System. In each run of real time PCR, 6 serial dilutions of plasmids of known 
concentration (internal standard and target) were included for standard curve 
construction (see 2.7.1c and 2.8.3c). The accuracy of fluorescence-based real time 
RT-PCR can be significantly affected by reagent and operator variability (Bustin, 
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2002). In this project, I tried to minimize the variability by using reagents from the 
same manufacturer with freshly prepared probes only. Furthermore, the same batch 
of templates for the standard curve was used and all samples (including samples for 
standard curves) were run in duplicates. 
Reaction condition 
Each reaction mixture was made up of a final concentration of 0.3|aM of each primer, 
0.2|LIM of probe, 200|LIM of each dATP, dCTP, dGTP and 400|AM dUTP, 3.5mM 
MgCh, Ix TaqMan reaction buffer, 0.25U of Amperase, 0.5U of Taq DNA 
polymerase and l|j,l cDNA template (see 2.5.12). The reaction volume was made up 
to 25|al using 1% DEPC water. 
The thermal cycle condition for quantification was first at 50°C for 2min, followed 
by lOmin at 95°C, continued with 40 cycles of 20sec at 95°C and 40sec at 58°C. 
Calculation 
Results were analyzed using Sequence Detection System software version 1.7. The 
baseline range and threshold level were adjusted to achieve the highest correlation 
coefficient of the standard curve. The copy number of the target gene and the 
internal standard were calculated separately. The Ct values obtained for the 
duplicated samples were averaged and the copy number was extrapolated from the 
standard curve. The copy number of each sample was obtained by subtracting the 
copy number of the negative control (without RT) sample. The copy number of the 
internal standard (16S rRNA) was used as a denominator for the copy number of the 
sample to obtain the standardized RNA copy number of the target gene and it was 
expressed as copy number per 10" 16S rRNA. 
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2.5.14 Construction of GenomeWalker Libraries 
Extraction of genomic DNA 
Extraction of genomic DNA was carried out using NudeoSpin®. Colony was picked 
and inoculated in BHI and shaked at 37°C overnight. 1ml culture was centrifuged 
for 5 min at 7,500 rpm. After removing the supernatant, the pellet was re-suspended 
in 170|al buffer Tl. Poteinase K (25|LI1) was added to the suspension and then the 
reaction mixture was incubated at 56°C for at least 3hr with shaking occasionally. 
After incubation, 200fil B3 was added and mixed by vortex. The reaction was 
incubated at 70°C for lOmin. Ethanol (210}il) was added to the reaction mixture and 
vortex immediately. After placing a NudeoSpin Tissue column into a 2ml collecting 
tube, the sample was applied to the column and centrifuged at 10,000rpm for Imin. 
The flowthrough was discarded and then 500|LI1 BW was added, followed by 
centrifuging at 10,000rpm for Imin. After discarding the flowthrough, 600|al B5 was 
added to the column and centrifuged for Imin at 10,000rpm. The flowthrough was 
again discarded and repeat the centrifugation step at full speed for 3min. The 
NudeoSpin Tissue column was placed into a new 1.5ml microfuge tube and 200|il 
prewarmed elution buffer TE was added to the column. After incubating at room 
temperature for Imin, the reaction was centrifuged at full speed for Imin to collect 
the genomic DNA. 
Digestion of genomic DNA 
Four reaction mixtures were prepared by four restriction digestion, EcoRW 
(GATATC), Oral (TTTAAA), Pvull (CAGCTG) and Sspl (AATATT). Each of the 
reaction contained about 2.5)ag genomic DNA, of each restriction enzyme, 10|al 
commercially supplied buffer and 57|ul ddHzO. The reaction mixture was mixed 
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gently by inverting the tube several times. After 2 hr incubation at 37°C, the reaction 
mixtures were mixed at slow speed for 5-lOsec using vortex and then incubated at 
37°C overnight. 
Purification of DNA 
Equal volume (about 95|il) of phenol was added to each reaction mixture prepared 
from the restriction digestion. The mixture was mixed gently using vortex and then 
centrifuged briefly. The upper layer was transferred into a new 1.5ml microfuge tube. 
Equal volume (about 95)il) of chloroform was added to the reaction mixture. It was 
mixed gently using vortex and then centrifuge briefly. The upper layer was 
transferred into a new 1.5ml microfuge tube. To each tube, 2 volumes (about 190|il) 
of ice-cold 95% ethanol and 1/10 volume (about 9.5|al) of 3M NaOAc were added. 
After mixing gently using vortex at slow speed for 5-lOsec, the mixture was 
centrifuged at 12,000xg for lOmin and the supernatant decanted. The pellet was 
washed in lOOjal of ice-cold 80% ethanol and then centrifuged at 12,000xg for 5min. 
After decanting the supernatant, the pellet was air-dried. The dried pellet was 
dissolved in 20|j.l of TE. 
Ligation of the digested genomic DNA to GenomeWalker adaptor 
.. To prepare the ligation, 4|al of digested, purified DNA was transferred into a new 
0.5ml microfuge tube and then mixed with 1.9|il of the GenomeWalker adaptor 
(25|iM), 1.6|il of lOx ligation buffer, and 0.5)^ 1 of T4 DNA ligase (6U/|al). After 
incubating the reaction mixture at 16°C overnight, the reaction was stopped by 
incubating at 70�C for 5min. Finally 72|il of TE was added to each reaction mixture 
and mixed using vortex at slow speed for 10-15 sec. 
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2.6 Selection of acinetobacters from ICU, blood culture and 
other clinical isolates 
2.6.1 Isolates from existing stock cultures 
2.6.1a Blood culture isolates (1999-2000) 
Repeated positive isolates with same GDG from each patient were retrieved from 
-70°C stocks (see 2.4.3) for PFGE examination (see 2.5.4). Those repeated isolates 
with a Dice coefficient of similarity > 80% were further taken for MIC 
determination of 8 antimicrobial agents (see 2.5.5). The repeated isolates from each 
patient with different MIC patterns were identified as epidemiologically and clonally 
related isolates (in set) for further study. The selected isolates were examined for the 
presence of the resistance genes (aph(3 ')-VIa, aac(6’)-Ib, bla\y[？-a, integrase I and 
flrr-aacA4) and the mutation of gyrA andparC (see 2.5.7). 
2.6.1b Existing sets of serial isolates 
The clonality and the changes of resistance pattern of serial isolates obtained from a 
^ previous study (Houang et al., 1998) were re-confirmed by PFGE (see 2.5.4) and 
MIC (see 2.5.5) determination. The isolates were then detected for the presence of 
the common resistance mechanisms (see 2.5.7). 
2.6.2 New isolates obtained for this study 
ICU 
Isolates reported as Acinetohacter sourced from ICU (7.2000-2.2001) were collected 
from routine laboratory. A loopful of colonies from the sensitive test plate was 
sub-cultured on NA slant and incubated at 37°C overnight and then store at room 
temperature. The identity of Acinetohacter was checked by simple identification 
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tests (see 2.4.1) and then stored at -70°C (see 2.4.2). For the repeated positive 
isolates from a patient, the susceptibility results reported by the routine laboratory 
were compared. The repeated isolates with changes in resistance patterns were 
retrieved (see 2.4.2) for further analysis. 
The isolates were first re-examined by disc diffusion test (see 2.5.6). Repeated 
isolates confirmed with changes in resistance patterns were further examined for 
clonal relatedness by PFGE (see 2.5.4) and GDG determination by ARDRA (see 
2.5.3). Those with Dice coefficient of similarity >80% were taken for MIC 
determination (see 2.5.5). Repeated isolates with changes in resistance patterns were 
identified as set of isolates and the presence of the common resistance mechanisms 
was detected (see 2.5.7). 
2.7 Study of expression level of the gene 
2.7.1a Verification of the specificity of primers for 办/tfiMP-4 
Primers and probe design 
Primers RTIMP4A and RTIMP4B (Table 2.10) were purchased during the visit to 
the PHLS Central Public Health Laboratory in London from Sigma Genosys (The 
Woodlands, USA). The nucleotide sequence of the probe RTImp4probe was labeled 
with dye FAM at 5' end and TRMRA at 3, end (Table 2.10). 
Table 2.10 Nucleotide sequences of primers and probe used for studying the 
expression of blamvA gene 
Nucleotide sequence 
Forward primer: RTIMP4A 5’-TAGAAGCTTGGCCAAAGTC-3, 
Reverse primer: RTIMP4B 5’-GTTTCAAGAGTGATGCGTC-3’  
‘ Product size - 105bp 
Probe： RTImp4probe 5'FAM-CAGCTTCACTGTGACTTGGAACAA-TAMRA3' 
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CYBR Green Assay 
A control strain for the blam?^ gene 74510 (see 2.1.5) was used as template (see 
2.5.2a) to study the specificity of the primers. The specificity was verified by 
examining the dissociation curve of the amplicon obtained from the real time PCR 
using CYBR Green as the fluorescent dye (see 2.5.11). 
Sequencing of the amplicon 
PCR using primers RTIMP4A and RTIMP4B and template from isolate 74510 was 
performed. The PCR was carried out in a total volume of 25|il, containing 0.5}iM of 
each primer, lU of Taq DNA polymerase, 200|iM of each deoxynucleoside 
triphosphate, Ix PCR buffer and 3|il of template (see 2.5.2a). 
PCR was performed with an initial denaturation of 95°C for 5min, followed by 35 
cycles of Imin at 95°C, Imin at 57°C and Imin at 72°, and a final extension of 5min 
at 72°C. Amplicon was analyzed by gel electrophoresis (see 2.5.2c). The amplicon 
of 105 bp was cloned (see 2.5.8) for DNA sequencing (see 2.5.9). The DNA 
sequence obtained was search for matched sequence in GenBank (see 2.5.10b). 
2.7.1b Verification of the specificity of primers for 16S rRNA gene 
Ribosomal RNA 16S was used as an internal standard for standardization in 
quantification. 
Primers and probe design 
Primers and probe for 16S rRNA (Table 2.11) were designed from the consensus 
regions of the alignment (see 2.5.10c) of different Acinetohacter species - A. 
baumannii, A. junii, A. calcoaceticus, A. johnsonii, and A. Iwoffi. The alignment and 
the regions of primers are shown in Figure 2.1. 
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Table 2.11 Nucleotide sequences of primers and probe used for internal standard 
(16S rRNA). 
Nucleotide sequence  
Forward primer: RT16S606A 5�-GAATTGCATTCGATACTGG-3’ 
Reverse primer: RT16SB 5,-TAGGCCAGATGGCTGC-3, 
Product size - 118bp 
Probe： RT16Sprobe 5'JOE-TCGCCATCGGTATTCCTCCA-TAMRA3' 
CYBR Green Assay 
The control strain for the adeB gene BM4454 (see 2.1.5) was used as template (see 
2.5.2a). The specificity of the primers was verified by examining the dissociation 
curve of the amplicon obtained from the real time PCR using CYBR Green as the 
fluorescent dye (see 2.5.11). 
< 
Sequencing of the amplicon 
PCR using primers RT16S606A and RT16SB, and template (see 2.5.2a) from strain 
BM4454 was performed. Reaction mixtures were made up of 0.5|aM of each primer, 
0.5U of Taq DNA polymerase, 200|^M of deoxynucleoside triphosphate, Ix PCR 
buffer and l|il of DNA template. The mixtures were made up to 25|j.l with ddHzO. 
The PCR reaction mixture was heated for 5min at 94°C, followed by 30 cycles of 
30sec at 95°C, 30sec at 58°C and 30sec at 72�C. The reaction was finished with a 
final extension step with 5min at 72°C. Amplicon was analyzed by gel 
electrophoresis (see 2.5.2c). The 118 bp amplicon was cloned (see 2.5.8) for DNA 
sequencing (see 2.5.9). The DNA sequence obtained was search for matched 
sequence in GenBank (see 2.5.10b). 
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baumannii /^aGGGCCTAAAGCCTGajmGGCGGCnTmMCTCGGATCTCMATCCCCG/^GCTTAA 600 
junii ACTGGGCGTAMGCGTGCGTAGGCGGCrmTAAGTCGGATGTGAMTCCCCGAGCTTM 600 
calcoaceticus ACTGGGCG�AMGCGTCCGTTV^GCGGCrmTAAGTCGG/VTCTCAMTCaXGMnTM 600 
J ohnsonn i i /^CTGGGOTrMAGCGTXnTr�GGCGGOmTAAGTCGG�TCTCAMTCGCTGAGCTTM 600 
Iwoffi i ACTGGGCGTMAGCGCGCGTAGGTGGCCMrrAAGTCAAATGTGAMTCCCCGAGCTTM 600 
氺;！：氺氺氺氺氺: i：氺氺氺氺氺承本氺氺氺氺氺本本中氺氺 本本氺氺氺氺：{: 氺 本 : 氺 氺 氺 氺 氺 本 水 氺 氺 氺 氺 : i ； 氺 氺 氺 
baumannii OTGGGAyTTGCATTCGATACTGGTGAGCTAGAGTATGGGAGAGGATGGTAGAAnCCAG 660 
junii CTTGGGAyTTGCATTCGATACTGGGAAGCTAGAGTATGGGAGAGGATGGTAGAATTCCAG 660 
calcoaceticus CTTGGGAyTTGCATTCGATACTGGGAAGCTAGAGTATGGGAGAGGATGGTAGAATTCCAG 660 
johnsonnii CTTAGGAy TTGCATTCGATACTGGGAAGC TAGAGTATGGGAGAGGATGGTAGAATTCCAG 660 . 
Iwoffi i CTTGGGAyTTGCATTCGATACTGGnGGCTAGAGTATGGGAGAGGATGGTAGAATTCCAG 660 
氺本氺氺:}:氺:i；氺氺氺：^：承氺本氺氺氺:i：氺:i；承氺 氺氺氺氺氺氺氺牟氺氺氺氺氺氺氺氺氺氺氺本氺; i；氺: i；氺氺氺术氺氺氺承氺 
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baumanni i GTGTAGCGGTGAAATGCGTAGAGATCTGGAa AATACCGATGGCGAAGNCAGC ZK 'CTGG 720 
junii GTGTAGCGGTGAAATGCGTAGAGATCTGGAa AATACCGATGGCGAAGGCAGC CA' ’CTGG 720 
calcoaceticus GTGTAGCGGTGAAATGCGTAGAGATCTGGAGClAATACCXJATGGCGAAGGCAGCZK'CTGG 720 
johnsonnii GTGTAGCGGTGAAATGCGTAGAGATCTGGAa ；AATACCGATGGCGAAGGCAGC CA' 'CTGG 720 
Iwoffii GTGTAGCGGTGAAATGCGTAGAGATCTGGAa AATACCGATGGCGAAGGCAGCCA''CTGG 720 
氺氺氺氺氺氺氺; i J氺氺氺;}：氺氺氺氺氺氺氺水氺氺氺氺氺氺氺氺氺氺氺:{iJ i：氺氺氺氺氺氺氺氺氺氺氺: i J氺氺氺氺: i：氺氺氺氺氺本*氺氺 
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baumannii CCTAAT�CTGACGCTGAGGTACGAMGCATGGGGAGCAMCAGGATTAGATACCCTGGTA 780 
junii CCTAATOGACGCTGAGGTACGAAAGCATGGGGAGCAAACAGGATTAGATACCCTGGTA 780 
cal coace t i cus CCTAAC OGACGCTGAGGTGCGAAAGCATGGGGAGCAAACAGGATTAGATACCCTGGTA 780 
“ j ohnsonnii CCTAAT �CTGACGCTGAGGTACGAAAGCATGGGGAGCAAACAGGATTAGATACCCTGGTA 780 
Iwoffi i CCTAAT、(：TGACACTGAGGTGCGMAGCATGGGGAGCMACAGGATTAGATACCCTGGT八 780 
* * * * * * 本：！：：！：：！：本：!；氺;i：** 氺 本 * * * ： ( ! * ： ! ： 本 * 氺 本 木 * * 
1 
,baumannii GTCCATGCCGTAAACGATGTCTACTAGCCGTTGGGGCCnTGAGGCTTTAGTGGCGCAGC 840 
junii GTCCATGCCGTMACGATGTCTACTAGCCGTTGGGGCCnTGAGGCnTAGTGGCGCAGC 840 
calcoaceticus GTCCATGCCGTMACGATGTCTACTAGCCGTTGGGGCCnTGAGGCTTTAGTGGCGaGC 840 
J ohnsonn i i GTCCATGCCGTAAACGATGTCTACTAGCCGTTGGGGCCTTTGAGGCnTAGTGGCGCAGC 840 
Iwoffi i GTCCATCCCGTAAACGATGTCTACTAGCCGTTGGGGCCnTGAGGCTmGTGGCGCAGC 840 
氺 j i：*!)：!!；氺本：！：本：！：傘：!：****氺*>1：：!：*：!；氺*氺氺氺本木本=i==i=氺木木本氺本=i=氺 
Figure 2.1 Part of multiple sequences alignment result of 16S ribosomal RNA of A. baumannii, A. junii, A. 
calcoaceticus, A. johnsonii, and A. Iwoffi. Asterisks (*) show consensus regions. Boxed sequences 
with arrows (‘ are the primers while boxed sequences with line ended with circles ( • • ) 
are the probe used in real time PCR as internal standard 16s. 
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2.7.1c Construction of standard curve 
Genes to be studied require standard curve for quantification in each run of real time 
RT-PCR. 
Standard curve for blam?./^  
Amplicon of blam?-A obtained from PCR (see 2.7.1a — Sequencing of the amplicon) 
was cloned (see 2.5.8). The plasmid obtained was quantified by loading in agarose 
gel (see 2.5.2c) with serial dilutions of known amount X DNA marker. The plasmid 
copy numbers were calculated from the size (about 4 kb) and the concentration of 
the plasmid. Assuming the average molar mass of one base pair is 620 and using the 
Avogadro's number (6x10^^), the copy number may be calculated in the following 
manner: 
The molar mass of the plasmid 4 x 10^  x 620 g/M, 
Therefore the weight of 6 x copies of the plasmid would be 2.5 x 10^ g 
molecules. 
6 23 J g 
The weight of each plasmid would therefore be 2.5 x 10 g / 6 x 10 = 4x10' g, 
o 
and 1 ng of plasmid would contain 2.5 x 10 copies. 
By comparing the intensity of the plasmid containing bla\u?-A to the known amount 
of X DNA marker on the agarose gel, the concentration of the plasmid containing 
hla\u?.A can be converted to copy number. Quantified plasmid was serial diluted 
.. (10-fold dilution) and 6 different dilutions were used in each real time RT-PCR run. 
Standard curve for 16S rRNA 
The procedures for construction of standard curve for 16S rRNA were same as 
2.7.1c — Standard curve for hla\u?-A- The PCR condition for 16S rRNA are described 
in 2.7.1b - Sequencing of the amplicon. 
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2.7.2 Expression levels of _ M P 4 and meropenem MIC in 
blood culture isolates 
Nineteen bla\u?A blood culture Acinetobacter isolates (1997-1998) with varied 
meropenem MIC (1 to > 32)j.g/mL) were used for studying the transcript level of 
blaxuvA by real time RT-PCR. cDNA of the isolate to be studied was prepared (see 
2.5.12) as template for real time RT-PCR (see 2.5.13). The primers and the probe 
described in 2.7.1a and 2.7.1b were used for studying the mRNA levels of hla\u?-A 
and the internal standard 16S rRNA, respectively. 
2.7.3 Intra-assay reproducibility 
To study the intra-assay reproducibility, coefficient variations (CVs) of the « 
duplicated samples were calculated as (SD / mean) x 100%. The CVs were plotted 
on a scatter plot and the median of the CVs of bla\u?-A and the internal standard 16S 
rRNA were calculated. 
2.7.4 Detection of the production of metallo-P-lactamase 
‘ A disk diffusion test was conducted for detection of the production of 
‘metallo-p-lactamase (Arakawa et al, 2000). Two caftazidime disks were placed on a 
MHA plate on which a bacterial suspension was spread according to the NCCLS 
(1999). The distance between the disks was kept to about 4 to 5cm and a filter disk 
was placed near one of the ceftazidime disks with a center-to-center distance of 
_ 1.5cm. Two microliters of 2-mercaptopropionic acid was added to the filter disk on 
the agar and each agar plate was incubated at 37°C overnight. Expanded growth 
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inhibitory zone between the two disks should be observed for of 
metallo-P-lactamase producing strains, while no evident change in the shape of the 
growth inhibitory zone was observed for ceftazidime-resistant strains producing 
non-metallo-(3-lactamase. 
2.8 Study of adeABC expression 
2.8.1 Determination of the presence of the adeB gene 
2.8.1a Verification of primers 
Amplicon (980 bp) obtained from the amplification (PCR parameters, see 2.8.1b) of 
the internal fragment of adeB of BM4454 using primers O3 (5'-GTA TGA ATT GAT 
GCT GC-3') and O4 (5,-CAC TCG TAG CCA ATA CC-3') described by Magnet et 
al. were cloned (see 2.5.8) for DNA sequencing (see 2.5.9). The DNA sequence 
obtained was searched for matched sequences in the GenBank (see 2.5.10b). 
2.8.1b Detection of the presence of adeB by PCR 
Primers O3 and O4 (see 2.8.1a) were used to detect the presence of adeB in 
Acinetobacter. Amplicon of 980 bp was produced from control strain BM 4454 (see 
2.1.5). PCR was carried out in a total volume of 25|il containing 0.5}iM of each 
... primer, 0.5U of Tag DNA polymerase, 200|LIM of each deoxynucleoside triphosphate, 
Ix PCR buffer and \[x\ of template (see 2.5.2a). 
PCR was performed with an initial denaturation of 95°C for 5min, followed by 30 
cycles of 40sec at 95°C, 40sec at 58°C and 55sec at 72°C, and a final extension of 
7min at 72°C. Amplicon was analyzed by gel electrophoresis (see 2.5.2c). 
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2.8.2 Entirety of the adeABC operon 
To check the entirety of the adeABC operon and the 3 open reading frames (ORF) 
upstream to the operon, ten primer pairs a — j (including O3 and O4) were designed 
according to the 10,629 bp sequence acquired from GenBank under accession no. 
AF370885 (Magnet et al, 2001). Adjacent primer pairs were slightly overlapped 
with each other and the primers are summarized at Table 2.12 and Figure 2.2 shows 
the locations of different primer pairs. 
2.8.2a Verification of the specificity of primers 
Amplicons obtained from the amplification of the 10 primer pairs (PCR parameters, 
see 2.8.2b) were cloned (see 2.5.8) for DNA sequencing (see 2.5.9). The DNA 
sequences obtained were searched for matched sequence in GenBank (see 2.5.10b) 
to confirm the identity of the product 
2.8.2b PCR detection 
PCR reactions were carried out in a total volume of 25|il containing 0.5fiM of each 
primer, 0.5U ofTaq DNA polymerase, 200fj.M of each deoxynucleoside triphosphate, 
Ix PCR buffer and 1]LI1 of template (see 2.5.2a). 
For the above primer pairs, except primer h (for the PCR parameters for 0 3 and 04, 
, see 2.8.1b), PCR reaction mixtures were heated for 5min at 94°C, followed by 30 
cycles of 40sec at 95°C, 40sec at 53°C and 55sec at 72°C. The reaction was finished 
with a final extension step with 5min at 72�C. Amplicon was analyzed by gel 


















































































































































































































































































































































































































































































































































































































































































































































































































































2.8.3 Expression level of the adeB gene 
2.8.3a Verification of the specificity of primers for internal control 
Primers RT16S606A and RT16SB were used to amplify the internal control 16S 
rRNA gene. The specificity of the primers was verified as described in 2.7.1b. 
2.8.3b Verification of the specificity of primers for adeB 
Primers and probe design 
Primers RTAdeB2535A and RTAdeB2646B were used in real time PCR to study the 
expression aflfeB (Table 2.13 and Figure 2.2). 
Table 2.13 Nucleotide sequences of primers and probe for adeB. 
Nucleotide sequence 
Forward primer: RTAdeB2535A5AGGTATTGGCTACGAGTGG-3‘ 
Reverse primerrRTAd评2646B 5'-TGCCCAGCTTTCATAGAGT-3' 
Product size — 129bp 
Probe: RTAdeBprobe 5'FAM-CAGCCAAGACAAGGAAGACAACTAAC-TAMRA3' 
CYBR Assay 
“ Control strain for the adeB gene BM4454 (see 2.1.5) was used as template (see 
2.5.2a). The specificity of the primers was verified by examining the dissociation 
-curve of the amplicon obtained from the real time PCR using CYBR Green as the 
fluorescent dye (see 2.5.11). 
Sequencing of the amplicon 
A reaction mixture was made up of 0.5|aM of each primer (RTAdeB2535A and 
RTAdeB2646B), 0.5U of Taq DNA polymerase, 200|^M of deoxynucleoside 
triphosphate, Ix PCR buffer and l|ul of DNA template (see 2.5.2a). The mixture was 
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made up to 25)il with ddHsO. 
The PCR reaction was heated for 5 min at 94°C, followed by 30 cycles of 30sec at 
95°C, 30sec at 58�C and 30sec at 72°C. The reaction was finished with a final 
extension step with 5min at 72°C. Amplicon obtained was cloned (see 2.5.8) for 
DNA sequencing (see 2.5.9). The DNA sequence obtained was searched for matched 
sequence in GenBank (see 2.5.10b) to confirm the identity of the amplicon. 
2.8.3c Construction of standard curve 
Genes to be studied require standard curves for quantification in each real time 
RT-PCR run. 
Standard curve for adeB 
The amplicon obtained from the amplification of adeB, using RTAdeB2535A and 
RTAdeB2646B (se‘e Table 2.13), from the DNA template (see 2.5.2a) of control 
strain BM4454 (see 2.1.5) was cloned (see 2.5.8). The standard curve was 
constructed as described in 2.7.1c 一 Standard curve for blampA- The PCR condition 
for adeB was described in 2.8.3b — Sequencing of the amplicon. 
Standard curve for 16S rRNA 
Construction of standard curve for 16S rRNA was described in 2.7.1c - Standard 
curve standard curve for 16S rRNA. 
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2.8.4 Expression levels of adeB in sets of serial isolates 
Sets of serial isolates (see 2.6) were used for studying the mRNA level of adeB. 
cDNA of the isolates to be studied was prepared (see 2.5.12) as template for real time 
RT-PCR (see 2.5.13). Primers and probe described in 2.8.3b for adeB and 2.7.1b for 
the internal standard 16S rRNA were used. 
2.8.5 Intra-assay reproducibility 
The CVs (calculation, see 2.7.3) were plotted on a scatter plot and the median of the 
CVs for adeB and the internal standard 16S rRNA were calculated. 
2.8.6 Inter-assay reproducibility 
The samples of the internal standard (16S rRNA) for standard curve construction in 
each run were used to study the inter-assay reproducibility. The duplicated samples 
were averaged. The CV (calculation, see 2.7.3) of the results of the same dilution 
from the 7 real time RT-PCR runs was calculated. The median of the CVs from 
different dilutions obtained was also calculated. 
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2.9 Investigation of other efflux pumps in acinetobacter genomic 
DNA group 3 
2.9.1 Detection of adeB homologue in a genomic DNA group 3 
isolate 
PCR amplification of GDG 3 Acinetobacter (IN 4365) total DNA (see 2.5.2a) with 
degenerate primers A2 and A4 (see Table 2.14), gifted from Dr. T. Lambert, Institut 
Pasteur, was performed. Reaction mixture was made up of 100r|g of each primer, 
0.5U of Tag DNA polymerase, 200)iM of deoxynucleoside triphosphate, Ix PCR 
buffer and l|al of DNA template (see 2.5.2a). The mixtures were made up to 25|il 
with ddH20. 
The thermal cycle used was 5min at 94°C, followed by 30 cycles of 30sec at 95°C, 
30sec at 48°C and 55sec at 72°C. The reaction was finished with a final extension 
step of 7mia at 72°C. Amplicon was analyzed by gel electrophoresis (see 2.5.2c). 
PCR products were cloned (see 2.5.8) and the one with size at about 1.2 kb 
(pAdeEOOl) was taken for DNA sequencing (see 2.5.9). The DNA sequence 
obtained was searched for matched DNA and aa sequence in GenBank (see 
2.5.10a-b). 
Table 2.14 Nucleotide sequence of degenerate primers used 
, for detection of adeB homologue. 
Primer Nucleotide sequence*  
‘ T a 5'-ACW ACW ATW GCR TCR TCW AC-3' 
‘ - M 5,-MGW CCW GTW TTY GCW TGG GT-3, 
* lUB Group Code (appendix 3) was used 
Two specific primers, AdeE-79A (5'- CAA TAT CCT GAC ATT GCA C-3') and 
AdeE-538B (5'- CCA GAT ACG CAT TGC ATA-3') with amplicon 459 bp were 
designed according to the sequence obtained from pAdeEOOl. 
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DNA sequences of the matched RND-type transporters, the putative efflux pump of 
E.coli (accession no. NC 002655) (Perna et al., 2001), multidrug efflux protein of 
Yersinia pestis (NC 003143) (Parkhill et al., 2001) and the AcrBDF family protein of 
Caulobacter crescentus (NC 002696) (Nierman et al., 2001), were aligned (see 
2.5.10c) (Figure 2.3). Degenerate primers (Table 2.15) were designed based on the 
conserved regions in the alignment, taking into account the genetic codon preference 
of Acinetobacter. 
Table 2.15 Degenerate primers designed according to the alignment of the 
RND-type transporters. 
Forward primer Nucleotide sequence* 
54TA 5，-TAY GCN ATG CGN ATH TGG YT-3， 
1207A 5，-ATY GGD YTN YTN GTN GAY GA-3' 
1393A 5,-ATY TAY MGN CAR TTY WCN ATY AC-3' 
startA ： 5'-ATG YTY KCS CGY TTY TT-3' « 
Reverse primer 
1207dB 5,-TCR TCN CAN ARN ARH CCR AT-3' 
1393dB 5'-GTRATN GWR AAY TGN CKRTAR AT-3’ 
1603dB 5,-AGC ATG CGG TTA ACA CCA-3’ 
2256dB 5'-CCR CGR TCR ATR AAR TCR TT-3， 
.’ 3032dB 5,-TVCCGCCVAKDA YGCC-3, 
3183dB 5,-CAV BAG RAA RAA SMG G-3' 
* lUB Group Code (appendix 3) was used. 
‘ D i f f e r e n t combinations of forward and reverse primers were used to amplify the total 
DNA of an Acinetobacter GDG 3 isolate 4365. The PGR reaction was performed in a 
total volume of 25|LI1 reaction mixture, containing 0.5|LIM of each primer, 0.5U of Tag 
DNA polymerase, 200|^M of each deoxynucleoside triphosphate, Ix PGR buffer and 
0.2|.L1 of template (see 2.5.2a). 
The condition used was 5min at 94°C, followed by 30 cycles of 30sec at 95°C, 30sec 
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at 48°C and Imin at 72°C. The reaction was finished with a final extension step with 
7min at 72°C. Amplicon was analyzed by gel electrophoresis (see 2.5.2c). PCR 
products of interest were cloned (see 2.5.8). pAdeYOOl and pAdeY002 were 
obtained and taken for DNA sequencing (see 2.5.9). The DNA sequences obtained 
were searched for matched DNA and aa sequences in GenBank (see 2.5.10a-b) and 
were combined to obtain the partial sequence oiadeY. 
2.9.2 Chromosome walking of the adeB-\\\it genes 
G e n o m e W a l k e r rM Kit was used in chromosome walking of the adeB-Vikt genes. 
GenomeWalker library of isolate 4365 was constructed (see 2.5.14) for accessing the 
genomic DNA sequences adjacent to the known adeB and adeE sequences. The 
libraries prepared from the four restriction digestion, £coRV (GATATC), Dra\ 
(TTTAAA), PvuW (CAGCTG) and Ssp\ (AATATT), were labeled as DL-^coRV, 
DL-Dral, DL-PvwII and DL-Sspl respectively. Figure 2.4 shows the principle in 
constructing one library. 
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Yersinia ATGTTTGCCCGTTTCnTATTTATCGCCCGGrmTGCCTGGGTCATTGCCATTGmTT 60 
E.coli ATGTTTTCGCGCrmTTGTTCGCCGCCCGGTCTTTGCCTGGGmTCGCCATnTGATT 60 
Cau 1 obac t e r ATGCTCTCGCGTTTCTTCATCGACCGGCCCATCTTCGCATGGGTCATCGCCATCGTGATC 60 
I 氺氺；!；氺 ；!; ^^ » » ^ 氺 : ^ ^ 氺：!！ ：!：* ：！：**^ ：* * 氺 ^*：!：** 承 ** 
startA 
Yersinia ATGTTGGGCGGGGTGGTTGCGCTGGAMCCTTGCCGATAGCCCAGTATCCCGATGTCGCA 120 
E.coli ATGTTGGCGGGGATTCTGGCTATTCGCACATTGCCCGTCGCGCMTATCCTGACGTTGCG 120 
Cau 1 obac t e r ATGCTGGCCGGGGCGCTCGCCATCCGGACCCTGCCGATCGCGCMTATCCTGAAATCGCC 120 
^^^ ^ ^ ^ 氺氺氺 氺； i；氺； i c 氺:K 氺泳承氺 氺 氺 氺 氺氺本：^；乐氺承氺 ^ 乐氺 
Yersinia CCACCATCTATTTCCATTAMGCCACCTATACCGGTGCTTCAGCAGAAACACTCGAAAAC 180 
E.coli CCACCGACCATTMAATTTCAGCCACTTATACTGGTGCTTCTGCCGMACGCTGGAGMC 180 
Cau 1 obac t e r CTGCCGCAGGTGTCGATCTCGGCCMCTATCCCGGCGCCTCGGCCAAGACCGTCGAGGAC 180 
Yersinia AGTGTGACGCAGGTCATTGAGCAAGMCTGACCGGATTGGATGGTCTGCTCTATmTCC 240 
E.coli AGCGTGACTCAGGTCATCGAGCMCMCTCACTGGGCTTGATAATTTACTCTmTCAGC 240 
Cau 1 obac t e r AGCGTCACCCAGGTCATCGAACAGMGATGAAGGGCCTGGACGGTCTGGACTACATGTCC 240 
； J ;承；{；氺氺氺氺氺氺氺泳氺; { c ；i；氺氺氺 ^ ^ ^ ^ ^ ^ ^ ^ 氺 氺 氺氺氺 氺 氺 
Yersinia TCCTCCAGCGGTTCCGATGGTAATGCCAAGATCGTCGCCACATTTMGCAGGGGACTAAT 300 
E.coli TCMCCAGCAGCTCTGATGGTTCOTCAGTATTMTGTGACCTTTGAACAAGGTACCGAT 300 
Caul obac ter TCGACCAGCGACGGCTCGGGCTCGGCCACGGTGACCCTGACCTTCMGGCCGGCACCGAC 300 
氺氺 ；！：氺氺氺氺 氺;i： ^ ^^ ^ 氺氺 ^ 氺 氺 ： ^ ： 氺 氺 
Yersinia GCTGATACCGCGCAGGTACAGGTGCAAMTMGGTTCAGCAGGOJCTMCCCGTTTGCCA 360 
‘E:coli CCAGATACTGC ACAGGTGCAGAATAAAATTCAGCAGGCGGAGTCGCGCCTACCC 354 
• Caulobacter ATCGACATCGCCCAGGTCCAGGTCCAGMCAAGCTGCAGACCGCCACCGCCCTCTTGCCG 360 
‘ 氺氺；！；氺：^; 氺 氺 氺 氺 氺 氺 氺 ； 氺 氺 氺 泳 氺 本氺 氺 氺 氺 氺 本 
Yersinia ACAGAGGTGCAGGCGCMGGGGTCACGGTGACCMGTCGCAGACTMCTTCTTGTTGATC 420 
E.coli AGCGMGTGCAGCAAACGGGTGmCGGTGGAGAAATCACMAGCAACmTTGCTGATT 414 
• Cau 1 obac t e r CAGGMGTGCAGCAGCMGGCCTGACGGTCGCCMGTCGGCGCGCAACTTCATGATGGTC 420 
• 本氺木氺氺;i； 氺氺 氺 *氺氺木氺 氺 氺 氺 氺 氺;i；;}：承氺 氺 氺 氺 氺 氺 
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Yersinia ATGTCGCTGTATGATGAAAAAGACAMCACACCGGMCGGATATTGCCGACTATCTGGTC 480 
E.coli GCTGCCGTGTATGACACCACTGACMAGCCTCCAGTTCGGATATCGCCGACTGGTTGGTT 474 
Caulobacter ATCGGCCTCTATTCCGAGGATCCGMGACCACCGGCGCGGATCTGGCCGACTACATGGCC 480 
氺 氺 氺 氺 氺氺 氺 氺 * 氺 氺氺承; i c s j c氺氺氺氺氺氺氺氺 氺氺;i； 
Yersinia AGCMCCTGCMGACCCACTGGCTCGCCTCGMGGGGTAGGGAGTGTGCAGGTGTTTGGT 540 
E.coli AGTAACGTTCAGGACCCGCTGGOGCGTGTTGMGGTGTGGGGAGTCTGCMGTCTTTGGC 534 
Cau 1 obac t e r TCGMCCTGCAGGACCCGCTGAGCCGCGTCGACGGCGTCGGCGACATCCAGCTGTTCGGC 540 
Yersinia TCGCMTATGCGATGCGGATrTGGTTAAATCCGACCAMCTGGCCGCmCMTCTGATG 600 
E.coli GCGGMTACGCTATGCGCATCTGGCTTGACCCGGCCAAACTGGCGTCTTACTCGCTAATG 594 
Caulobacter TCGCMTATGCGATGCGCATCTGGCTGGACCCGCAGAAGCTGGCCAGCTTCAGCCTGACG 600 
本氺 氺氺 p氺 氺氺 氺;i；氺氺氺 氺氺 丨 氺 氺 氺氺氺 ^^ ：！： H^si； si； ^  ^ ^ 氺 氺 氺 
54 Id A 
Yersinia CCCAGCGATGTTCAATCCGCCATTACGGCACAGMCACACAGGTTTCTGCTGGCMAATC 660 
E.coli CGTTCAGACGTGCAMGTGCTATTGMGCGCAAMCGTGCAGGTTACTGCCGGGAMATA 654 
Caul obac t e r CCGGCCGACGTCGCCGCCGCGATCCGCGCCCAGAACGCCCAGGTCTCGGCCGGCCAGATC 660 
氺氺 块 氺 氺 氺 氺; f :氺氺 氺承He氺：；:氺氺 氺氺氺氺氺 氺 ； 氺 氺 氺 氺 *氺 
Yersinia GGGGCGTTACCGAGCGGTAAAGAGCAGCMTTGACCGCGACAGTCATGGCGCMTCCCGC 720 
E.coli GGGGCATTGCCTTCACCGMTACTCAGCMCTGACCGCMCGGTTCGTGCGCAGTCTCGC 714 
“ C a u l obac t e r GGCGGCACGCCGAACCTGCCGGGCACGGGCCTGMCGCCACGATCACGGCGCAGTCGCGC 720 
氺 ； ^ 氺氺承 氺氺 氺 氺氺氺氺氺； i；氺氺氺氺 
“Yersinia CTGAAMCACCGGAGCAGTTCMCMTATTATTGTTAAMGTGACAGCACGGGCGCGGTG 780 
, E . c o l i TTGCAGACGGTGGATCAGTTCAAAMTAmTCGTGAAMGCCAGTCAGACAGCGCAGTT 774 
‘ Cau1obac t e r CTGCAGACCCCCGAGCAGTTCCGCCAGATCATCGTCAAGAACACCAGCGGCGGCGCCACC 780 
承 水 氺 ； f : 氺 氺华氺氺氺氺氺承 氺 氺 氺 氺 氺 氺 氺 氺 氺氺氺氺 
Yersinia GTACGACTGCGCGATGTGGCCCGTGTTGAGCTGGGCMTGAAGATTACAGCGTGACGACC 840 
E.coli GTTCGTATAAMGATGTGGCTCGCGTTGAGATGGGCAGTGMGATTATACCGCTATCGGC 834 
Caulobacter GTGCGCCTGAGCGACGTGGCCCGTGTCGMCTGGGCGCGGAMGCTACGCCTCGATCGCC 840 
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Yersinia CGCTTGAACGGCCATCCAGCCGCGGGGATCGCGGTGATGCTGGCACCTGGTGCTMTGCG 900 
E.coli AAACTTMCGGTCACCCGTCTGCCGGGGTTGCTGTMTGCnTCGCCCGGTGCGMTGCG 894 
Caulobacter AAGTTCMCGGCTATCAGGCGGCCGGCATGGCCATCAAGCTGGCCCCCGGCGCCAACGCG 900 
Yersinia CTGGCGACCGCCGAGCGGGTAMGGCCAAGGCTGCCGAGTTTGAATTGMCTTGCCTGAC 960 
E.coli CTGMTACGGCGACGCTGGTCAAGGATAAGATTGCCGAATTCCAGCGGMCATGCCGCAG 954 ' 
Cau1obacter CTGGATACCGCCGCCGCCGTGAACGCCAGGATGGCCCAGCTCGAGAAGAACTTCCCAGCC 960 
承本氺 ；ic 傘承；!： H：* * * * * =!： * * * * * * * * * * * * * 
Yersinia GGATACAAMTCGCGTATCCAAMGACAGCACTGATTmTTAMGTTTCGGTCGAGGAA 1020 
E.coli GGATACGACATCGCTTACCCGAMGACAGCACTGMTTTATTAAMTCTCTGTAGAGGAC 1014 
Cau 1 obac t e r AACTACMGTACGTCATTCCCTATGACTCGACGCCGTTCGTGMGCTGTCGATCGAGGAA 1020 
Yersinia GTGGTGAAMCGCTGATCGMGCCATCTTGCrGGTGGTTATCGTGATGTACATCTTCCTA 1080 
E.coli GTAATrCAGACGCTGTTTGMGCCATCGTATTGGTGGTTTGCGTGATGTATTTATTCCTG 1074 
Cau lobacter GTGGTCAAGACGCTGGTCGAGGCCATCATCCTGGTGTTCATCGTCATGTTCCTGTTCCTG 1080 
Yersinia CAAMTATCCGTGCCACTTTGATACCGGCTATTGCCGTCCCAGTTGTGTTGTTAGGGACG 1140 
E.coli CAAAACCTGCGTGCCACACTGATTCCGGCGTTAGCTGTCCCCGTCGTTTTGCTGGGCACA 1134 
Cau lobacter CAGMCTGGCGCGCGACCCTGATCCCGACCATCGCCGTGCCGGTCGTCOTCTGGGCACC 1140 
水;Jc氺氺 ； J ; 傘氺乐水氺 承氺氺氺水氺;i： ^ ； i c 氺氺；| <氺； j c 氺水氺氺氺 氺 氺 埃 氺 氺 氺 
Yersinia TTTGGGGTGTTGGCCATATTCGGCTACTCMTCMTACACTGACACTmTGGTATGGTG 1200 
‘E.coli TTCGGCGTTCTTGCGTTGTTTGGCTATTCGATTMTACCCTGACGTTGTTTGCTATGGTG 1194 
• Cau 1 obac t e r TTCGGCGTGCTGGCCGCCTTCGGCTACTCGATCMCACGCTCACCATGTTCGGCCTGGTG 1200 
‘ 氺;i； 氺氺 ^ ^ 氺 傘 氺 氺氺 sf:氺承;i；氺氺氺承氺承氺氺氺氺氺氺氺 * 氺 氺 * 氺氺华本氺 
Yersinia CTGTCGATCGGOTGTTGGTCGACGATGCTATTGTCGTGGTGGAMACGTTGAGCGGGTG 1260 
E.coli CTGGCGATCGGCTTGCTGGTGGACGATGCCATTGTGGTAGTGGAGMCGTCGMCGCATT 1254 
Cau 1 obac t e r CTGGCCATCGGCCTTCTGGTCGACGACGCCATCGTCGTGGTCGAGMCGTCGAGCGCGTC 1260 
, 承;i；泳 ^ * * * * * 氺 氺 氺 承 氺 氺 块 氺 氺 华 ^^ 氺氺;1；氺氺氺氺；}:氺 氺 
1207dA/ 1207dB 
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Yersinia ATGCGGGMGACMTCTCCCGCCCCGTGMGCGACTGAGAAATCTATGAGTGAGATCGCC 1320 
E.coli ATGCGTGACAAAGGGTTGCCCGCGCGTGAAGCCACGGAAAAATCAATGGGCGAGATTTCT 1314 
Cau 1 obac t e r ATGAGCGAGGMGGCCTCT(XCCCMGGMGCCACCCGCAAGTCGATGAACGAGATCACC 1320 
* 承 氺 氺 氺 氺 Ji： 氺 氺 氺氺氺氺;ic ；|c氺 ^：^ 木氺 ^^^ 氺氺氺氺氺 氺 
Yersinia AGCGCACTGATTGGGATTGCACTGGTGCTCTCGGCAGTATTCCTGCCCATGGCCnunT 1380 
E.coli GGCGCACTGGTTGCCATTGCGCTGGTGTTGTCAGCCGTATTCCTGCCTATGGCCTTCnr 1374 
Caulobacter GGCGCCCTGATCGGCATCGCCCTCGTTCTGGCGGCGGTGTTCGTGCCGATGGCOTCTTC 1380 
Yersinia GGTGGGGCGACCGGCGTTATCTACCGCCAGTTCTCCATCACCATTGTGTCAGCGATGGGG 1440 
E.coli GGGGGATCTACGGGGGTMTTTATCGTCAGTTTTCGATAACCATTATCTCCGCAATGCTG 1434 
Cau 1 obac t e r GGCGGCTCGCAGGGCGTGATCTACCGCCAGTTCTCGATCACCATCGTCTCGGCCATGGCC 1440 
1393dA/ 1393dB 
Yersinia CTATCCGTGTTGGTCGCATTAACCCTCACGCCAGCATTGTGCGCCACCTTCCTGAAACCC 1500 
E.coli . CTTTCCGTGGTGGTGGCATTGACCTTGACTCCCGCCCTGTGCGGTTCCGTCCT C 1488 
Cau 1 obac t e r CTGTCGGTGGTCGTCGCCCTGGTGCTGACGCCCGCCCTCACCGCCACGATGCTGAAGC-C 1499 
氺氺 ^ ^ 氺 氺 氺 承 ； i i i f : 氺 氺 氺 � ； 氺 氺 氺 氺 氺 ； } ; 氺 氺：^：� 氺 
Yersinia AACCATAAACCGCCATCA GAGCACGGTTTCTTCGGCGGGTTCAACCGTCGCTA 1553 
E.coli CAGCATGTTCCGCCACAT M M M G G C m T T C G G C G C A T T T G A C C G C m T A 1541 
Cau 1 obac t e r GGTCMGGCCGGTCACCACGAGGAGMGACCGGCTTCTTCGGCTGGTTCAACCGCAGCTT 1559 
Yersinia TGACCGGATGCAGACCCGmTGAMGCCTGGTAGGGCATGTTATTCACCGCTCTTTGCG 1613 
E.coli CCGCCGTACTGAAGATAMTATCAGCGAGGCGTMTTTATGTCCTGCGCCGTGCTGCTCG 1601 
• Cau 1 obac t e r CMCGACATGTCGTCGCGCTATCAGGGCTCGGTTCGCMGATCCTGGGCMGCGCGGCCG 1619 
‘ 傘 ： 氺 * 氺 氺 ^ � » 氺 氺 I氺 
^ 1 6 0 3 d B 
Yersinia CTATTTACTGATTTACGCCGTGCTGATTGGGGTGATGTGTGTGTTGTTTATTCGCCTGCC 1673 
E.coli MCGATGGGGCnTATCTCGTACTGGGTGGTGGMTGGCCCTGATGATGTGGAMCTGCC 1661 
Caulobacter CTGGATGGCCATCTACGCCGCGATCATCGTGGCCATGGGCCTGCTGTTCGTCCGCCTGCC 1679 
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Yersinia MCGGGCmTTACCGACCGAAGATCAGGGTGATGTCATGGTGCMTATACCTTGCCAGC 1733 
E.coli GGGCAGnTCTTACCCACTGAAGACCAGGGCGMATCATGGTGCAGTACACGCTGCCGGC 1721 
Caul obac t e r CAGCGCCTTCCTGCCCGAAGAAGACCAGGGGACCATGTTCACCCTGGTGCAGCTGCCCGC 1739 
氺* 氺氺氺 氺;i；氺氺承承氺;i；氺氺 乐 * ^ 氺氺氺氺氺氺 
Yersinia AGGGGCAACCAGTGGGCGCACCATGGAGGTCAGTMGGCGGTAGAAMCTATTTCATGAC 1793 
E.coli CGGGGCGACCGCTGCCCGTACAGCAGMGTGAATCGCCAGATTGTTGACTGGTTCCTGAT 1781 
Cau 1 obac t e r CGGCGCGACCGAGGAGMGACCCTGGCCGTGCTGGACCAGGTGCGCGACCACTTCCTGGT 1799 
Yersinia GCAGGAAMGGACMTACCAMGCGGTCTTCACTATCTCCGGTnTGGCTTTAGTGGTAG 1853 
E.coli TMCGAGAAAGCAAATACCGATGTCATTTTTACCGTTGATGGTTTCAGTTTTAGCGGCAG 1841 
Cau 1 obac t e r CGGCGAGMGGAGGCCGTCCAGTCGGTGTTCACCGTCTCGGGOTCAGCTTCGCCGGCGC 1859 
氺氺；is* 氺 * * * ** * =i�* * ** 
Yersinia CGGGCAAAATGCCGGTATGGCGTTTATTGCATTGAAACACTGGCGTGACCGGCCGGGCAG 1913 
E.coli , CGGACAGAACACCGGGATGGCGTTTGTTTCGTTGAAAMCTGGTCTCMCGTAMGGGGC 1901 
Cau 1 obac t e r CGGCCAGMCGCGGGTCTCGCCTTCGTGCGCCTGMGGACTTCGAGCACCGCMGTCGGC 1919 
氺:i?氺 本氺 氺氺 ^ 本氺 氺 氺氺 氺氺 氺 氺本氺氺 氺本氺 氺 氺氺 
Yersinia TGAAMTACCGCCACAGCCATTGCAGATCGCGCGATGMGGCACTGTCGAGTATTCGCGA 1973 
E.coli AGAAMCACCGCCCAGGCTATCGCCCTACGGGCMCCAMGAGCTGGGCACAATTCGTGA 1961 
Cau 1 obac t e r CMCCTGMGGCCCAGGCCGTGGCCGGTCGCGCCATGGGCGCCTTCAGCCAGTTCCGTGA 1979 
^ 氺 H： * * 氺* 水水：i： 氺 * =i： ** Si：* 
Yersinia TGCCCAMTTTTCAGTATGACGCCACCTGCGGTGGATGGGTTAGGCCAGTCGMTGGCTT 2033 
‘E.coli TGCCACGGTATTTGCGATGACGCCGCCAGCCGTTGATGGGCTGGGGCAMGCMTGGTTT 2021 
• Caul obac ter CGCCATGGTGTTCGCCATCGTTCCGCCGGCCGTGCAGGAGCTGGGCMCTCGTCCGGCTT 2039 
‘ 氺氺* 氺 ^^ 氺氺 氺 氺 氺 氺 氺 氺 氺 泳 氺 译 * 氺；}:氺 承 氺氺水氺 
Yersinia TACTnTGAGTTGCMGCCACAGGGGATACCAGCCGCGAGCMCTGCTGACCTTGCGCGA 2093 
E.coli TACGTTTGMTTGTTAGCTAACGGTGGMCCGATCGCGAAACACTACTGCAAATGCGTM 2081 
Cau1obac t e r CGACTTCCAGCTGCAGGACGTCGGCGGCGTCGGCCACGAGGCCCTGATGAACGCCCGCM 2099 
, 氺 氺 水 來 氺 氺 氺氺氺 氺 氺 承 氺 : i ： 氺氺 氺;i： 氺氺 * 
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Yersinia TCMCTGAmGCMGGCGMTMAGACCCTATnTGGCCTCAGTTCGCGCCAATACCTT 2153 
E.coli TCAGTTGATAGAAAMGCGMTCAMGTCCGGAGmCATTCTGTTCGTGCCMTGATTT 2141 
Cau1obacter CATGATGCTGGGCATGGCCTCGCAGGATCCCAGCCTGGTGGGCGTGCGCCCCAACGGCCA 2159 
承水；i： 中 氺 氺 ；jc 承木 * ^^ *木*=!： 
Yersinia GCAACAAATGCCGCAGTTACAAGTAGATATCGATMCGATMAGTCGCGGCATTAGGGCT 2213 
E.coli GCCACAMTGCCGCMTTGCAGGTAGATATTGATAGTMTAMGCGGTGTCATTAGGGTT 2201 
Cau 1 obac t e r GGACGACACCCCGCAGCTGMGATCGAGGTCGACCAGGCCMGGCCGGCGCGCTGGGCCT 2219 
水 氺；i； 承氺:i：承:i； * 水 -t 本 ^^ ^ * 本 * ** ^ 
Yersinia GTCGATCAGTGATGTGMTGCCACATTMGTGCCGCCTGGGGTGGGACGTATATCMTGA 2273 
E.coli GAGTTTGMTGATGTCACCGACACCCTGTCCAGTGCGTGGGGCGGTACTTATGTGMTGA 2261 
Cau 1 obac t e r GACCACCGCCGACATCAACAGCGCCCTCAGCGCCGCCTGGGGCGGGTCGTACGTCMCGA 2279 
^ ！ ^ ^ ^ * 氺if： 氺氺 氺：i；氺 * ^ I 
Yersinia CTTTATTGATCGTGGGAGAGTGAAAAMGTGTATATGCAGGGTGATGTGGATACCCGCTC 2333 
E.coli . CTTTATTGACCGTGGTCGTGTGAMAMGTCTACATTCAGGGCGACAGTGAAnTCGTTC 2321 
Cau 1 obac t e r CTTCATCGACCGCGGCCGCGTGMGAAGGTCTACATGCAGGCCGACGCCCCGTTCCGCAT 2339 
* 氺 氺 氺 氺 氺 *氺 I 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 承 氺 * 氺氺 氺氺 
2256dB 
Yersinia TAMCCGGAGGATCTCMCCMTGGTTCGTGCGCGGTAGCAGTGATGCCATGACATCGTT 2393 
E.coli CGCGCCGTCAGACTTAGGTAMTGGmGTGCGCGGTAGTGATAACGCCATGACACCATT 2381 
Cau 1 obac t e r GACGCCCGAGGACCTGAACCGCTGGTACGTGCGCMCMCCMGGCCAGATGGTCGCCTT 2399 
；i；氺 氺 氺 水泳;J；氺氺氺 氺 氺氺;i； 氺 ；^氺 
Yersinia TTCTGCCTTTGCGACMCTCGCTGGATTTACGGCCCGGAAACGCnTCCCGCTATAACGG 2453 
E.coli CTCTGCrnTGCGACCACCCGCTGGCTGTATGGACCGGAAAGACTGGTGCGCTACMCGG 2441 
,Caulobacter CCCGGCCTTCGCCACGGCGTCGTGGACCTACGGCTCGCCGCGCCTGGAGCGCTACAACGG 2459 
‘ 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺氺* 氺氺 ^^ 氺氺 ^^ 本氺氺氺氺氺氺氺氺氺 
Yersinia GCAGACGTCCTATGAMTTCAGGGGCAGGCCGCTTCCGGCAGCAGTTCGGGCACCGCMT 2513 
E.coli TTCTGCAGCCTATGAMTTCAGGGGGMMTGCGACTGGCnTAGTTCCGGCGATGCMT 2501 
Cau 1 obac t e r CCTGTCGTCGGTCAACATCCAGGGCGCCCCGGCCCCGGGCMGAGCTCGGGCGACGCGAT 2519 
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Yersinia GGATCAAATGGAGAAACTGGCGGCTGMTTACCTG---GCACCAGTTATGCGTGGAGCGG 2570 
E.coli GACMAAATGGAGGMCTGGCAAACAGTCTTCCTGCGGGAACMCCTGGGCCTGGAGTGG 2561 
Caulobacter CGCGGCGATGGAGMGATCGCGGCCMGCTGCCGCCCGGCGTCGGCTATGAGTGGACCGG 2579 
Yersinia GCTGTCTTATCAGGAGCGTTTAGCCAGCGGGCAAGaTTATCGCTGTATGCCATTTCMT 2630 
E.coli TTTGTCATTGCAGGAGMACTGGCCAGCGGTCAGGCATTGAGTCTGTATGCAGTTTCTAT 2621 
Cau 1 obac t e r CCTGTCGGCCCAGGMCTGGAGGCCGGCMTCAGGCCCCCGCCCTGTACGCCATCTCGAT 2639 
Yersinia CTTGGTGGTATTCCTGTGCTTGGCGGCGTTGTATGAGAGTTGGTCAGTCCCGTTCTCGGT 2690 
E.coli TCTGGTGGTTTTCCTCTGCCTTGCAGCACTGTACGAAAGCTGGTCAGTCCCGTTCTCGGT 2681 
Caulobacter CCTGGTGGTGTTCCTGCTGCTGGCCGCGCnTACGAGAGCTGGTCGATCCCGCTGGCGGT 2699 
；i；氺;i； *氺;I? :i：本jJ:；}；氺 氺 氺 氺 承 ; i ； 氺 ^ ^ 氺;i： 氺氺氺氺;J；氺氺 ：！：氺;承氺 氺氺氺氺 
Yersinia CATGATGGTTATTCCGTTGGGGATAATCGGTGCAGTAGCGGCAGCGACGCTGCGGGGATT 2750 
E.coli , CATTCTGGTGATCCCTCTGGGGOTCTTGGCGCGGCGCTGGCGGCCTGGATGCGTGATTT 2741 
Cau 1 obac t e r GATCATGGTCATCCCGCTGGGCGTCATCGGCGCCCTGCTGGCGACCTTCGCCCGTGGCCT 2759 
氺氺 氺氺； }：承本氺承 ;氺氺氺 ; i ： 氺 氺 氺 ; J : 氺 氺 氺氺氺 氺 氺 * 氺 氺 
Yersinia GGAAMTGATATTTACTTCCAGGTGGCGTTGTTGACGACCCTGGGTCTGGCATCGAAAAA 2810 
E.coli AMCMCGATGTTTACTTCCAGGTGGCGCTATTMCCACTATCGGCTTGTCGTCGAAAM 2801 
Cau lobacter CAGCMCGACATCTACTTCCAGGTGGGCCTGCTGACGACCATGGGCCTGGCGGCCMGM 2819 
水 氺 氺 * ^ 水氺氺承氺承氺;icjic珍:i；承氺 承 ^ ^^ 氺 * 氺 氺 * 氺 农承; f： ；f：氺 
Yersinia CGCCATTCTGATTGTTGMTTTGCCGMGCGGCCTATTTACGCGGCGMCCGCTGGTGGT 2870 
'E.coli CGCCATTCTGATTGTGGMTTTGCTGAAGCGGCGGTTGCAGAGGGTTATTCCTTGAGTCG 2861 
Caulobacter CGCCATCCTGATCGTCGAGTTCGCCMGGACCTCTACGAGAAGGGCATGGGCCTGATCGA 2879 
' 氺氺氺氺氺氺氺*氺氺承；！：泳氺氺；1；木氺氺 承 氺 氺氺 氺氺 
Yersinia GGCGGCGTTGCAGGGCGCTGCMCTCGCTTACGGCCTATCCTGATGACATCGCTGGCATT 2930 
E.coli TGCGGCATTACGCGCGGCGCAGACTCGTTTACGCCCMTCATCATGACCTCGCTGGCGTT 2921 
Cau1obacter GGCCACGCTGGAGGCGGTTCGCCTGCGCCTGCGCCCGATCATCATGACCTCGCTGGCCTT 2939 
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Yersinia TATTGCTGGGG-TAATGCCTCTGGCMTGTCTACCGGTGCCGGTGCTAACAGCCGCATTT 2989 
E.coli TATTGCGGGGGGTMTGCCGCTGGCGATAGCMCCGGCTCAGGGGCGMCAGCCGCATCG 2981 
Can 1 obac t e r CGTCTTCGGCG-TGCTGCCGCTGGCGATCTCCMOGGGGCTGGATCGGGGGCCCAGCACG 2998 
Yersinia CMTCGGCAGCGGCAmTTGGCGGCACCTTAACGGCGACAGTGTTGGCCGTCmTTTG 3049 
E.coli CCATTGGTACGGGCATTATTGGCGGTACGCTGACCGCTACGTTGCTGGCTATTTTCTTTG 3041 
Caulobacter CGATCGGCACCGGCGTCATCGGCGGCATGATCTCGGCaCCCTGCTCGCCATCTTCTTCG 3058 
3032dB 
Yersinia TCCCGCTCTmTTGTCTTGATTCGTCGAGTGTTCAGCGGCMGTCAAAAAATATCACTG 3109 
E.coli TTCCTCTGTTTTTTGTACTGGTGAAGCGTTTGTTTGCCGGTM--. 3084 
Caulobacter TCCCGCTGTTCTTCGTGGTGGTCGAGMGATCTTCAAACCCMGCACAACGGTCACGACG 3118 
； 氺 r 氺 水 氺 氺 ^ ^ ^ ^ 氺 氺氺氺 氺氺 
^ 3183dB 
Yersinia AACATAAAGGAGTATAA 3126 
E.coli  
Caulobacter . CCGCCCAAGGCCAAGTGTCGTCGACGGAGGCTCACTGA 3156 
Figure 2.3 Design of degenerate primers base on the alignment of RND type transporter genes: 
putative efflux pump of Escherichia coli (accession no. NC 002655), multidrug efflux 
protein of Yersinia pestis (NC 003143) and the AcrBDF family protein of Caulobacter 
crescentus (NC 002696). 
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Genomic DNA is digested with restriction 
广 t y enzyme that recognizes six-base site and leaving 
J[ blunt end. The known sequence is depicted as an 
orange line. Filled and open boxes represent the 
V upstream and downstream flanking regions. 
t t t t 
峰 — j • 
I I DNA fragments of different length 
are ligated to the GenomeWalker 
� , Adaptor (blue boxes). 
r I 11 
After self-iigation of the adaptor, DNA library 
is constructed. The sequence of the flanking 
region can be amplified by the gene specific 
primer (GSP), designed based on the known 
sequence, and the primer on the adaptor (AP). 
V 
Figure 2.4 The principle of chromosome walking using GenomeWalker Kit. There 
are four restriction enzymes to construction four DNA libraries. Only 
one library is constructed in this figure from one restriction enzyme. 
The other flanking region (open box) can be amplified by designing 





First round chromosome walking 
Four gene-specific primers, A-D (Table 2.17), were designed for the upstream and 
downstream region, based on the known sequence of adeE (Figure 2.5a). Adaptor 
primer, API (5'-GTA ATA CGA CTC ACT ATA GGG C-3') provided by the Kit 
was used with the gene-specific primers, B and D (Table 2.17) in the primary PCR to 
amplify the four DNA libraries from isolate 4365. The products obtained from the 
primary PCR were then used for secondary PCR. Adaptor primer, AP2 (5'- ACT 
ATA GGG CAC GCG TGG T-3，）was used with the specific primers A and C (Table 
2.17) in the secondary PCR. The reactions (1-8) are shown in Table 2.16. 
Amplification reactions were done in a thermal cycler and a total volume of SOjil was 
used. The reaction mixture contained 0.2U of Taq DNA polymerase, 0.2|iM of each 
primer, lOOi^ iM of 6ach deoxyribonucleoside triphosphate, Ix PCR buffer, and \[x\ of 
the DNA library (see 2.5.14) (for primary PCR) or PCR product from primary PCR 
(for secondary PCR). 
Two steps cycle parameters were used for the primary PCR with the first step of 7 
cycles of 2 sec at 94 °C and 3 min at 72 °C. Then followed by the second step of 35 
cycles of 2 sec at 94 °C and 3 min at 67 °C, and a final extension of 67 °C for 4 min. 
Amplicon was analyzed by gel electrophoresis (see 2.5.2c). 
, For the secondary PCR, two steps cycle parameters were also used, with the first step 
of 5 cycles of 2sec at 94 °C and 3min at 72 °C, followed by the second step of 20 
cycles of 2sec at 94 °C and 3niin at 67 °C, and a final extension of 67 °C for 4min. 
The amplicon was analyzed by gel electrophoresis (see 2.5.2c). Interested PCR 
products were cloned (see 2.5.8). The inserts of the plasmid, pAdeE002, pAdeE003 
and pAdeE004 (Table 2.16, reactions 1-8), obtained from the clones were DNA 
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sequenced (see 2.5.9) and the results were searched for matched DNA or aa 
sequences in GenBank (see 2.5.10a-b). The DNA sequences obtained from 
pAdeE002, pAdeE003 and pAdeE004 were aligned (see 2.5.10c) and combined with 
the known adeE sequence (Figure 2.5a). 
Second round chromosome walking 
Two gene-specific primers E and F (Table 2.17) were designed according to the 
combined sequence of adeE from the first round reaction (Figure 2.5a). Each specific 
primer was used with the adaptor primer (API) to amplify the four DNA libraries 
(see 2.5.14) from isolate 4365. The reactions are shown in Table 2.16 (reactions 
9-16). 
Amplification reactions were done in a thermal cycler and a total volume of 50|al was 
used. Reaction mixture contained 0.2U of Taq DNA polymerase, 0.2|j,M of each 
primer, 100|aM of each deoxyribonucleoside triphosphate, Ix PCR buffer, and 1^1 of 
the DNA library (see 2.5.14). 
Two-step cycle parameters were used for the primary PCR with the first step of 7 
cycles of 2sec at 94 °C and 3min at 72 °C. Then followed by the second step of 35 
cycles of 2sec at 94 °C and 3min at 67 °C, and a final extension of 67 °C for 4min. 
The amplicon was analyzed by gel electrophoresis (see 2.5.2c). Interesting products 
were cloned (see 2.5.8) for DNA sequencing (see 2.5.9). Plasmids pAdeE005, 
pAdeE006, pAdeEOO? and pAdeE008 (Table 2.16, reactions 9-16) were generated 
from the cloning. The sequencing results were searched for matched DNA or aa 
sequences in GenBank (see 2.5.10a-b), and were aligned and combined with the 
adeE sequence obtained from the first round chromosome walking. 
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Table 2.16 The combination of DNA libraries and gene-specific primers used, 
and the plasmids generated for the characterization of adeE. 
Reaction DNA library Specific primer Specific primer Plasmid generated after 
1 DL-£coRV 砂ed with A P I w i t h AP2c lon ing 
2 DL-五 coRV D C -
3 DL-Dral B A -
4 DL-Dral D C pAdeE004 
5 DL-Pvull B A pAdeE002 
6 DL-PvwII D C pAdeE003 
7 DL-Sspl B A -
8 DL-Sspl D C -
9 DL-五 coRV E 
10 DL-£coRV F - -
11 DL-Dral E - -
12 DL-Dral F - -
13 DL-PvuU E - pAdeE006 
14 DL-PvwII F - pAdeEOO? 
15 D L -鄉 I E - pAdeEOOS 
16 DL-Sspl F - pAdeE008 
17 DL-£coRy G - -
18 DL-£coRV H - -
19 DL-Dral G - pAdeEOOll 
20 DL-Dral H - pAdeE009, pAdeEOlO 
21 DL-PvwII G - -
22 DL-PvuU H - -
^ 23 D L -卻 I G - -
24 DL-Sspl H - -
AP1，adaptor primer used for primary PGR 
AP2, adaptor primer used for secondary PGR 
y • 
Third round chromosome walking 
Two gene-specific primers G and H (Table 2.17) were designed according to the 
combined sequence of adeE from the second round reaction (Figure 2.5a). Each 
specific primer was used with the adaptor primer (API) to amplify the four DNA 
libraries (see 2.5.14). The reactions are shown in Table 2.16 (reactions 17-24). 
The amplification reactions and cycle parameters were the same as the PGR in the 
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second round chromosome walking. The amplicon was analyzed by gel 
electrophoresis (see 2.5.2c). Interesting products were cloned (see 2.5.8) for DNA 
sequencing (see 2.5.9). Plasmids pAdeE009, pAdeEOlO and pAdeEOll (Table 2.16, 
reactions 17-24) were generated from the cloning. The sequencing results were 
searched for matched DNA or aa sequences in GenBank (see 2.5.10a-b), and were 
aligned and combined with the available adeE sequence to obtain the whole 
sequence of adeE (Figure 2.5a). 
The full sequence of adeE was searched for matched DNA or aa sequences in 
GenBank (see 2.5.10a-b). 
Table 2.17 Nucleotide sequences of gene-specific primers used in chromosome 
walking of adeE. 
Primer name Nucleotide sequence 
A u p 7 1 B - G S P 2 5'-CAA TGT CAG GAT ATT GCT CAA TGG GTA-3，^ 
B upl71B-GSPl 5，-CCA TCAATA CCC TTAATT TGT TGC TCC-3' 
C down600-GSP2 5'-AGC ACA AAA CAC TCA AAT TAG AGC AGG-3' 
D down565-GSPl 5,-GGA TTA ATG CCA TCA GAT GTT AGA ACC-3’ 
E downl010-GSP3 5'-GCT GAA GCA ATT GTT CTC GTC ATT A-3' 
F downl086-GSP4 5’-TTG CTG TTC CAG TTG TAT TGT TAG G-3’ 
G down-GSP5 5'-CTA CTG GCG AAT GGA CAT ATG GTT CT-3' 
H down-GSP6 5,-CAT CGG TTA ACA TTC AAG GTA CAC CTG-3’ 
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2.9.2b adeY 
First round chromosome walking 
Four gene-specific primers, I-L (Table 2.19), were designed for the upstream and 
downstream region, based on the known sequence of adeY (Figure 2.5b). Adaptor 
primer, API (5'-GTA ATA CGA CTC ACT ATA GGG C-3') was used with the 
gene-specific primers, J-L (Table 2.19) independently, in the primary PCR to amplify 
the four DNA libraries (see 2.5.14) from isolate 4365. Interesting products obtained 
from the primary PCR were then used for secondary PCR. Adaptor primer, AP2 (5'-
ACT ATA GGG CAC GCG TGG 丁-3，）was used with the specific primers I (Table 
2.19) in the secondary PCR. The reactions (25-36) are shown in Table 2.18. 
The amplification reactions and the PCR cycle parameter (primary and secondary 
PCR) were the same as in the first round chromosome walking of adeE (see 2.9.2a -
First round chromosome walking). Interesting PCR products were cloned into 
pCR2.1 (see 2.5.8). The inserts of the plasmids, pAdeY003, pAdeY004, pAdeY005 
and pAdeY006 (Table 2.18, reactions 25-36), obtained from the clones were DNA 
sequenced (see 2.5.9) and the results were searched for matched DNA or aa 
sequences in GenBank (see 2.5.10a-b). The sequences obtained were aligned (see 
2.5.10c) and combined with the known at/e7sequence (Figure 2.5b). 
, Second round chromosome walking 
Two gene-specific primers M and N (Table 2.19) were designed according to the 
combined sequence of adeY from the first round reaction (Figure 2.5b). Each specific 
primer was used with the adaptor primer (API) to amplify the four DNA libraries 




The amplification reactions and the PCR cycle parameters were the same as in the 
second round chromosome walking of adeE (see 2.9.2a — Second round chromosome 
walking). Interesting products were cloned (see 2.5.8) for DNA sequencing (see 
2.5.9). Plasmids pAdeY007, pAdeYOOS, and pAdeY009 (Table 2.18, reactions 37-44) 
were generated from the cloning. The sequencing results were searched for matched 
DNA or aa sequences in GenBank (see 2.5.10a-b), and were aligned and combined 
with the available oJeF sequence to obtain a full sequence of adeY. The full sequence 
of adeY 观s searched for matched DNA or aa sequences in GenBank (see 2.5.10a-b). 
Table 2.18 The combination of DNA libraries and gene-specific primers used, 
and the plasmids generated for the characterization of adeY. 
Reaction DNA library Specific primer Specific primer Plasmid generated after 
DL-五coRV ysed with AP1 ~psed with AP2clon ing 
26 DL-^coRV K - -
27 DL-EcoRV L - -
28 DL-Dral ‘ J I -
29 DL-Dral K - pAdeY004 
30 DL-Dral L - -
31 DL-PvwII J I pAdeY003 
32 DL-PvwII K - -
33 DL-PvwII L - pAdeY005, pAdeY006 
34 D L -細 I J I -
35 DL-Sspl K - -
36 DL-Sspl L - -
‘ 3 7 DL-EcoKV M - -
38 DL-EcoRW N - -
39 DL-Dral M - -
40 DL-Dral N - pAdeY008, pAdeY009 
41 DL-PvuU M - -
42 DL-Pvi/II N - pAdeYOO? 
43 DL-SspI M - -
44 DL-SspI N - -
API, adaptor primer used for primary PCR 
AP2, adaptor primer used for secondary PCR 
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Table 2.19 Nucleotide sequences of gene-specific primers used in chromosome 
walking of adeY. 
Primer name Nucleotide sequence 
1 upl35B-GDP2 3’-GCT GTT ATC TGG TGA GTA GAA TGC AAT-5' 
J up350B-GSPl 3,-CCT AAT TGA CCT ACT GCT ACT TGT GAG-5' 
K downl582-GSP2 3'-GCT TCG TTA AAT TGA AAG ACT GGA G-5' 
L dwonl281-GSP5 3'-AAT GGT GTT A AC CGC ATG CTT AAG G-5' * 
M down2300-GSP6 3'-CTA CTG GCG AAT GGA CAT ATG GTT CT-5' 
N down240Q-GSP7 3，-CAT CGG TTA ACA TTC AAG GTA CAC CTG-5’ 
y ‘ 












































































































































































































































































































































































































































































































































2.9.3 Sequences of AdeE and AdeY and their comparison 
DNA sequences of adeB (Magnet et al., 2001), adeE and adeY were aligned using 
the program Clustal W (see 2.5.10c). The DNA sequences of adeE and adeY were 
translated into aa sequences (see 2.5.10a) and then aligned (see 2.5.10c) with the aa 
sequences of AdeB (Magnet et al., 2001) from A. baumannii, AcrB (Ma et al., 1993) 
and AcrD (Rosenberg, Ma and Nikaido, 2000) from E.coli, MexB (Poole, Heinrichs 
and Neshat, 1993), MexD (Poole et al., 1996) and MexY (Mine et al., 1999) from P. 
aeruginosa, MtrD (Hagman et al, 1997) from Neisseria gonorrhoeae, AmrB (Moore 
et al., 1999) from Burkholderiapseudomallei. 
2.9.4 Topology prediction of AdeE and AdeY 
After translating the DNA sequences of adeE and adeY into aa sequences (see 





2.9.5 The role of the putative pump AdeE 
The procedures to study the role of the putative pump adeE are summarized in 
Figure 2.6. Target disruption was used as described in Magnet et al (2001) with 
minor changes (Figure 2.7). 
PCR and Ligation 
A fragment internal to the adeE gene was amplified from the total DNA of isolate 
4365 (see 2.5.2a). Primers AdeE-79A and AdeE-538B were used and the product 
size was 459 bp. 
A PCR reaction was carried out at a total volume of 25|il containing 0.5|iM of each 
primer, 0.5U of Taq DNA polymerase, 200^M of each deoxynucleoside triphosphate, 
Ix PCR buffer and \\i\ of template (see 2.5.2a). 
PCR reaction mixtures were heated for 5min at 94°C, followed by 30 cycles of 30sec 
at 95°C, 30sec at 4 8 � C and Imin at 72°C. The reaction was finished with a final 
extension step with 5min at 72°C. The amplicon was analyzed by gel electrophoresis 
(see 2.5.2c) and was ligated (see 2.5.8 - Ligation) to obtain pAdeE012. 
Selection of recipient isolate 
The recipient isolate should be adeE^ and ticarcillin sensitive because ticarcillin was 
used for the selection of the transformed cell. GDG 3 isolates (see 2.1.3b) were tested 
for the presence of adeE by PCR using primers AdeE-79A and AdeE-538B. The 
PCR reaction and the PCR cycle parameter were same as mentioned before (see 
2.9.5 — PCR and Cloning). The ticarcillin sensitivity of the GDG 3 isolates was tested 
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Competent cell preparation 
Fresh colony (see 2.4.3) from MHA of isolate 8108 was inoculated into 10ml BHI 
broth and shaken at 200 rpm overnight. Culture (100|al) was transferred into another 
10ml BHI and shaken at 200 rpm for about 3-4hr to achieve 0.5A at OD600 using 
spectrophotometer. The 10ml culture was centrifuged at 10,000 rpm at 4 °C for 
lOmin. After discarding the supernatant, 10ml of ice-cold ddHsO was added to 
re-dissolve the pellet. This step was repeated 4 times, andon the last time 10ml of 
10% ice-cold glycerol was used instead of ddH20. Finally�after centrifuging at 
10,000 rpm at 4 °C for 10 min, 50|il of 10% ice-cold glycerol was added to 
re-dissolve the pellet and then transferred into a 1.5ml microfuge tube, and then 
stored at -70 °C. • 
Electroporation ‘ 
Using 0.4 cm cuvette for electroporation, 50|al competent cell and lOfil of the 
ligation mixture of pAdeE012 (see 2.9.5 - PCR and ligation) were added into the 
cuvette. The parameters for electroporation were set with resistance of 1,000Q, 
capacity of 25|aF and voltage 2,000V. After the electric shock, 1ml BHI was added to 
the reaction mixture and then transferred into a 1.5ml microfuge tube. The mixture 
was shaken at 37 °C for 3hr. 
Selection of transformed isolates 
After 3hr incubation with shaking, different volume of the culture (50}il and lOOjil) 
were plated on 900|ig/ml ticarcillin containing MHA. The plates were incubated at 
• 
37°C overnight. The ticarcillin-resistant colony was randomly selected and 
sub-cultured onto MHA. After incubating at 3 7 � C overnight, it was kept at -70�C 
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(see 2.4.2) for further characterizations and it was designated as 8108-15. 
PCR confirmation 
The total DNA (see 2.5.2a) of the ticarcillin-resistant isolate 8108-15 was analyzed 
by PCR using Ml3 reverse primer with the gene-specific primer AdeE-79A and Ml3 
(-20) forward primer with AdeE-79A to confirm the presence of the at/e五-containing 
vector in the isolate 8108. Furthermore, another PCR reaction using Ml3 reverse 
primer and Ml3 (-20) forward primer was performed to confirm the at/e五-containing 
vector was incorporated into the genome of the isolate 8108. The rationale for the 
choice of PCR primers is shown in Figure 2.8. 
A PCR reaction was carried out in a total volume of 25}al containing 0.5|aM of each 
primer, 0.5U of Taq DNA polymerase, 200|aM of each deoxynucleoside triphosphate, 
Ix PCR buffer and" 1 of template (see 2.5.2a). 
The reactions were carried out with initial denaturation of 5min at 95°C, followed by 
30 cycles of 30sec at 95°C, 15sec at 50°C and Imin at 72°C, and then a final 
extension of 3min at 72�C. Amplicon was analyzed by gel electrophoresis (see 
2.5.2c). 
PFGE confirmation 
, To confirm the ticarcillin-resistant isolate 8108-15 came from 8108, PFGE was used 
to check the similarity of their fingerprints (see 2.5.4). 
Susceptibility testing 
‘ Antibiotic susceptibility was tested by disc diffusion (see 2.5.6) on methicillin, 
oxacillin, piperacillin, imipenem, cefepime, cefotaxime, cefoperazone, cftazidime, 
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cefuroxime, amikacin, gentamicin, netilmicin, neomycin, tetracycline, ciprofloxacin, 
nalidixic acid, ofloxacin, chloramphenicol, rifampin and sulfamethoxazole, and the 
MIC of amikacin, chloramphenicol, ceftazidime, ciprofloxacin, erythromycin, 
meropenem, rifampin, tetracycline and ethidium bromide were determined (see 
2.5.5). 






























































































































































































































































































































































































































2.10 Distribution of AdeB and the putative efflux pumps AdeE 
and AdeY in acinetobacters from different bacterial 
collections 
2.10.1 Distribution of adeB and the putative pumps {adeE and adeY) 
in blood cultures (1997-2000) 
PCR detection of adeB 
Primers 03 and 04 described by Magnet et al. (2001) were used to screen for the 
presence of adeB in Acinetobacter blood culture isolates collected between 
1997-2000 (see 2.4.1a). The PCR reaction was described in 2.8.1b. 
Clonal relatedness of adeB+ and adeB' isolates 
To exclude the possibility that adeB+ isolates were clonally related, PFGE (see 2.5.4) 
was carried out on 38 randomly selected GDG 2 isolates. 
PCR detection of adeE 
Specific primers AdeE-245A (3，-GTA GTA GTT CGG CAG GAC AA-5') and 
AdeE-620B (3'-GCG GTT CTA ACA TCT GAT GG-5') were designed based on the 
sequence of the adeE gene, with the product size of 376 bp. They were used to 
screen for the presence of adeE in the blood culture isolates collected 1997-2000 (see 
2.4.1a). 
r Amplification reactions were done in a thermal cycler and a total volume of 25|j.l was 
used. The reaction mixture contained 0.5U of Taq DNA polymerase, 0.5|iM of each 
primer, 200|aM of each deoxyribonucleoside triphosphate, Ix PCR buffer, and 1|liI of 
the DNA template (see 2.5.2a). 
The PCR reaction mixtures were heated for 5min at 94°C, followed by 30 cycles of 
30sec at 95°C, 30sec at 53°C and 30sec at 72°C. The reaction was finished with a 
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final extension step with 5min at 72°C. The amplicon was analyzed by gel 
electrophoresis (see 2.5.2c). The positive reaction mixtures were used for further 
characterization (see 2.10.2 - adeE). 
PCR detection of adeY 
Specific primers AdeY-343A (3'-CAA TCT GCA ACT GCG CTT-5') and 
AdeY-920B (3'-TCA ACA GCT TCT GCG GTA-5’）were designed based on the 
sequence of the adeY gene, with product size of 587 bp. The-primers were used to 
screen for the presence of adeY in the blood culture isolates in 1997-2000 (see 
2.1.4a). 
The amplification reactions and the PCR parameter were same as for PCR detection 
of adeE (see 2.10.1 - PCR detection of adeE). The positive reaction mixtures were 
used for further characterization (see 2.10.2 - adeY). 
adeE and adeY in GDG 3 isolates 
Combining the results obtained from PCR detection of adeE and adeY, the number of 
isolates of the four conditions (AdeE+ and AdeY+，AdeE+ and AdeY", AdeE" and 
AdeY+, as well as AdeE" and AdeY" isolates) were obtained. 
i " 
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2.10.2 Confirmation of the identity of the amplification products of 
adeE and adeY 'm blood culture isolate (1997-2000) 
To confirm the identity of the PGR products of adeE and adeY, RFLP of the products 
were done. 
adeE 
Four restriction enzymes, Hha\ (GCGC), Hinfi (GANTC), Hindi (GTYRAC) and 
Mse\ (TTAA), were used to digest the 376 bp AdeE-245A — AdeE-620B PGR 
products. Figure 2.9 shows the restriction site of the enzymes at the sequence of 
adeE. For each digestion reaction, 1.5U of enzyme was used, together with 4|il of the 
PGR product and Ix of the commercially supplied buffer, and then made up to 10)li1 
by ddH20. After incubating in a water bath at 37°C overnight, the products were 
analyzed by gel electrophoresis (see 2.5.1b). Numbers were assigned for different 
patterns obtained from each restriction digestion. The combination of the numbers of 
the four restriction patterns constituted a RFLP profile for each individual isolate. 
adeY 
‘ Four restriction enzymes, Hhal (GCGC), Hinfi (GANTC), ApaU (GTGCAC) and 
�I . . (GTAC), were used to digest the 587 bp AdeY-343A — AdeY-920B PGR 
.products . Figure 2.10 shows the restriction site of the enzymes at the sequence of 
adeY. The reaction condition and the interpretation of the patterns were the same as 
y ' 
described for adeE (see 2.10.2 — adeE). 
Clonally relatedness of the different profiles found in adeE and adeY 
.To exclude the possibility that isolates with the same RFLP profile were clonally 
related, PFGE (see 2.5.4) was carried out on 64 randomly selected GDG 3 isolates. 
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2.10.3 The presence of adeE in GDG 3 acinetobacters from 
different sources 
All the GDG 3 acinetobacters (see 2.1.4b) from different sources, including 
surveillance, clinical and environmental samples, were screened for the presence of 
adeE by using the primers AdeE-79A and AdeE-538B. The reaction condition and 
cycling parameter were same as described in 2.9.5. The amplicon was analyzed by 
gel electrophoresis (see 2.5.2c). 
2.10.4 The presence of adeB, adeE and adeY in antibiotic 
susceptibility 
The mean, geometric mean, minimum, maximum, and the 25, 50 and 90 percentiles 
of MIC of amikacin, gentamicin, netilmicin, imipenem, ciprofloxacin, tetracycline, 
rifampin and ceftazidime for 57 GDG3 and 49 GDG2 isolates (randomly selected) 
and chloramphenicol for 23 GDG3 and 30 GDG2 isolates (existing data from 
Houang's laboratory) were calculated. The non-parametric method of Mann-Whitney 
U Test (SPSS, version 11.0) was used to compare the MIC of adeB+ and adeB' 
isolates of GDG 2, and isolates of RFLP—profiles 2111 and 3111 of adeE. 
2.10.5 adeB， adeE and adeY and the clonally and 
epidemiologically related sets of isolates 
The results from section 2.6 (Selection of acinetobacters from ICU, blood culture and 
other clinical isolates) and section 2.10.1 (Distribution of adeB and the putative 
J . • 
pumps {adeE and adeY) in blood culture (1997-2000)) were combined and tabulated. 
2.10.6 adeB, adeE and adeY and the blaiM?.A isolates 
The results from section 2.7 (Study of expression level of the bla\y[?-A gene) and 
section 2.10.1 (Distribution of adeB and the putative pumps {adeE and adeY) in 
blood culture (1997-2000)) were combined and tabulated. 


















































































































































































































































CHAPTER 3 SELECTION OF ACINETOBACTERS FROM 
ICU, BLOOD CULTURE AND OTHER 
CLINICAL ISOLATES 
To study the transcript levels of adeB, epidemiologically and clonally related isolates 
that exhibited different resistance patterns were sought. For this purpose, sequential 
isolates from the same patients in ICU, collections of blood culture isolates 
(1999-2000) and other clinical specimens were investigated. 
3.1 RESULTS 
3.1.1 Isolates from existing stock cultures 
3.1.1a Blood culture isolates (1999-2000) 
In the 1999-2000 collection, there were 110 blood culture isolates from 70 patients, 
and the GDG of these isolates had already been determined by others using ARDRA. 
For this project, MIC (see Chapter 2.5.5) and PFGE (see Chapter 2.5.4) were 
performed on them. 
Genomic DNA group 2 
All together there were 30 isolates from 23 patients identified as GDG 2 in the 
1999-2000 collection. Fourteen isolates were obtained from 6 patients and 
examined by PFGE, and MIC of gentamicin, amikacin, tetracycline, 
ciprofloxacin, chloramphenicol, rifampin, meropenem and ethidium bromide, 
was determined. Figure 3.1 shows the dendrogram results of PFGE. After 
comparing the MICs (data not shown), 2 sets of isolates, 2B and 2C, each with a 
Dice coefficient of similarity >95% were selected for use in my thesis. Isolate 
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5343B and 5343S of set 2B were morphological variants of 5343 — big and 
small colonies seen on a routine sensitivity test plate. The selected isolates in 2B 
and 2C were further examined for the presence of the resistance genes 
(aph(3 ’)-VIa, aac(6’)-Ib, blam?-^, and arr-aacA4), integrase I and the mutation 
of gyrA and parC (Table 3.1) (see Chapter 2.5.7). 
Genomic DNA group 3 
Twenty-three isolates from 17 patients were identified as GDG 3 in blood 
culture isolates in the 1999-2000 collection. Ten isolates from 4 patients were 
taken for PFGE, and MIC of different antimicrobial agents listed above was 
determined. Figure 3.2 shows the dendrogram results of PFGE. Two sets of 
isolates, 3B and 3C, were selected. Isolates within each set shared a Dice 
coefficient of similarity of 93% and showed changes in antimicrobial 
susceptibility (Table 3.1). They were then examined for the presence of different 
resistance mechanisms as listed above (Table 3.1). 
“ Other genomic DNA groups 
There were 57 isolates from 36 patients identified as GDGs other than group 2 
- or 3. Eleven patients had 30 repeat positive isolates and of the same GDGs. 
‘ These isolates were examined by PFGE (Figure 3.3) and MIC was determined. 
Four sets (B12, C5, DU, EU) of 10 isolates were selected. Isolates within each 
set shared a Dice coefficient of similarity of more than 95% and were examined 
for the presence of different resistance mechanisms as listed above (Table 3.1). 
、 . 120 
CHAPTER 2 
3.1.1b Existing sets of serial isolates 
In Dr. Houang's laboratory, there was already a collection of serial isolates that were 
identified as epidemiologically and clonally related, showing differences in 
antimicrobial susceptibility. They were used in previous studies by other members of 
Department of Microbiology (Houang et al, 1998). 
Genomic DNA group 2 . 
Two sets of sequential isolates (2D and 2E), belonging to GDG 2 Acinetobacter, 
were used in this project. The clonal relatedness of each set was re-confirmed 
with PFGE. Isolates of 2D and 2E were shown to have a Dice coefficient of 
similarity of 88% and 97% respectively (Figure 3.1). 
Genomic DNA group 13TU 
One set of GDG 13TU isolates (A13TU) was included in this study. The isolates 
were resistant variants which were observed inside the zone of inhibition during 
" disc susceptibility testing in the routine laboratory. They shared a Dice 
coefficient of similarity of 97% (Figure 3.3). 
‘ The presence of resistance genes {aph(3 ')-VIa, aac(6')-Ib and blampA, and 
J-- ‘ 
arr-aacA4), integrase I, the mutation of gyrA and parC and MIC of the same agents 
as listed above (3.1.1) were determined (Table 3.2). 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.1.2 New isolates obtained for this study 
Intensive care unit (ICU) 
From the routine clinical laboratory, 145 Acinetobacter isolates were collected from 
ICU from July 2000 to Feb 2001 and stored on the nutrient agar (NA) slants. One 
hundred and thirty three isolates from 65 patients were revived. Thirty-four patients 
had more than one isolate. By comparing the susceptibility results reported by the 
routine laboratory, 70 isolates from 22 patients showed changes in sensitivity 
patterns. They were first re-examined by disc diffusion test (see Chapter 2.5.6). 
Thirty isolates from 9 patients were further examined for clonal relatedness by PFGE 
(Figure 3.4). Isolates from 4 patients showed coefficients of similarity of > 89% and 
were therefore further examined to determine MIC of the eight antimicrobial agents 
listed above. However, none of the isolates were selected because the differences of 









































































































































































































































































































































































































































3.2.1 Identification of clonally related isolates by PFGE 
PFGE has been accepted as one of the methods to determine the relatedness of 
isolates in recent studies (Gouby et al, 1992; Graser et al, 1993; Seifert et al, 1994; 
Tenover et al., 1995). Tenover et al., 1995 suggested that strains with differences in 
less than 6 fragments could be regarded as genetically related and differences in 2-3 
fragments as closely related. In this project, those isolates with differences in < 3 
fragments would yield a Dice coefficient of similarity > 88% by the unweighted pair 
group method. Therefore, the Dice coefficient of similarity of > 88% was considered 
as clonally related sets of isolates in my work. 
Tenover et al, 1995, also suggested that the minor differences in restriction patterns 
are the results of occurrence of different genetic events, such as point mutation, 
insertion and deletion of DNA. Those (B12 and C5) with identical fingerprints 
(100% similarity) can be regarded as genetically indistinguishable and may be 
considered to represent the same strain (Tenover et al., 1995). The MIC results 
showed that the isolates in each set, though genetically related, had different 
resistance phenotypes. Macro-restriction of PFGE is not capable of showing all 
•  changes in the genome. Sequencing is required for such elucidation. 
J-'� ‘ 
3.2.2 Correlation between the presence of common resistance 
mechanisms and the changes in antimicrobial susceptibility 
The presence of the enzyme APH(3')-VI with other modifying enzymes (AAC(3’)-I 
or ANT(2")) has been found to confer resistance to several aminoglycosides, 
including amikacin and gentamicin (Towner, 1997). All the 5 isolates (5322B, 1098， 
1100, 1101, 111702R) showed PCR positive to aph(3 ’)-Via and had gentamicin MIC 
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> 16 i^g/ml and amikacin MIC > 8 |Lig/ml. So far, only AAC(6，)-I and APH(3')-VI 
have been showing capable of inactivating amikacin (Ploy et al., 1994; Vila et 
(3/.,1999). Nevertheless, two aac(6')-Ib positive isolates (5343B, 111702A) remained 
relatively susceptible (amikacin MIC of 2 and 3 |Lig/ml, respectively) in this study. 
One isolate (5033) was PCR negative to aac(6')-Ib and aph(3’)-VIa and had 
amikacin MIC of 32 |ag/ml, showing other mechanism(s) could account for amikacin 
resistance. However, the PCR technique cannot detect point mutation(s) of the genes, 
thus limiting the understanding of the role of the genes studied. 
Alteration in gyrA at codon Ser-83 is the most commonly reported cause of 
quinolone resistance. Mutation at codon Ser-83 of gyrA without involvement of parC 
was described in Acinetobacter isolates with ciprofloxacin MICs 2-64 |ig/ml 
(Houang et al., 1998). Here, 21 isolates showed gyrA mutation at codon Ser-83 but 
no parC mutation was detected. Eighteen of them had ciprofloxacin MICs of < 
0.25 - 1 i^g/ml while MIC of the other 3 isolates were 3-32 |ig/ml. Work on 
Enterobacteriaceae indicates that mutation at codon Ser-83 is associated with a 
- decreased susceptibility to nalidixic acid first (Deguchi et al., 1997; Ruiz et cd., 
2002). Susceptibility to nalidixic acid had not been studied here. In E. coli, P. 
• aeruginosa and A. baumannii, isolates with mutations in both gyrA and parC were 
‘ shown to be significantly more resistant to fluoroquinolones than those with a single 
muation in gyrA (Piddock, 1995; Vila et al., 1997; Vila et al., 2002). 
The arr genes have been shown to confer rifampin resistance (MIC > 32 |ig/ml) 
(Quan，Venter and Dabbs, 1997; Houang et al., submitted). There were 2 arr positive 
isolates and both of them had rifampin MIC > 64 jig/ml. However, one isolate (5033) 
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with rifampin MIC > 64 |ag/ml was arr negative, indicating other mechanisms may 
be responsible for rifampin resistance. 
It is interesting that for isolate 5033, none of the resistance genes tested was positive 
but it had high MICs of amikacin (32 jug/ml), rifampin (> 64 |ig/ml) and meropenem 
(16 |ig/ml). The other 2 isolates (5032, 5034) within the set, both genetically and 
epidemiologically related to 5033 with Dice coefficient of similarity of 97%, were 
also negative for the resistance genes tested, but had much lower MIC. It may be that 
other resistance mechanism e.g. multidrug efflux system(s) may contribute to the 
multi-drug resistance seen in 5033. 
The method used for MIC determination relies on double dilutions and may be 
insensitive to detect small changes in susceptibility. It is not certain whether other 
methods e.g. E-test, a gradient diffusion test, would be good enough for this purpose. 
3.2.3 Deve lopment of resistance in serial isolates 
- It is often thought that resistance would develop readily during antibiotic therapy via 
vertical and horizontal evolution (Martinez and Baquero, 2000). Development of 
‘ antibiotic resistance can be rapid, especially in ICU, because of the high 
• consumption of antimicrobials. Using PFGE typing, the best discriminatory method 
currently available (Seifert et a!., 1994; Marcos et al., 1995; Tenover et al, 1995), 
the epidemiologically related serial isolates showing difference in antimicrobial 
susceptibility, were found unrelated. From the 236 blood culture isolates (170 
patients) in 1997-2000, 20 isolates from 8 patients, a small number, were mostly 
found to have a significant (> 4 fold difference in MIC) difference in antimicrobial 
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susceptibility. Over a period of 7 months, 133 sequential isolates from 65 patients 
were studied. No significant change in antimicrobial susceptibility was detected in 
them. Other studies showed that most strains of multidrug-resistant 
Enterobactehaceae found in the neurology and neurosurgery wards were unrelated 
(Leverstein-van Hall et al., 2002). 
Heterogeneity among isolates of the same GDG from the same site was shown to be 
a common feature in previous studies (Chu et al., 1999; Houang et al., 2001). This 
was again supported by data shown here. Limitations in the number of colonies 
picked from the primary culture for identification might have exaggerated the picture 
of heterogeneity. Acinetobacters can be contaminants or transient residents in 
carriage sites on patients or hospital staff (Chu et al., 1999; Houang et al., 2001). 
One or more strains may contaminate, colonize, or infect the sampled sites at any one 
time. The continuous presence of isolates belonging to two or more GDGs or two or 
more clones of the same GDG cannot be excluded. However, repeat isolation of the 
same strain(s) may represent a greater likelihood of infection or colonization than of 
- transient contamination. The clinical significance of the isolates studied here had not 
been investigated. 
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CHAPTER 4 STUDY OF bla醫^ EXPRESSION 
To date, carbapenems, such as imipenem, meropenem, are the most important 
agents available for the treatment of infections caused by nosocomial pathogens 
resistant to third generation cephalosporins. Recently, IMP-type 
metallo-P-lactamases was described in acinetobacters (Cornaglia et al., 1999; 
Takahashi et al., 2000), which have a very broad substrate profile, hydrolyzing 
efficiently carbapenems and a range of p-lactams. Chu et cd., 2001, studied 19 
blood culture Acinetobacter isolates (1997-1998) positive for the 
metallo-(3-lactamase bla\u\>A- The MIC for blam?-A isolates varied from 1 to > 
32|j,g/ml, indicating the possibility of variations in the gene expression. 
OXA-23 (class D p-lactamase) was found in only 1 of the 19 blamvA isolates 
and none'of these isolates contained OXA-24, indicating the importance of the 
contribution of bla\u?A to carbapenem resistance in these isolates. To gain 
further insight into the role of blam?.A and the resistance phenotypes, real time 
RT-PCR was used to study the transcript levels of bla\y[？a- Furthermore, the 
- experience gained in setting up real time RT-PCR for blamvA would be useful 




4.1.1 Study of expression level of the bla體4 gene 
Verification of the specificity of primers for blawnn (see Chapter 2.7.1a) 
� 
The specificity of the primers, RTIMP4A and RTIMP4B (see Chapter 2, Table 
2.10), for studying the expression of blajMPA was verified by examining the 
dissociation curve of the amplicon obtained from the real time PCR using 
CYBR Green as the fluorescent dye. 
One significant peak of Tm = 77.8°C was obtained in the dissociation curve 
analysis. This indicates the primer pair, RTIMP4A and RTIMP4B, produced 
only one PCR product. The dissociation curve is shown in Figure 4.1. 
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Figure 4.1 Dissociation curve (Plot of fluorescence signal against temperature) of the expected 
amplification product (105 bp) from the primers (RTIMP4A and RTIMP4B). The 
melting temperature (Tm) of the product (拟“膽4) was 77.8�C. 
NTC, negative control 
The identity of the 105 bp PCR product was confirmed by DNA sequencing 
and the sequence showed 100% match to the expected 606 - 724 bp region of 
the blajMpA gene. 
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Verification of the specificity of primers for 16S rRNA gene (internal control) 
The specificity study (see Chapter 2.7.1b) of the internal standard, the 16S 
rRNA gene, is described in Chapter 5. 
Construction of standard curve (see 2.7.1b) 
For the target and internal standard gene being measured, a sequence-specific 
standard curve was generated using the appropriate primers and the 10-fold 
serial dilutions (lO^-lO'^copies/p-l) of plasmid DNA containing the sequence of 
interest. 
The concentration of the plasmid was estimated by comparing with serial 
dilutions of known amounts of X DNA marker on the agarose gel (calculation, 
see Chapter 2.7.1c). By comparing the intensity of the plasmid containing 
bla\Mp.4 to the known amount of X DNA marker on the agarose gel, the 
concentration of the plasmid containing bla\M?-4 was estimated to be lOOng/pi, 
which was equivalent to 2.5 x 10'°copies/|il. Similarly, the concentration of the 
- plasmid containing the internal standard 16S rRNA gene was also 
approximately 100ng/|^l, thus 2.5 x lO'^copies/jil. 
The cloned plasmid was serially diluted (10-fold dilutions) and 6 different 
dilutions were used for both the target and the internal standard in each run of 
real time RT-PCR, by TaqMan assay, for the construction of standard curves. 
Figure 4.2 shows the standard curve obtained from serial dilutions of blamp-A-
The regression coefficients obtained for the standard curve of blam?-4 was 0.99. 
The standard curve for the 16S rRNA gene is shown in Figure 5.3 in Chapter 5. 
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_ 
Starting quantity (copy numbers) 
Figure 4.2 The standard curve for blam?A constructed by the ABI 
PRISM® 7700 Sequence Detection System (version 1 . 7 
software) using 6 different dilutions. 
4.1.2 Expression levels of 办/fliMP-4 and meropenem M I C in 
bla\u?A blood culture isolates 
Nineteen hlam?A blood culture Acinetohacter isolates (1997-1998) were used 
to study the relationship between the expression of bla\u?A and the MIC 
phenotypes. The expression was studied by real time RT-PCR (TaqMan assay) 
as described in Chapter 2.7.2. The amount of the bla\M?-A gene obtained was 
standardized with the expression of the 16S rRNA gene and the levels of RNA 
, ‘transcripts of the bla\u?A gene were expressed as the number of copies per 
lOiOcopies of the 16S rRNA gene. The expression levels of blam?-^ and 
meropenem MIC are shown in Table 4.1 and their relationship is plotted in 
Figure 4.3. The Spearman's rho correlation coefficient was 0.627 (p = 0.007), 
excluding the results 4352 and 4334. While the coefficient was 0.674 (p = 
0.023), excluding all the uncertain MIC results of MIC > 32 |ag/ml. 
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Figure 4.3 A plot of blam?-A copy numbers (expressed per 10 16S rRNA) 
against meropenem MIC. The two exceptional cases (see 
Discussion 4.2.3) are shown as dots. 
4.1.3 Intra-assay reproducibility 
To examine the reproducibility of duplicated samples (see Chapter 2.7.3), a 
.scatter plot of coefficient of variations (CVs) of threshold cycle (Ct) values in 
intra-assay of the duplicated samples of blamvA and the internal standard (16S 
rRNA) was constructed (Figure 4.4). The median of CVs of bla\u?-A and the 
internal stand were 0.24 and 1.8% respectively. 
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. Figure 4.4 Scatter plot of coefficient of variations (CVs) of Ct values in intra assay of different 
, ‘ duplicated samples tested. The bars represent the median of the CVs. 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.1.4 Detection of the production of metallo-P-Iactamase 
The nineteen blaiu?-A isolates, together with a positive strain 74510 (see 
Chapter 2.1.5) and two randomly selected bla\u?A isolates from blood 
culture 1997-1998 (see Chapter 2.1.4a), were tested for 
metallo-p-Iactamase production (see Chapter 2.7.4). All the nineteen 
bla\u?A isolates and the positive strain 74510 showed changes in the 
shape of the growth inhibitory zones while no change for the two 
bla\y[？-A isolates was observed. . 
4.2 Discussion 
4.2.1 ‘ Dissociation curve 
The fluorescence-based real time RT-PCR is widely applied for quantifying levels of 
specific mRNA. Among the current methods in real time PCR, the 5’-nuclease assay 
using hydrolysis probes — Taqman assay is most popular (Bustin, 2002). In this work, 
“ before using Taqman to study the mRNA level of the gene of our interest, the DNA 
binding dye - CYBR Green was used to generate the dissociation curve to check the 
specificity of the primers planned for Taqman assay. The dissociation curve (Figure 
‘ 4.1) showed only one product, with Tm 77.8�C, was produced from the amplification 
of bIajMP-4, suggesting that the primers for b/aiMP-4 were sufficiently specific. 
4.2.2 Reproducibility of real time RT-PCR 
The accuracy of fluorescence-based real time RT-PCR can be significantly affected 
by reagent and operator variability. Bustin, 2002 showed that there were significant 
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variations in results from different operators, different batches of reagent kits, probes 
from different manufacturers and probes with different storage period. In this project, 
I tried to minimize the variability by using reagents from the same manufacturer with 
freshly prepared probes only. Furthermore, the same batch of templates for the 
standard curve was used and all samples were run in duplicates. The experience 
gained in setting up real-time RT-PCR would be useful to the study of the 
flJe^-mRNA levels of in Chapter 5. 
A satisfactory regression coefficient (0.99) was obtained from the standard curve of 
bla\u?A (Figure 4.1). Similar values of coefficients (0.997-0.998) were reported by 
Johnson et al., 2000. The sensitivity attained allowed the detection of blampA to a 
concentration of 2.5x10^ copies/^il. Bustin, 2000 reviewed the literature and 
suggested the lower detection limit should be around 50 - 500 copies of target 
mRNA in most cases. Therefore the sensitivity for the detection of bla\u?-A was 
satisfactory. The intra-assay coefficient of variations (CVs) of the Ct value ranged 
from 0 to 2.17% and 0.11 to 8.1% for samples of bla\y[?.A and the internal standard 
respectively. The distributions of CVs of bla\y[?-4 and the internal standard are shown 
- in Figure 4.4. The median of the CVs of bla\u?-A and the internal control are 0.24 and 
1.8% respectively. A wide range of intra-assay coefficients of variation was reported 
‘ by others (Abe et al., 1999; Barragan et al., 2001; Gruber et al, 2001; Yang et al, 
‘ 2002). The CV has been described as small as 0.29% (Gruber et al., 2001) or up to 
7% (Barragan et al., 2001). Bustin et a!.，2000, reported that the variability between 
duplicates and triplicates within the same run and between different runs ranged from 
0 to 5%. The CVs of blamp-4 and the internal control obtained here fell within these 
‘ ranges and therefore should be acceptable. 
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4.2.3 Relationship between mRNA level of b/amp-4 and the meropenem MIC 
When comparing with imipenem, meropenem is more stable than imipenem 
(Mudaliar et al., 1996) and therefore easier to handle in experiments. The two 
compounds have similar clinical and bacteriological efficacy (Wiseman et al., 1995). 
Also, meropenem is available in our laboratory. Therefore, meropenem was used 
instead of imipenem for MIC determination of carbapenem susceptibility in this 
project. 
One should be mindful that the method used for MIC determination may not be 
sensitive enough to detect the small changes in susceptibility associated with the 
expression of bla\u?-4- All the isolates were capable of producing active 
metallo-p-lactamase in the disk diffusion test (see 4.1.4). 
Isolates 4334 and 4352 had elevated copy numbers of bla\u?-A mRNA but their 
meropenem MICs were 1 and 4fig/ml respectively. The metallo-p-lactamase 
produced do seem not to be very active against meropenem. Some possible 
explanations may be offered for these: (1) Mutation in DNA might cause translation 
of reduced activity or malfunctional protein(s) or enzyme(s). All isolates were 
- showed to produce an active metallo-p-lactamase in the disk diffusion test with an 
inhibitor (see Chapter 2.7.4 and 4.1.4), and therefore malfunctioning protein did not 
- seem to be the likely explanation. Substitution with a wrong amino acid at a critical 
‘ point could cause misfolding of the protein and may lead to a reduction in activities 
(Twyman and Wusden, 1998, Chapter 15). (2) Absence or reduced expression of 
other synergistic mechanisms that could have facilitated bla\y[?.A to exert its function. 
Multidrug efflux pumps play an important role in extruding a wide range of 
• antibiotics out of the cell. Li, Nikaido and Poole, 1995, described that MexAB-OprM 
was able to efflux p-lactam in P. aeruginosa. Outer membrane barriers, 
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MexAB-OprM efflux system and P-lactamase production together were found to 
account for penem resistance in P. aeruginosa (Okamoto, Gotoh and Nishino, 2001). 
(3) The membrane permeability was shown as one of the factors contributing to 
imipenem resistance. In P. aeruginosa, a lack of or reduced expression of porin OprD 
accounted for the reduced susceptibility to carbapenems (Margaret, Drusano and 
Mobley, 1987; Perez et al., 1996). The presence of a small number of small-sized 
porins was attributed to the high antibiotic resistance of A. calcoaceticus (Obara and 
Nakae, 1991; Sato and Nakae, 1991). Clark (1996) also described that decreased 
expression of an outer membrane protein was associated with imipenem resistance in 
A. baumannii. 
Besides the explanations described above, the high copy number measured could be 
explained by the fact that RT-PCR measured the steady state mRNA levels which is 
a balance between transcription of DNA (mRNA formation) and degradation of the 
mRNA (Lewin, 1997, p 162 - 165). Degradation of bacterial mRNA is a two-stage 
process: endonucleolytic cleavages of mRNA to release fragments and exonuclease 
degradation of the released fragments. Bacterial mutants that have a defective 
ribonuclease E have increased stability of mRNA. RNAase E is the enzyme that is 
responsible for processing 5' rRNA from the primary transcript by a specific 
endonucleolytic processing event. Also, a region of secondary structure within the 
mRNA may provide an obstacle to the exonuclease (Lewin, 1997, p 173 - 175). On 
the other hand, increased in transcription is often a result of alteration in the 
regulatory genes (Lewin, 1997, Chapter 29). For example, the level of the 
. chromosomal-encoded p-lactamase production in Klebsiella pneumoniae varied with 
a point mutation in promoter sequence (Rice et al., 2000). Therefore, resistance to 
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degradation or an increase in transcription could lead to a higher copy number 
measured in the cell. However, further examination of the above mechanisms is 
necessary for a better understanding of the effect of blam?-A on meropenem MIC. 
春 
Nevertheless, for all other isolates, the transcript levels of the hlam?-A isolates with 
meropenem MIC ranging from 12 to > 32|^g/ml were higher than those with MIC 2 — 
6|uig/ml. The overall result therefore indicates the bla\u?-A transcript level might be 
moderately associated with meropenem MICs for the majority of isolates 
(Spearman's rho coefficient of correlation = 0.627). 
The isolate (4431) containing OXA-23 had meropenem MIC > 32|ig/ml. It is not 
certain how these two p-lactamases would have interplayed. 
< 
J-' ‘ 
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CHAPTER 5 STUDY OF adeABC EXPRESSION 
AdeABC is the first ever published efflux system in Acinetohacter (Magnet et al., 
2001). The three adeABC genes are arranged as an operon. The dideB gene encodes a 
protein with 1,035 amino acids which has the characteristics of a proton motive force 
dependent RND type transporter (Magnet et al., 2001). AdeA and AdeC are the 
membrane fusion protein and the outer membrane protein components respectively. 
AdeB is capable of recognizing structurally unrelated compounds, including 
aminoglycosides, fluoroquinolones, tetracyclines, chloramphenicol, erythromycin 
and ethidium bromide (Magnet et al., 2001). Thus, the AdeABC system is 
considered to be associated with multidrug resistance in Acinetohacter. 
In order to determine the role of the efflux pump in multidrug resistance in clinical 
Acinetohacter isolates, the relationship between adeB-mRHh levels and the resistant 
phenotypes was investigated. 
5.1 RESULTS 
5.1.1 Determination of the presence of the adeB gene 
Detection of the presence of adeB in the selected sets of isolates was performed by 
PGR using the primers O3 and O4 (see Chapter 2.8.1a). 
i * 
Verification of the specificity of primers (see Chapter 2.8.1a) 
The 980 bp fragment obtained from amplification was cloned into the vector pCR2.1 
and then sequenced. The GenBank library was used to search with the data obtained. 
Both the size and the sequence of the amplicon demonstrated that the primers could 
be used effectively for the detection of adeB in our laboratory. 
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Detection of the presence of adeB by PCR (see Chapter 2.8.1b) 
None of the sets of serial isolates identified in blood culture 1999-2000 (Chapter 
3.1.1a) was found to be adeB^. Three sets (2D, 2E and A13TU) among the existing 
sets of serial isolates (Chapter 3.1.1b) were positive to adeB and they were therefore 
further studied. The entirety of ade ABC (see 5.1.2) and the adeB-mRNA levels (see 
5.1.3) were examined. 
5.1.2 Entirety of the adeABC operon 
The adeB+ isolates were further taken for examining the entirety of the adeABC 
operon and the three open reading frames (ORFs) upstream by PCR mapping (see 
Chapter 2.8.2). The primers (see Chapter 2，Table 2.12) for mapping were validated 
for their specificity by cloning and sequencing the PCR products obtained from the 
amplification of the positive control BM4454 obtained from Dr. T. Lambert (Magnet 
et al 2001). 
Validation of the specificity of primers (see 2.8.2a) 
All the primer pairs produced the product of the expected size. Sequencing results 
revealed the products were the expected fragments of the adeABC gene cluster. 
PCR detection (see Chapter 2.8.2b) 
PCR mapping results were summarized in Table 5.1. Only 1 set (2D) of genomic 
DNA group 2 isolates was positive to all primers' detection and was therefore 
believed to contain the whole adekBC operon as well as the three upstream ORFs, 
the putative regulatory genes (Magnet et al. 2001). For the other 2 sets of isolates 
tested, they were only positive to some of the primer pairs. 







































































































































































































































































































































































































































5.1.3 Express ion level of the adeB gene 
Verification of the specificity of primers for 16S rRNA gene (internal control) 
The specificity of the primers, RT16S606A and RT16SB, (see Chapter 2，Table 2.11) 
for the internal control 16S rRNA gene was validated by examining the dissociation 
curve of the amplicons generated at the end of the real time PCR run using CYBR 
Green as the fluorescent dye (see Chapter 2.8.3a). 
The dissociation curve is shown in Figure 4.1. One peak of Tm = 81.4°C was 
obtained. The identity of the 118 bp PCR product was cloned and sequenced. 
Matching to the GenBank database revealed that the fragment has the expected DNA 
sequence (606 - 735 bp) of the 16S rRNA gene. This indicated the primer pair, 
RT16S606A and RT16SB, can be used for amplification of the 16S rRNA gene 
satisfactorily. 
Verification of the specificity of primers for adeB 
The specificity of the primers, RTAdeB2535A and RTAdeB2646B (see Chapter 2, 
Table 2.13) was also validated by examining the dissociation curve of the amplicons 
generated at the end of the real time PCR run using CYBR Green as the fluorescent 
dye (see 2.8.3b). One peak of Tm = 79°C was obtained (Figure 5.1). The identity of 
’ t h e 129 bp PCR product was cloned and sequenced. Comparing of the sequence 
obtained to the GenBank database revealed that the fragment has expected DNA 
sequence (2535 — 2653 bp) of the adeB gene. This indicated the primer pair, 
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Figure 5.1 Dissociation curve (Plot of fluorescence against temperature) of the 
adeB and 16S rRNA amplicons monitored by GYBR Green florescence. 
The Tm ofackB product was 79X while 16S rRNA was 81.4�C. 
Construction of standard curve 
For the target and internal standard gene being measured, a sequence-specific 
standard curve was constructed by using of target-sequence-bearing plasmid (see 
Chapter 2.8.3c) in a series of known quantities as the template. 
The concentration of plasmid was estimated by comparing with serial dilution of 
known amount of X DNA marker on the agarose gel (see Chapter 2.7.3a). By 
comparing the intensity of the plasmid containing adeB to the known amount of X 
DNA marker on the agarose gel, the concentration of the plasmid was estimated to be 
100 ng/jiil, which was equivalent to 2.5 x copies/fil. Similarly, the concentration 
of the plasmid containing the internal standard 16S rRNA gene was also 
approximately 100 ng/|Lil，thus 2.5 x copies/jul. 
The cloned plasmid was serially diluted (10-fold dilutions) and 6 different dilutions 
were used for both the target and the internal standard in each run of real time 
RT-PCR to construct the standard curves. Figure 5.2 and 5.3 are the standard curves 
for adeB and 16S rDNA respectively. The regression coefficients of the standard 
curves of adeB and the internal standard (16S rDNA) are 0.99 and 0.97 respectively. 
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Starting quantity (copy numbers) 
Figure 5 .2 Standard curve for adeB constructed by the A B I PRISM® 7700 
Sequence Detection System (version 1.7 software) using 6 
different dilutions. 
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Figure 5.3 Standard curve for the internal standard 16S rRNA gene constructed 
by the A B I PRISM® 7700 Sequence Detection System (version 1.7 
software) using 6 different dilutions. 
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5.1.4 Expression levels of adeB in sets of serial isolates 
The amount of the adeB transcripts obtained was standardized with the expression of 
the 16S rRNA gene and the levels of mRNA transcripts are expressed as numbers of 
copies per 1 0 � copies of the 16S rRNA gene (see Chapter 2.8.4). Table 5.2 shows 
the mRNA levels of adeB and 16S rDNA and the quantity of adeB transcript 
standardized with 16S rRNA. Table 5.3 shows a summary of the standardized adeB 
transcript levels and the MIC results. 























































































































































































































































































































































































































































































































































































































































































































































































































































































5.1.5 Intra-assay reproducibility 
To examine the reproducibility of duplicate samples (see Chapter 2.8.5), a scatter 
plot of coefficient of variations (CVs) of Ct values in intra-assay of different 
duplicated samples tested was constructed (Figure 4.3). The median of CVs of adeB 
and the internal control are 0.79 and 2.16% respectively. 
5 “ + . 
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Figure 5.4 Scatter plot of coefficient of variations (CVs) of Ct values in intra assay of different 
‘ duplicated samples tested. The bars represent the median of the CVs. 
5.1.6 Inter-assay reproducibility 
For the assessment of inter-assay reproducibility (see 2.8.6), data in duplicates 
generated from samples used in the 16S rRNA gene standard curve construction 
were compared. Table 5.4 shows the inter-experimental variability in this study. The 
inter-assay for coefficient variation ranged from 3.48 to 10.93% and the median of 






































































































































































































































































5.2.1 Detection of the adeB gene 
Among the acinetobacters belonging to different GDG tested, none of the group 3 
isolates was positive to the PCR detection. Only GDG 2 (A. baumannii) and 13TU 
showed positive results. Magnet et al., 2001, investigated A. baumannii (GDG 2) and 
A. haemolyticus (GDG 4), and found adeB in A. baumannii only. In chapter 6, pump 
homologues in genomic DNA group 3 and their distribution would be described. 
5.2.2 Entirety of the adeABC operon 
Only one set (2D) of isolate was positive to all the primer pairs across the adeABC 
operon as well as the 3 putative regulatory genes (ORFl-3). Another set, A13TU, 
were PCR positive to the primers located across the adeABC operon but not the 3 
ORFs located upstream. This set of isolates seems to contain the adeABC operon but 
it is uncertain whether the regulatory genes are present. Perhaps another regulatory 
genes are responsible for the expression of the adeABC operon and this remains to be 
investigated further. Further tests are required, for example performing RFLP and 
sequencing the products obtained from the amplifications, to find out the identity of 
the adeABC. 
Another set, 2E, was only PCR positive to certain regions of the adeABC operon, and 
was adeB+, as seen in Figure 5.4. It would carry the 3 putative regulatory genes 
upstream and contain adeA and adeB. It is possible that adeC was lost, or mutation 
occurred at the regions of the primers' sequences, or outer membrane protein other 
than adeC was present. In P. aeruginosa, OprM can interplay with other pumps and 
expressed independently of MexAB (Zhao et cd., 1998). 
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5.2.3 Reproducibility of real time RT-PCR 
The regression coefficients obtained for standard curves of adeB and the internal 
standard 16S rRNA gene were 0.99 and 0.97 respectively. The sensitivity for the 
detection for adeB and 16S rDNA were 2.5xl0' and 2.5x10^ copies respectively. The 
intra-assay coefficient of variation (CVs) of the Ct value, as shown in Figure 5.4, 
ranged from 0 to 3.18% for the duplicated adeB samples, and 0.27 to 5.14% for the 
16S rRNA gene duplicates. The median for the CVs were 0.79 and 2.16% for the 
adeB gene and the 16S rRNA gene respectively. As discussed in Ch 4.2.2, these CVs . 
are acceptable. 
The CV for the inter-assay (4.91%) was higher than intra-assay (0.24-2.16% for 
blam?A, adeB and 16S rDNA). Others have also observed high CVs for inter-assay 
(Abe et al, 1999; Barragan et al, 2001; Jardi et al., 2001; Yang et al., 2002). This 
was thought to be related to the reagent variability. Bustin, 2000 described the 
variability between duplicates and triplicates in inter-assay and intra-assay was 0-5%. 
Therefore CVs of 4.91% for inter-assay obtained here should be acceptable. 
5.2.4 Relationship between adeB-mRNA level and antimicrobial 
susceptibility 
, N o detectable adeB transcript was measured in set 2E and A13TU. Both of them 
were positive to the 3 primer pairs located at the adeB gene during PCR mapping 
detection (Table 5.1). It is possible that they were not expressed. In P. aeruginosa, 
mexCD-oprJ (Poole et al, 1996b) and mexEF-oprN (Kohler et al., 1997b) operons 
apparently were not expressed during growth under normal laboratory conditions, but 
were expressed in nficB (Poole et al, 1996b) and nficC (Kohler et al.’ 1997b) 
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multidrug resistance mutants, respectively. Point mutation in the regulatory genes 
nficB and nficC upstream to the mexCD-oprJ and mexEF-oprN operons respectively, 
was found leading to an overexpression of the systems. Magnet et al” 2001, 
suggested that the ORFs upstream to the adeABC operon include a two-component 
regulatory system and a protein partly homologous to a putative transcriptional 
terminator-antiterminator (Henkin, 1996). However, further characterization of the 
regulatory genes upstream to the operon is necessary to confirm this. 
The MIC levels of the 8 antimicrobial agents were similar with the exception of 
genetamicin and amikacin. The MIC of these two aminoglycosides differed by at 
least 4 folds and this could be explained by the presence of aph(3 ')-VIa, aac(6')-Ib in 
1098 (see Chapter 3, Table 3.2). The similar mRNA levels found in both isolates 
indicate that adeB had not played a significant part with different resistance 
phenotypes. 
In the studies of the entirety of the adeABC operon and the mRNA levels of adeB, 
there is no direct relationship between the presence of the putative regulatory genes 
(ORF 1-3) and the ability of expression of adeB as the presence of the 3 putative 
regulatory genes does not show the expression of the operon as seen in set 2E. 
However, it is uncertain that in set A13TU, whether there were regulatory genes 
controlling the expression of adeB. 
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CHAPTER 6 INVESTIGATION OF OTHER EFFLUX PUMPS IN 
ACINETOBACTER GENOMIC DNA GROUP 3 
The RND-type efflux pump, AdeABC, was previously identified from a multidrug 
resistant Acinetohacter baumannii (GDG 2) (Magnet et al, 2001). AdeABC is a 
tripartite efflux pump. The three genes - ade A, adeB and adeC are arranged as 
operon and they encode membrane fusion protein, RND-type transporter and outer 
membrane protein respectively. The adeB gene was only detected in A. baumannii 
(GDG 2) but not in A. haemolyticus (GDG 4) (Magnet et al, 2001). In this chapter,. 
the finding of an adeB homologue in GDG 3 is presented. 
6.1 Results 
6.1.1 Detection of adeB homologue in a genomic DNA group 3 
isolate 
Degenerate primers A2 and A4 (gift from Prof. T. Lambert, Institut Pasteur, Paris, 
see Chapter 2, Table 2.14) were used to amplify adeB-VikQ sequence from the total 
DNA of a GDG 3 isolate 4365 (reaction a in Table 6.1) (see Chapter 2.9.1). Several 
“amplicons with different sizes were produced as shown in Figure 6.1 and were 
cloned into pCR2.1 vectors for further identification. 
One plasmid with an insert sized at about 1.2 kb was chosen for DNA sequencing. 
Comparison of the deduced product with those in the GenBank database revealed a 
high degree amino acid (aa) sequence of identity (approximately 40%) with the 
internal region 16 - 242 aa of a RND type transporter of E. coli (accession no. 
NC002655) (Perna et al, 2001). This putative pump protein was tentatively 
designated as AdeE {Acinetobacter drug efflux). The sequence from pAdeEOOl was 








Figure 6.1 Gel picture of the products of the amplification of the total DNA of a 
GDG 3 isolate (4365) with the degenerate primers, A2 and A4. 
MK: lambda DNA/P^/I marker. Lane 1: strain 4365; lane 2: positive 
control (strain BM 4454); lane 3: negative control. 
The sequence obtained (25 - 860 bp) in the previous section (6.1.1) was used to 
design two primers AdeE-79A and AdeE-538B. An amplicon of predicted size 459 
bp was obtained. Sequences of similar RND type transporter genes, the putative 
efflux pump of Escherichia coli (accession no. NC 002655) (Perna et al., 2001), 
multidrug efflux protein of Yersinia pestis (NC 003143) (Parkhill et al, 2001) and 
the AcrBDF family protein of Caulobacter crescentus (NC 002696) (Nierman et al., 
2001) were used for alignment (see Chapter 2, Figure 2.3). Based on the conserved 
regions found after the alignment, degenerate primers were designed. For details of 
the primers, please refer to Chapter 2, Table 2.15. The positions of the primers are 
shown in Figure 6.9. 
Different combinations of forward and reverse primers were used to amplify the total 
DNA of isolate 4365 and the results are shown in Table 6.1. 
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Table 6.1 Primers used for detecting the putative pump sequences in IN 
^ 4365 of GDG 3. 
Estimated size 
of the PCR Plasmid generated 
PCR Forward primer Reverse primer product^ after cloning^ 
a A2 A4 -1200 bp pAdeEOOl 
b AdeE-79A 1207dB -
d AdeE-79A 1393dB -
e AdeE-79A 1603dB � 1 3 0 0 bp pAdeYOOl 
f 541dA 1207dB -
g 541dA 1393dB -
h 1207dA 2256dB -
i 1393dA 2256dB -900 bp pAdeY002 
j startA 1207dB -
k StartA 1603dB -
1 1393dA 3032dB -
m 1393dA 3183dB -
a indicates no product or products of unexpected size and not characterized 
further. 
b the amplicon was cloned into the vector pCR2.1. 
Matching the deduced product of the insert sequence of clone pAdeYOOl (reaction e 
in Table 6.1) to the GenBank database revealed a high degree of amino acid identity 
(approximately 42%) with the internal regions (100 - 344 aa) of the putative RND 
protein of Stenotrophomonas maltophilia (accession no. AJ252200) (Alonso and 
Martinez, 2000). However, the expected overlapping sequences from pAdeEOOl and 
“pAdeYOOl could not be identified and the insert sequence in AdeYOOl was 
speculated to be another putative efflux protein and tentatively designated AdeY. 
The insert sized at about 0.9 kb of the plasmid pAdeY002 (reaction i in Table 6.1) 
was sequenced. The deduced protein was revealed of 49% amino acid similarity to 
the AcrB protein of Klebsiella pneumoniae (AJ318073) (Domenech-Sanchez et al., 
unpublished) in the GenBank database. 
Analysis of the insert sequences from pAdeYOOl and pAdeY002 with the software 
ClustalW (EBI, UK) revealed they formed parts (about 310 to 2122 bp) of the 
putative efflux protein AdeY (Figure 6.9b and Table 6.5). 
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6.1.2 Chromosome walking of the adeB-\\]^e； genes 
adeE (see Chapter 2.9.2a) 
First round chromosome walking 
Four gene-specific primers (A - D, see Chapter 2, Table 2.17) were designed for the 
upstream and downstream region, based on the sequence result of adeE from the 
previous section (Figure 6.8a). Adaptor primers provided by the G e n o m e W a l k e r ™ 
Kit were used with the gene-specific primers to amplify the DNA libraries in the 
primary and secondary PCR. The amplicons were cloned into the vector pCR2.1 and 
plasmids pAdeE002, pAdeE003 and pAdeE004 (Table 6.2) were generated for 
further characterization. For gel picture results of the secondary PCR products, see 
Figure 6.2. 
Table 6.2 The combination of DNA libraries and gene-specific primers used in 
the primary and secondary PCR, and the plasmids generated for the 
characterization of adeE. 
Gene-specific primers used Gene-specific primers used Plasmid 
in primary PCR in secondary PCR with generated after 
DNA library reaction with API AP2 cloning* 
D L - E c o K V 1 B-upl7丨B-GSPl A -up71B-GSP2 ； 
“ 2 D-down565-GSPl C - down600-GSP2 -
DL - Dra I 3 B - upl71B-GSPl A-up71B-GSP2 -
4 D-down565-GSPl C - down600-GSP2 pAdeE004 
DL - Pvu il 5 B - u p l 7 1 B - G S P l A-up71B-GSP2 pAdeE002 
6 D-down565-GSPl C - down600-GSP2 pAdeE003 
D L - & p I 7 B - u p l 7 1 B - G S P l A-up71B-GSP2 -
‘ . 8 D-down565-GSPl C - down600-GSP2 -
^ * indicates the amplicons obtained were not cloned for further characterization. 
The insert sequences obtained from pAdeE002, pAdeE003, pAdeE004 and those 
obtained (25 - 860 bp) previously (Ch 6.1.1) were aligned, and the sequence of the 
putative pump AdeE from the ATG start to 1348 bp was thus generated (Figure 6.8a 
and Table 6.5). 
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Second round chromosome walking 
Two gene-specific primers (E and F, see Chapter 2, Table 2.17) were designed for the 
downstream region of the ddeE sequence (start - 1348 bp). This time, the amplicons 
from the amplification of the DNA libraries in the primary PCR were cloned into 
pCR2.1 and pAdeE005, pAdeE006, pAdeEOO? and pAdelOOS were generated for 
further characterization. Results are shown in Table 6.3. 
Table 6.3 The combination of DNA libraries and gene-specific primers used, and the 
plasmids generated for the characterization of adeE. Adaptor primer — API 
was used as the other primer in each reaction. 
Plasmid generated 
DNA library reaction Gene-specific primer after cloning* ^ Gel picture 
DL - EcoK V 9 E-downl010-GSP3—- Fig. 6.3 
10 F-downl086-GSP4 - Fig. 6.3 
DL - Dra I 11 “ E - downl010-GSP3 - Fig. 6.3 
12 F-downl086-GSP4 - Fig. 6.3 
DL - Pvu II 13 E-downl010-GSP3 pAdeE006 Fig. 6.4 
14 F-downl086-GSP4 pAdeEOO? Fig. 6.4 
DL - Ssp I 15 E-downl010-GSP3 pAdeE005 Fig. 6.3 
16 F-downlQ86-GSP4 pAdeEOOS Fig. 6.3 
* indicates the amplicons obtained were not cloned for further characterization. 
"a the amplicon was cloned into vector pCR2.1. 
Sequence of adeE from start to base 2485 bp was obtained after combining the 
sequence results (start to 1348 bp) from the first round chromosome walking and the 
J" " 
insert sequences from pAdeE006, pAdeE006, pAdeEOO? and pAdelOOS (Figure 6.8a 
and Table 6.5). 
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Third round chromosome walking 
Two gene-specific primers (G and H, see Chapter 2, Table 2.17) were designed at the 
downstream region of the known sequence (start to 2485 bp) of adeE (Figure 6.8a). 
The PCR products obtained from the amplication of the DNA libraries in the primary 
PCR was cloned into vector pCR2.1 and pAdeE009, pAdeEOlO and pAdeEOl 1 were 
generated (Table 6.4). For gel picture result of the secondary PCR products, see 
Figure 6.5. 
Table 6.4 The combination of DNA libraries and gene-specific primers 
used, and the plasmids generated for the characterization of 
adeE. Adaptor primer — API was used as the opposite primer 
in each reaction. 
DNA library plasmid generated 
(DL) Reaction Gene-specific primer after cloning* ^  
DL - EcoR V 17 G — down-GSP5 = 
18 H - down-GSP6 -
DL - Dra I 19 ‘ G - down-GSP5 pAdeEOll 
20 H-down-GSP6 pAdeE009, pAdeEO 10 
DL - Pvu II 21 G - down-GSP5 -
22 H-down-GSP6 -
DL - Ssp I 23 G - down-GSP5 -
24 H - down-GSP6 -
* indicates the amplicons obtained were not cloned for further 
characterization. 
a the amplicon was cloned into vector pCR2.1. 
The insert sequences obtained from pAdeE009, pAdeEOlO and pAdeEOl 1 and the 
known sequence (start to 2485 bp) were aligned, and the sequence of the putative 
pump AdeE from start to TGA (stop codon) at 3111 bp was obtained (Figure 6.8a 
and Table 6.5). 
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Table 6.5 Summary of bases retrieved for AdeE from 
different plasmids obtained.  
Sequenced position at AdeE 
Plasmid Start at base Stop at base 
pAdeEOOl T5 MO 
pAdeE002 Start 118 
pAdeE003 627 1348 
pAdeE004 627 1348 
pAdeE005 1044 2012 
pAdeE006 1044 2485 
pAdeEOO? 1112 2485 
pAdeE008 1329 2012 
pAdeE009 2391 3111 (stop) 
pAdeEOlO 2489 3111 (stop) • 
pAdeEOll ^ 3111 (stop) 
AdeY (see Chapter 2.9.2b) 
First round chromosome walking 
Four gene-specific primers (I to L, see Chapter 2, Table 2.19) were designed, 2 at the 
upstream and 4 at the downstream region, based on the sequence of adeY obtained 
(310 - 2122 bp) above (Ch 6.1.1) (Figure 6.8b). Adaptor primers and the 
gene-specific primers were used to amplify the DNA libraries in primary and 
secondary PCR. The PCR products were cloned into vector pCR2.1 and plasmids 





Table 6.6 The combination of DNA libraries and gene-specific primers used in 
primary and secondary PCR, and the plasmids generated for the 
characterization of adeY. 
Gene-specific primers Gene-specific primers 
used in primary P C R used in secondary P C R Plasimid generated Gel 
D N A library Reaction with API with AP2十 after cloning picture 
D L - EcoKV 25 J - up350B-GSPl 1 - upl35B-GSP2 - Fig. 6.2 
26 K-downl582-GSP2 - Fig. 6.6 
27 L-downl281-GSP5 - Fig. 6.6 
D L - Dra\ 28 J - up350B-GSPl I - upl35B-GSP2 - Fig. 6.2 
29 K-downl582-GSP2 pAdeY004 Fig. 6.6 
30 L-downl281-GSP5 - Fig. 6.6 
D L - PvuW 31 J-up350B-GSPl I - upl35B-GSP2 pAdeY003 Fig. 6.2 
32 K-downl582-GSP2 - Fig. 6.4. 
33 L-downl28l-GSP5 pAdeY005, pAdeY006 Fig. 6.4 
D L - Ssp\ 34 J-up350B-GSPl I - upl35B-GSP2 - Fig. 6.2 
35 K-downl582-GSP2 - Fig. 6.6 
36 L-dwonl281-GSP5 - Fig. 6.6 
‘no secondary PCR was done when gene-specific primer was not quoted. 
* ‘-, indicates the amplicons obtained were not cloned for further characterization. 
The insert sequences of pAdeY003, pAdeY004, pAdeYOOS and pAdeY006 (Figure 
6.8b and Table 6.8) and the adeY sequence obtained (310 — 2122 bp) previously (Ch 
6.1.1) were aligned, and the sequence of the putative pump AdeY from start to 2616 
bp was generated (Figure 6.8a and Table 6.5). 
Second round chromosome walking 
Two gene-specific primers (M and N, see Chapter 2, Table 2.19) were designed at the 
downstream region of the partial adeY sequence obtained from the first round 
chromosome walking (Figure 6.8b). PCR products of the amplification of the DNA 
libraries in the primary PCR were cloned into the vector pCR2.1 and plasmids 
pAdeYOOT, pAdeYOOS and pAdeY009 (Table 6.7) were generated. 
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Table 6.7 The combination of DNA libraries and gene-specific primers used, 
and the plasmids generated for the characterization of adeY. Adaptor 
primer — API was used as the opposite primer in each reaction. 
' Remarks 
(plasimid generated after 
D N A library reaction Gene-specific primer cloning) Gel picture 
D L - EcoK V ^ M-down2300-GSP6 - Fig. 6.7 
38 N - down2400-GSP7 - Fig. 6.5 
D L - D m 1 39 M - down2300-GSP6 - Fig. 6.7 
40 N - down2400-GSP7 pAdeYOOS, pAdeY009 Fig. 6.5 
D L - Pvu II 41 M - down2300-GSP6 - Fig. 6.7 
42 N - down2400-GSP7 pAdeYOO? Fig. 6.5 
D L - Ssp I 43 M - down2300-GSP6 - Fig. 6.7 
^ N - down2400-GSP7 - Fig. 6.7 
* indicates the amplicons obtained were not cloned for further characterization. 
The complete sequence of adeY from start to the TAA (stop codon) at 3162 bp was 
obtained by combining the known sequence (start - 2616 bp) and the insert 
sequences of pAdeY007, pAdeY008 and pAdeY009 (Figure 6.8b and Table 6.8). 
Table 6.8 Summary of bases retrieved for adeY from different 
plasmids obtained. 
sequenced position at adeY 
plasmid Start at base Stop at base 
pAdeYOOl 3T0 
pAdeY002 1414 2122 
“ pAdeY003 start 444 
pAdeY004 1883 2616 
pAdeYOOS 1951 2500 
pAdeY006 1951 2584 
pAdeYOO? 2472 3019 
. . pAdeYOOS 2472 2711 
厂 . pAdeY0Q9 i m 3162 (stop) 
The deduced product of the 564 bp of pAdeY009 beyond the putative pump adeY 
revealed a high degree of identity (55%) with the amino acid sequence of AdeC, the 




28 25 31 34 MK 3 1 5 7 4 2 6 8 
P H m H 
H i H s m 
Figure 6.2 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The number above 
each lane corresponds to the reaction number for genome walking 
(Table 6.2 and Table 6.6). 
reaction reaction 
15 11 9 MK 16 12 10 
圔 H E W 
H E 9 H 
Figure 6.3 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The number above 





MK 32 33 13 14 
_ 
H 
Figure 6.4 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The number above 
each lane corresponds to the reaction number for genome walking 
(Table 6.3 and Table 6.6). 
reaction reaction 
40 42 38 23 19 21 17 MK 24 20 22 18 MK 
Figure 6.5 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The numbers above 
each lane corresponds to the reaction number for genome walking 




MK 35 ^ 2 9 ^ 26 MK 36 30 27 
sn^iMi tfi i t^ � i 镄 
；赫,二;：、义、-输 
_ 
— I ^ B B U M 
Figure 6.6 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The number above 
each lane corresponds to the reaction number for genome walking 
(Table 6.6). 
reaction 
MK 43 39 41 37 44 
_ 
I B 
f ^ i a M 
•滅 idii—aw—Ml 
Figure 6.7 Gel picture of chromosome walking results. 
Lane MK, molecular size marker (100 bp ladder). The number above 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.1.3 Sequences of AdeE and AdeY and their comparison 
The 3,111 bp sequence of adeE of strain 4365 (GDG 3) has been deposited in the 
GenBank data library under accession no. AY 147867. Appendix 4 shows the 
alignment of the adeB, adeE and adeY genes and the locations of the specific 
primers. 
Comparison of the deduced products from adeE and adeY with other well-known 
RND-type proteins with the software ClustalW (EBI, UK) is shown in Table 6.9. The 
level of identity between the putative proteins deduced from adeE and at/eFwas 50% 
(Table 6.9). The comparison of the DNA sequences of adeE and adeYmmg the same 
software ClustalW (EBI, UK) revealed that they shared 58% identity. 
The peptide sequence alignment of AdeE, AdeY and a collection of other RND-type 





































































































































































































































































































































































































































































































































































6.1.4 Topology prediction of AdeE and AdeY 
Using the software for topology prediction of membrane proteins TopPred (Pasteur 
Institut, Paris, France, http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html), the 
transmembrane helices for AdeE and AdeY were predicted (Figure 6.10 and 6.11). 
Whilst the hypothetic structure for AdeE is typical, AdeY exhibites some differences 
to a classical RND-type protein. 
anonymous 
] ‘ r n T i 11 丨 ‘ m r r 
^ ^ | ^ ^ a h y ( l r o p h o ^ ^ | k | 丨一 a hydrophobic | 
u) T T " ： T W 2 ] 4 ^ r 5 | ^ T M S 8 l o ^ l l l + 1 2 
i 4 編 f f 她 
.一 2 o n | f i J r o p h i l l Lgion 各黎1 本獨ts^ i念 -
t (periplasmic年“） i J J ^！ 一 
•c ^ I I Llppef CL t 6 f f  
" h l idrophob vc i t u  
- 4 1= 1 I I L y 
0 200 400 600 800 1000 
Figure 6.10 A plot of hydrophobicity value against the AdeE amino acid sequence. 
, ‘ The probability of formation of TMS is dependent on the 
hydrophobicity. The diagram and the graph are the results from 
TopPred (Pasteur Institut, Paris, France). 
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anonymous 
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Figure 6.11 A plot of hydrophobicity value against the AdeY amino acid sequence. 
The probability of formation of TMS is dependent on the 
hydrophobicity. The diagram and the graph are the results from 
TopPred (Pasteur Institut, Paris, France). 
176 
CHAPTER 6 
6.1.5 The role of the putative pump AdeE 
To study the role of the putative pump AdeE (see Chapter 2, 2.9.5), MIC was 
determined for the 五-disrupted mutant. AdeE was disrupted by incorporating the 
target sequence (fragment of adeE) into the adeE in the chromosome. A fragment 
internal to the adeE gene of isolate 4365 was amplified with the specific primers 
AdeE-79A and AdeE-538B. The 459 bp PCR product was ligated into vector pCR2.1 
to generate pAdeE012. 
Plasmid pAdeE012 DNA was introduced into a ticarcillin sensitive Acinetobacter 
isolate 8108 (GDG 3) by electrotransformation as 4365 is ticarcillin-resistant and 
therefore could not be used for selection. The transformants of 8108 were selected 
for ticarcillin resistance. The total DNA from the ticarcillin resistant clone was 
analyzed by PCR with Ml3 reverse primer and Ml3 (-20) forward primer with the 
specific primer AdeE-79A. Results are shown in Figures 6.12 and 6.13. 
In Figure 6.12, when the DNA template of 8108 was analyzed by PCR with Ml3 
-(-20) forward primer and AdeE-79A as the reverse primer (lane 1)，no product was 
observed. After target disruption, 8108-15 (lane 5) showed a band of the same size as 
positive control. 
In Figure 6.13, the templates were tested with Ml3 (-20) forward primer and M13 
reverse primer by PCR. No product was observed in both 8108 and 8108-15. 
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MK 1 2 3 MK 4 5 
•B 
Figure 6.12 Ticarcillin resistant clone analyzed by PCR with Ml3 (-20) forward 
primer and the specific primer AdeE-79A. 
Lane 1 was the DNA template of 8101, lane 2 and lane 4 was positive 
control - plasmid of pAdeEOOl. Lane 3 was negative control. Lane 5 
was the total DNA from 8108-15. 
1 2 3 MK 
I 
^ B E 
Figure 6.13 Ticarcillin resistant clone analyzed by PCR with Ml3 reverse primer 
and M13 (-20) forward primer. 
Lane 1 and lane 2 were the DNA templates of mutant 8108-15 and 




One of the mutants, 8108-15, was selected randomly for determining the 
antimicrobial sensitivity by disc diffusion and MIC. The inactivated mutant 8108-15 
showed decreased in susceptibility to ciprofloxacin, ofloxacin, tetracycline, 
imipenem, netilmicin, amikacin, gentamicin, neomycin and rifampin (Table 6.10). 
The MIC of ciprofloxacin, tetracycline, ceftazidime, meropenem, erythromycin, 
amikacin, rifampin and ethidium bromide were at least 4 times higher for strain 8108 
than the inactivated isolate 8108-15 (Table 6.11). 
To confirm that mutant 8108-15 came from 8108, PFGE was used and showed 
identical fingerprints (Figure 6.14). 
Figure 6.14 PFGE fingerprints of strains 8108 and 8108-15. 















































































































































































































































































































































































































































































































































































































































































6.2.1 The AdeE RND transporter 
RND transporters are ubiquitous ancient structures and found across Kingdoms. 
RND-type proteins are always associated with two other components - a membrane 
fusion protein (MFP) and an outer membrane protein (OMP). They transport 
substrates across the inner and outer membrane from cytoplasm to the environment. 
Many RND transporters (review Paulsen, Brown and Skurray, 1996; Putman, Veen 
and Konings, 2000) have been identified to be associated with multidrug resistance 
in many bacterial species, mostly Gram-negative bacteria. 
Magnet et al., 2001, described an RND-type efflux system, AdeABC, responsible for 
multidrug resistance, in Acinetobacter GDG 2 {Acinetobacter baumannii). The 
nucleotide sequence of adeE and adeY idiiXtd to match any known genes in GenBank, 
but the peptide sequence matched a number of RND efflux proteins. The highest 
degree of identity of the deduced product was found with AcrD and MexB in E. coli 
and P. aeruginosa respectively as shown in Table 6.9. 
All RND-type transporters exhibit similar topological features with 12 putative 
, transmembrane a-helical spanners (TMSs) and two large loops between TMS 1 and 2 
and TMS 7 and 8 (Saier et al., 1994). The predicted transmembrane helices of AdeE 
and AdeY (Figure 6.10 and 6.11) using the software TopPred (Pasteur Institut, Paris, 
France), showed that the hypothetic structure of AdeE appears typical of RND-type 
proteins but AdeY has exhibited some differences, though still comparable to the 
average hydropathy plot from different RND proteins (Tseng et al., 1999). 
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Tseng et al, 1999, described the average hydropathy plot as a single hydrophobic 
" peak at the N-terminal (TMS 1), followed by a long hydrophilic region (periplasmic 
region), and then five hydrophobic peaks arranged in 3 + 2 pattern (TMS 2-4 and 
5+6). It is then followed by the second repeat unit: a single hydrophobic peak, a long 
hydrophilic region and the 3 + 2 arranged hydrophobic peaks. As shown in Figure 
6.10, the hydrophobicity plot of AdeE matches the description given by Tseng et al, 
1999. For the hydrophobicity plot of AdeY (Figure 6.11), a hydrophobic peak is 
observed at the N-terminal but followed by an extra peak. Then a long hydrophilic 
region and the 3 + 2 arrangement of hydrophobic peaks match the description by 
Tseng et al, 1999. Similarly, the second repeat unit occurs afterward but the last 3 + 2 
pattern peaks are not obvious. Although AdeY has exhibited some differences to 
typical RND-type protein, the computer programs for protein prediction are not 
always accurate (Gotoh et al., 1999). 
The high degree of identity of the peptide sequences of AdeE and AdeY and the 
results of the membrane topology prediction suggest that AdeE and AdeY could 
-belong to RND transporters. 
Since the functionality of AdeY is not tested in this project, AdeY will be discussed 
‘separately in the next section. 
Ethidium bromide is a common substrate for efflux pump (Paulsen, Brown and 
Skurray, 1996), it is often used as a fluorescent indicator to study the level of its 
accumulation in the wild type and the pump-inactivated mutant (Giraud et al., 2000; 
Magnet et al., 2001). A decrease in ethidium bromide susceptibility in 8108-15 
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suggested that the transporter(s) in 8108-15 was disrupted. The results of altered 
MIC in different antibiotics and the decrease in resistance to ethidium bromide 
suggest that AdeE could be a functional RND transport. 
6.2.2 The theoretical AdeY protein 
AdeY was also found in an isolate of GDG 3 (4365). Comparison of the nucleotide 
sequences between adeE and revealed 58% homology. The level of identity of 
the putative proteins deduced from adeE and adeY was 50%. Comparison of the 
peptide sequence of AdeY with other RND transporters also revealed a high level of 
identity (42-56%) as shown in Table 6.9. In general, AdeY is of higher amino acid 
sequence identity to the RND-type proteins than AdeE. In addition to the membrane 
topology prediction of AdeY (discussed above, Ch 6.2.1), the results suggest that 
AdeY, similar to AdeE, could be a RND-protein and probably have similar functions. 
The peptide sequence beyond the putative adeY revealed a high degree of identity 
(55%) to the outer membrane protein AdeC as described by Magnet et al, 2001. 
"Therefore the adeY, perhaps the adeE as well, may be arranged as individual operons 
with membrane fusion protein and outer membrane protein genes, like AdeABC in A. 
baumannii (Magnet et al., 2001), MexAB-OprM in P. aeruginosa (Poole, Heinrichs 
and.Neshat, 1993) and many other efflux operons (review see Paulsen, Brown and 
Skurray, 1996). 
The functional role of AdeY had not been determined, and no further comment 
would therefore be made here. 
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CHAPTER 7 DISTRIBUTION OF AdeB AND THE PUTATIVE 
EFFLUX PUMPS AdeE and AdeY IN 
ACINETOBACTERS FROM DIFFERENT 
BACTERIAL COLLECTIONS 
Three pairs of specific primers were used to screen for the presence of adeB, adeE 
and adeY'm blood culture isolates (1997-2000) by PCR. The distribution of adeE in 
all GDG 3 acinetobacters from clinical and non-clinical sources was also studied 
(Table 7.5). Restriction fragment length polymorphism (RFLP) was used to confirm 
the identity of the PCR products obtained from the adeE^ and adeY^ samples. 
7.1 Results 
7.1.1 Distribution of adeB and the putative pumps {adeE and 
adeY) in blood cultures (1997-2000) 
PCR detection of adeB 
Primers 03 and 04 (see Chapter 2.8.1a) were used to screen for the presence of 
adeB sequence in Acinetobacter blood culture isolates collected between 1997 and 
- 2 0 0 0 (see Chapter 2.10.1 — PCR detection of adeB). Among the 271 acinetobacters 
examined, 39 (70%) isolates gave a positive result to the adeB PCR and all of them 
came from the 56 isolates of J . baumannii (GDG 2) (Table 7.1). 
, Clonal relatedness of adeB+ and adeB' isolates 
To exclude the possibility that adeB+ isolates were clonally related, PFGE was 
carried out on 38 GDG 2 isolates (see Chapter 2.10.1 — Clonal relatedness of adeB+ 
and adeB' isolates). Figure 7.1 shows that the adeB+ and adeB' isolates did not 
cluster together and their PFGE fingerprints share Dice coefficient of similarities 
<60%. 
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Figure 7.1 Dendrogram and fingerprints of 38 Acinetohacter GDG 2 isolates. 
Positive and negative sign under the adeB column indicate the 
presence of adeB and absence of adeB respectively. 
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PCR detection of adeE 
Primers, AdeE-245A and AdeE-620B (see Chapter 2.10.1 - PCR detection of adeE), 
were used to screen for adeE in the blood culture isolates (1997-2000). Among the 
271 acinetobacters of various GDGs studied, adeE was found mostly in GDG 3, 
70/83 (84%). A few other GDGs, 4/132 (3%), (13TU, 17 and 
ARDRA-unclassifiable acinetobacters), also showed the presence of adeE (Table 
7.1). 
PCR detection of adeY 
Primers AdeY-343A and AdeY-920B (see Chapter 2.10.1 - PCR detection of adeY) 
were used to detect the presence of adeY'm blood culture isolates in 1997-2000. Of 
the 271 isolates of various GDGs screened, adeY was found mostly in GDG 3 
isolates, 75/83' (90%). Some other GDGs (13TU, 17 and ARDRA-unclassifiable 
acinetobacters) were also adeY^, 6/132 (5%) (Table?. 1). 
^ Table 7.1 Summary of the distribution of adeB, adeE and adeY in 1997 - 2000 
blood culture isolates belonging to different genomic DNA groups. 
No. of isolates 
GDG* screened adeB adeE adeY 
2 Y6 39 ( 7 0 % ) - -
‘ 3 83 70 (84%) 75 (90%) 
‘ 13TU 24 - 1 (4%) 1 (4%) 
17 5 - 1 (20%) 1 (20%) 
U** 103 2 (2%) 4(40/0) 
* GDG: genomic DNA group 
** U: ARDRA-unclassifiable 
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adeE and adeY in GDG 3 isolates 
Table 12 shows the distribution of adeE and adeY in GDG 3 blood culture isolates. 
Most of the isolates, 68/83 (82%) were PCR positive to both adeE and adeY. Two 
and eight percent of isolates had either adeE or a^/eF respectively. There were 7% of 
isolates which were PCR negative to both adeE and adeY. 
Table 7.2 Distribution of adeE and adeY in GDG 3 isolates. 
Conditions No. of occurrence (%) 
AdeE+ AdeY+ 68 (82%) 
AdeE+ AdeY— 2 (2%) 
AdeE- AdeY+ 7 (8%) 
AdeE- AdeY- 6 (7%) 
7.1.2 Confirmation of the identity of the amplification products of 
adeE and adeY'm blood culture isolates (1997-2000) 
As it is not possible to sequence all the amplicons within the time frame of this study, 
RFLP of the PCR products of adeE and fl^/eF obtained in the previous section (7.1.1) 
was used to confirm their identity (see Chapter 2.10.2). 
‘adeE 
i ' 
Four restriction enzymes {Hhal, Hinfi, Hindi and Ms el) were used to digest the 376 
bp AdeE-245A — AdeE-620B PCR products. The patterns obtained were assigned 
numbers. Four different patterns (1-5) were obtained from the Hhal digestion, two 
(1-2) from the Hinfi and Hindi and 3 (1-3) from the Msel digestion. Figure 7.2 — 7.5 
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Figure 7.4 The two RFLP patterns encountered after digestion of the 376-bp PCR product by HincW 
of 72 different GDG isolates. 
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Figure 7.5 The three RFLP patterns encountered after digestion of the 376-bp PCR product by Mse\ 
of 72 different GDG isolates. 
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The combination of the four restriction patterns constituted a RFLP profile for each 
individual isolate. There was a total of 6 different profiles observed. Table 7.3 
summarizes the 6 combinations and the distribution of each profile in different 
GDGs. Profile 1111 was obtained from the adeE gene identified in this thesis (IN 
4365). Among the 70 adeE" GDG 3 isolates (2 adeE" not tested with RFLP), profile 
2111 and 3111 were the most prevalent, accounting for 44% and 40% of the adeE^ 
GDG 3 isolates respectively. 
Table 7.3 Summary of the distribution of the 6 composite RFLP profiles of adeE 
in different GDGs 
No. of isolates found with RFLP profile 
RFLP Profiles in different GDGs 
Hhal Hinfi Hindi Msel f ^ 3 13TU 17 U* 
1 i 1 71 5 5 - - -
2 1 1 1 31 30 1 -
3 1 1 1 29 28 1 - -
4 1 1 1 5 5 -
5 2 2 2 1 - - 1 
5 2 2 3 1 1 
“ T ^ ^ ^ i 1 2 
* ARDRA-unclassifiable isolates 
‘adeY 
Four restriction enzymes (Hhal, Hinfl, ApaLl and J^saV) were used to digest the 587 
bp AdeY-343A - AdeY-920B PCR products. Patterns were then assigned numbers. 
Four patterns (1-4) were obtained from the Hhal digestion, two (1-2) from ApaLl 
digestion and one (1) from each of Hinfi and Rsa\ digestion. Fig. 7.6 — 7.9 show the 
restriction patterns of the four restriction enzymes. 
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pattern 
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Figure 7.6 The four RFLP patterns encountered after digestion of the 587-bp PCR product by Hha\ 
of 78 different GDG isolates. 
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Figure 7.7 The one RFLP pattern encountered after digestion of the 587-bp PCR product by Hinj\ of 
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Figure 7.8 The two RFLP patterns encountered after digestion of the 587-bp PCR product by ApaLl 
of 78.different GDG isolates. 
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Figure 7.9 The one RFLP pattern encountered after digestion of the 587-bp PCR product by Rsa\ of 




The combination of the four restriction patterns constituted a RFLP profile for each 
individual isolate. Four composite profiles were observed. Table 7.4 summarizes the 
distribution of these profiles in different GDGs. Profile 1111 was derived from the 
adeY gQm identified in this thesis (IN 4365). Among the 72 adeY^ GDG 3 isolates 
tested (3 adeY^ not tested with RFLP), profile 1111 was the most prevalent (85%). 
Table 7.4 Distribution of the 4 composite RFLP profiles of adeY in different 
GDGs. -
No. of isolates found with RFLP profile 
RFLP Profiles in different GDGs 
Hhal Hinfi ApaL I Rsa I f ^ 3 13TU 17 U* 
1 1 i i ^ ^ i i -
2 1 2 1 10 6 4 
3 1 1 1 2 2 - - -
4 1 '1 . 1 1 1 - - -
f ^ ^ n 1 1 4 
* ARDRA-unclassifiable isolates 
Clonally relatedness of the different profiles found in adeE and adeY 
To exclude the possibility that isolates with the same RFLP profile were clonally 
related, PFGE was carried out on the 64 randomly selected GDG 3 isolates including 
, adeE and adeY negative isolates (Figure 7.10). Isolates with different RFLP profiles 
showed Dice coefficient of similarities of <50%. 
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Figure 7.10 Dendrogram and fingerprints of 64 blood culture GDG 3 acinetobacters. Letters A-D 
under adeE and adeY indicate the presence of the gene and represent the RFLP 
profiles. The RFLP profiles are shown in the boxes on the right. Positive sign indicates 
adeE or positive but not tested with RFLP. Negative sign indicates PCR negative 
to adeE or adeY. 
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7.1.3 The presence of adeE in GDG 3 acinetobacters from 
different sources 
All GDG 3 acinetobacters from different sources, including surveillance, clinical 
and environmental samples, were screened for the presence of adeE by using the 
primers AdeE-79A and AdeE-538B (see Chapter 2.9.1 and 2.10.3). Surveillance 
isolates included those from carriage sites of clinical staffs such as nurses and 
medical students at Prince of Wales Hospital (previously collected by Chu et al., 
1999). Clinical isolates included those from all types of clinical specimens of 
patients in ICU and wards, and blood culture isolates (Chu et al, 1999; Houang et 
al., 2001). Environmental isolates were from soil and vegetable samples (Houang et 
al, 2001). Among the 186 isolates studied, 143 (77%) isolates were positive to adeE. 
Table 7.5 shows the screening results of adeE from different sources. 
Table 7.5 PCR screening of adeE in GDG 3 acinetobacters from different 
sources. 
No. of samples 
source screened No. of positive* (%) 
Surveillance isolates 52 41 (79%) 
.Clinical isolates 114 93 (82%) 
Environmental isolates 20 9 (45%) 
‘ * Chi-square test, p = 0.002 (chi-square = 1297, degree of freedom = 2) 
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7.1.4 The presence of adeB, adeE and adeY in antibiotic 
susceptibility 
The mean, geometric mean, minimum, maximum, and the 25, 50 and 90 percentiles 
of MIC of amikacin, gentamicin, netilmicin, imipenem, ciprofloxacin, tetracycline, 
rifampin and ceftazidime for 57 GDG3 and 49 GDG2 isolates (randomly selected) 
and MIC of chloramphenicol for 23 GDG3 and 30 GDG2 isolates (existing data 
from Houang's laboratory) are tabulated in Table 7.6 - 7.8. The non-parametric 
method of Mann-Whitney U Test (SPSS, version 11.0) was used to compare the 
MIC of adeB^ and adeB' isolates of GDG 2. No significant difference was found 
(Table 7.6). The numbers of GDG 3 isolates with or without adeE^ or adeY^ were 
too small for a similar comparison. 
To study whether different RFLP-profiles (Chapter 7.1.2) had significantly different 
MIC, isolates of profiles 2111 (n = 18) and 3111 (n = 19) of adeE were compared. 
The non-parametric method of Mann-Whitney U test (SPSS, version 11.0) was used 
and the result are shown in Table 7.9. No significant difference in MIC was found. 
- T h e number of isolates with other RFLP-profiles of adeE and all the different 
profiles of adeY yNQXQ too small for a valid statistical comparison. 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































7.1.5 adeB，adeE and adeY and the clonally and epidemiologically 
related sets of isolates 
Table 7.10 shows the results of detection for the presence of adeB, adeE and adeY 
(Chapter 7.1.1); the common mechanisms of resistance to fluoroquinolones, 
aminoglycosides and carbapenems; and MIC of 8 antimicrobial agents in the 6 sets 
of serial isolates from blood culture 1999-2000 (Chapter 3.1.1a and Table 3.1). 
7.1.6 adeB, adeE and adeY und the blamp-/ isolates 
Table 7.11 shows the mRNA levels of bla\u?-A and meropenem MIC of 17 bla\u?.A 
blood culture Acinetobacter isolates in 1997-1998 (Chapter 4.1.2) and their PCR 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 7.11 The mRNA levels of M<3IMP-4 and meropenem MIC of 17 bla\u?.A 
blood culture Acinetohacter isolates in 1997-1998 and their PCR 
results of adeE and 7 detection. 
Transcript levels** of Meropenem MIC 
Isolate WMP-4 (^ig/mL) adeE adeY 
4 m 4.85x10^+4.10x10^ 6 + + 
4379 6.18x10^+1.44x10^ 4 - + 
4421 7.81x10^+1.23x10^ 6 + + 
4328 8.65x10^+2.19x10^ 2 + + 
4412 9.29x10^+1.46x10^ 16 + + 
4366 9.62X10M.02X10^ 12 + + 
4386 1.00x10^+0.29x10^ 12 + + • 
4407 1.17x10^+3.05x10^ 12 + + 
4 3 7 0 1.43X107 土4.48X105 >32 + + 
4431* 1.44x10^+2.52x10^ >32 - + 
4482 1.47x10^+5.89x10^ >32 + + 
4416 1.52x10^+2.12x10^ 24 + + 
4384 1.56X10M.15X10^ >32 + + 
4333 .. 1.58x10^+2.68x10^ 12 + + 
\4352 1.86x10^+8.32x10^ 4 + + 
4351 2.06x10^+3.40x10^ 12 + + 
4334 2.21x10^+3.26x10^ 1 + + 
* isolate 4431 was previously detected to contain a class D p-lactamase,OXA-23 
** transcript levels were expressed per 川⑴ 16S rRNA 
(+) presence of the relative gene 





7.2.1 PCR-RFLP typing 
In PCR-RFLP typing, the target sequence of interest is amplified by PCR and the 
product is cut with restriction enzymes and the RFLP patterns are compared. 
Struelens, 1998, compared ribotyping, macrorestriction analysis, PCR-gene RFLP 
typing, arbitrarily-primed PCR (AP-PCR) typing, repetitive element PCR (rep-PCR) 
typing and amplified fragment length polymorphism (AFLP) method, and concluded 
that RFLP was only moderately discriminatory. The target sequences of interest here 
were relatively short (376 and 587 bp for adeE and adeY respectively), and 4 
restriction enzymes (with 4 to 6 recognition bases) producing 2 to 4 bands in each 
digestion were used. Using more restriction enzymes would enhance the 
discriminatory power but also demanded more resources. The method applied 
appeared to divide the amplicons of adeE and adeY mio major groups satisfactorily. 
However, RFLP cannot detect all the nucleotide differences in the adeE and adeY 
sequences. To sequence the adeE and adeY is therefore necessary to detect the 
-nuc leo t ide differences. 
7.2.2 Distribution of adeB 
• Magnet et al., 2001, showed that adeB was present in the 6 A. baumannii (GDG 2) 
i ' 
isolates but not in A. haemolyticus (GDG 4) isolates tested. Table 7.1 shows 70% of 
GDG 2 (39/56) blood culture isolates were positive to adeB, and only GDG 2 
isolates were positive. Thirty-eight GDG 2 isolates were examined for clonal 
relatedness (Figure 7.1). Their PFGE fingerprints show a Dice coefficient of 
similarities <60%, indicating that adeB+ isolates were not clonally linked. A clone of 
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3 GDG 13TU isolates (111702A, 111702B and 111702R) which shared a Dice 
coefficient of similarity of 97% (see Chapter 3, Figure 3.3), was PCR positive to 
adeB (see Chapter 3, Table 3.2). The results indicate that AdeB is mostly associated 
with GDG 2 in acinetobacters. 
7.2.3 Distribution of adeE 
Screening of the blood culture isolates showed that adeE was found mainly in GDG 
3 and none of the GDG 2 isolates was adeE\ indicating that adeE is mainly 
associated with GDG 3. 
Table 7.5 shows 79%, 82% and 45% of surveillance, clinical and environmental 
isolates were PCR positive to adeE respectively, indicating that adeE could be found 
in isolates of GDG 3 from different sources. However isolates from clinical 
specimens were significantly more likely to be adeE^ than those from the 
environments (p = 0.001 Fisher Exact test, Odds Ratio: 5.41 (95% confidence limit, 
1.79 < OR < 16.56)). Clinical isolates were also found to be significantly more 
. l i k e l y to have higher MIC than environmental isolates in another study (Houang et 
al., submitted). The presence of adeE may be a contributing factor to this, but 
further studies on the presence and the activity of other resistance mechanisms 
would be required. 
y " 
Using 4 restriction enzymes, 6 different composite profiles were generated from 
RFLP of adeE. This suggests that there were at least 6 variants of adeE. The variants 
were probably caused by point mutation which led to changes in restriction sites. 




restriction sites of the sequence, the 4 enzymes (see Chapter 2.10.2), would yield the 
profile 1111. However, this profile was only found in 5 (7%) of the 72 adeE^ isolates 
tested. Profile 2111 and 3111 were more common than others. Since there was only 
one difference {Hhal) in the profiles of 2111 and 3111, there was possibly a high 
degree of similarity between them. However, further work on the variants by 
sequencing is necessary to confirm this. 
7.2.4 Distribution of adeY 
Similar to adeE, the adeY gene was found mainly in GDG 3 isolates and none in 
GDG 2, indicating that adeY was closely associated with GDG 3. 
Sixty-four GDG 3 isolates were examined by PFGE. No correlation can be found in 
adeY^ and adeT isolates (Dice coefficient of similarities of <50%). The 51 isolates 
which possessed profile A (profile 1111) shared a Dice coefficient of similarities of 
<50%, indicating that they were clonally unrelated. 
7.2.5 Distribution of adeE and adeY'm GDG 3 isolates 
From the discussion above, none of the GDG 2 isolates had adeE and adeY, and, on 
,the other hand, no GDG 3 isolate was PCR positive to adeB. In view of the 
• difficultly in differentiating the different GDG within the ^^c-complex and the high 
isolation rate of GDG 3 in our region, the presence of adeB, adeE or adeY may 
therefore be exploited as markers for rapid differentiation between GDG 2 and 3 in 
the clinical laboratory, if and when their identification is deemed necessary. 
Screening of the presence of adeE and adeY revealed that 82% of the GDG 3 
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isolates had both genes, i.e. two RND-transporters. In P. aeruginosa, two efflux 
systems, MexAB-OprM and MexEF-OprN were found to express simultaneously 
(Pumbwe and Piddock, 2000). Li, Varre and Poole, 2000, reported the influence of 
the MexAB-OprM expression on MexCD-OprJ and MexEF-OprN expression in P. 
aeruginosa. They suggested that the co-existence of different efflux systems has 
compensatory effect on each other, which together might maintain a basal level of 
efflux gene expression, emphasizing the important roles of these pumps in the cell. 
The presence of adeB, adeE and adeY in sets of isolates, and bla\u?A^ isolates will 
be discussed in Chapter 8. 
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CHAPTER 8 GENERAL DISCUSSION 
Multiple mechanisms of resistance can co-exist in the same bacterial isolate and it is 
likely that the resistance phenotype results from the interplay of these mechanisms. To 
validate the role of the efflux pump in multidrug resistance, experiments to study the 
phenotypic differences in the accumulation of antimicrobials in isolates within the sets 
are important but difficult to perform because of limited resources. To allow for a 
better understanding of the data on the expression of adeB and resistance phenotypes, 
the presence of the metallo-p-lactamase IMP-4 (accounting for carpabenem resistance 
in Hong Kong), the commonly found aminoglycoside modifying enzymes (accounting 
for amikacin resistance), and the gyrase mutation (accounting for ciprofloxacin 
resistance) were examined in the sets of serial isolates. The presence of these 
mechanisms was determined by PCR, i.e. at the DNA level, however, other factors 
such as expression levels and enzyme activities are also important in determining the 
resistance phenotypes. Measurement of the gene expression by quantification of the 
transcript levels of specific genes is commonly used to study the gene function 
- ( Z a m o r a n o , Mahesh and Brann, 1996; Bustin, 2000). However, studying the transcript 
levels might not always reflect the protein levels straightforwardly, nor the protein 
-activity (Gygi et cd., 1999). It should also be noted that the method used for MIC 
‘determination is not sensitive enough to detect small changes in susceptibility as it 
i- ‘ 
relies on double dilutions. Another method, e.g. E-test, a gradient diffusion test, may 
be better for this purpose, but commercial supplies of the strips are expensive. 
In this project, sets of epidemiologically and clonally related clinical isolates which 
exhibited different resistance patterns were our target organisms to study 
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longitudinally the emergence of multidrug resistance. However, epidemiologically 
related serial isolates showing differences in antimicrobial susceptibility were not 
found in ICU over a period of six months (Chapter 3.1.2), and found in only 8 sets of 
positive blood cultures 1999-2000 (Chapter 3.1.1a). The data here suggests that 
heterogeneity among isolates of the same GDG from the same site was a common 
feature in clinical specimens (Chu et al, 1999; Houang et al.，2001), although the 
limitation in the number of colonies picked from the primary culture for identification 
in the routine laboratory might have exaggerated the picture of heterogeneity. The fact 
that adeB and adeE were shown to be mainly associated with GDG 2 and 3 
respectively (Chapter 5.1.1 and 7.1.1) reduced further the chance of finding adeB+ or 
adeE^ isolates. 
Studies have shown that efflux pumps interplay with other resistance mechanisms, like 
P-lactamases in P. aeruginosa (Masuda et al., 1999; Nakae et al., 1999). Because of 
the importance of carbapenem in clinical practice, it would have been of great interest 
to study the interplay between the efflux pump and the hla\u?-^ in Acinetobacter. 
‘ H o w e v e r adeB, the only pump reported so far, is closely associated with GDG 2 and 
no blamp-4^ isolate has been found in this GDG in our laboratory (Chu et al., 2001). 
.Such a study is now possible on GDG 3 isolates, as my data show that there are 15 
‘bla\u?-A isolates which are also adeE^ in the collections studied. 
Another target studied was the collection of morphological variants (big and small 
colonies in 2B, DU, EU, A13TU). These isolates originally came from a single colony 
picked for sensitivity testing and were obtained after overnight incubation. Their 
generation time was likely to be shorter than that for serial isolates obtained from 
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clinical specimens taken days apart. The morphological variants shared 96-97% Dice 
coefficient of similarity to each other within the set (Table 3.1 and 3.2). The gaining of 
new resistance mechanisms (horizontal transfer) would be minimized in 
morphological variants, although remain possible through mutation (vertical 
evolution). The increased susceptibility of isolates in 2B, DU and A13TU (Table 7.10) 
was associated with a loss of the resistance mechanism examined here, aac(6’)-Ib, 
aph(3 ’)-Via, integrase I and blajMP-4, which has been shown to be plasmid / integron 
borne (Lambert, Gerbaud and Courvalin, 1988; Recchia and Hall, 1995; Houang et a!., 
submitted) and therefore could be spontaneously lost. These isolates may offer a good 
source to study the role of the pump in interplaying with different resistance 
mechanisms. 
8.1 Significance of adeB and the putative pumps {adeE and adeY) 
Inactivation of adeE (Chapter 6.1.5) revealed that the a^ief-disrupted mutant (8108-15) 
had increased susceptibility (4- to 64- fold decrease in MIC) to amikacin, 
-chloramphenicol, ceftazidime, ciprofloxacin, erythromycin, meropenem, rifampin and 
tetracycline (Table 6.11). Disk diffusion test showed that mutant 8108-15 was also 
more susceptible to ofloxacin, nalidixic acid, imipenem, netilmicin, gentamicin and 
neomycin than its parent isolate 8108. The results indicate that quinolones, 
J ' 
ceftazidime, carbapenem, aminoglycosides, tetracycline and rifampin could be 
substrates for AdeE. Thus AdeE seems to be capable of recognizing structurally 
unrelated substrates of a wide range of hydrophobic, amphiphilic and hydrophilic 
compounds. AdeE could therefore play a part in multidrug resistance. 
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Among the cephalosporins tested, only the cefotaxime MIC remained unchanged in 
the flt/e五-disrupted mutant (Table 6.10 and 6.11), suggesting that cefotaxime might not 
be the substrate of AdeE. Comparing the structure between ceftazidime and 
cefotaxime, cefotaxime does not contain a nitrogen atom on the R2 side chain (Figure 
8.1). The nitrogen atom on the side chain can be protonated and affects the 
amphiphilicity. Kohler et al.’ 1999 explained the different behavior of the three 
carbapenems (imipenem, meropenem and ER-35786) in the efflux system, 
MexAB-OprM, of P. aeruginosa by the differences in amphiphilicity due to the 
position of nitrogen atoms. 
. H H 
‘ CQN\ 
X = r / 
0 , 1 
COOH 
Generation RI R2 
Cefotaxime J 
\ X CH2OCOCH3 
‘ . 、 一 0 C H 3 
‘ Ceftazidime ？ ~ 
HaC-^ 
COO 
Figure 8.1 Chemical structures of cefotaxime and ceftazidime. 
X is the basic structure of cephalosporin. 
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The efflux pumps, AdeB found by Magnet et al., 2001, and AdeE described here 
shared a 50% amino acid identity, and their substrate profiles were identical except for 
ceftazidime, cefotaxime and rifampin (Magnet et al., 2001). AcrD in E. coli 
(Rosenberg, Ma and Nikaido, 2000) appeared to share a higher amino acid identity 
(54%) with AdeE (Table 6.9) but it participated in the efflux of aminoglycosides only 
(Rosenberg, Ma and Nikaido, 2000). The substrate specificities of AcrD (Rosenberg, 
Ma and Nikaido, 2000), AdeB (Magnet et aL, 2001) and AdeE are compared in Table 
8.1. 
Table 8.1 Comparison of the substrate specificities of AdeB, AdeE and AcrD. 
adeB-d\srupled mutant adeE-disrupted mutant acrD-disrupted mutant 
Acinetobacter GDG 2 Acinetobacter GDG 3 E.coli 
Antibiotics (Magnet et al., 2001) (This work) (Rosenberg et al., 2000) 
(/I ‘ 
c Ciprofloxacin (CIP) NT t in susceptibility NT 
"o Ofloxacin (OFX) T in susceptibility 个 in susceptibility NT 
I Nalidixic acid (NAL) NT T in susceptibility Unchanged 
^ Ceftazidime (CAZ) Unchanged 个 in susceptibility NT 
B Cefotaxime (CTX) 个 in susceptibility Unchanged NT 
•2 
- Meropenem (MEM) NT T in susceptibility NT 
^ Imipenem (IMP) NT 个 in susceptibility NT 
C/5 
o Gentamicin (GEN) 个 in susceptibility 个 in susceptibility T in susceptibility 
‘ Netilmicin (NET) t in susceptibility T in susceptibility NT 
‘ .1 Amikacin (AMK) 个 in susceptibility 个 in susceptibility T in susceptibility 
< 
Tetracycline (TET) 个 in susceptibility 个 in susceptibility NT 
^ Erythromycin (ERY) 个 in susceptibility 个 in susceptibility NT 
•B Chloramphenicol (CHL) T in susceptibility 个 in susceptibility Unchanged 
Rifampin (RIF) Unchanged 个 in susceptibility Unchanged 
Ethidium bromide (EBR) 个 in susceptibility 个 in susceptibility NT 
NT, not tested 
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Most RND transporters are associated with a membrane fusion protein and outer 
membrane protein, and they are arranged as operons (as below), like AdeABC in A. 
baumannii (Magnet et al., 2001) and MexAB-OprM in P. aeruginosa (Poole, 
Heinrichs and Neshat, 1993). The peptide sequence beyond AdeY revealed a high 
degree of identity to the outer membrane protein AdeC (Chapter 6.1.2) (Magnet et al., 
2001). Therefore sequencing the upstream and downstream regions of adeE and adeY 
may be helpful to determine whether they are arranged as operons individually with 
membrane fusion protein and outer membrane protein genes. 
The high degree of identity of the peptide sequence of AdeY with other RND-type 
efflux proteins (Chapter 6, Table 6.9), and the result of the membrane topology 
prediction (Chapter 6.1.4) suggest that AdeY could function as a RND transporter. 
Another piece of supporting data comes from the findings on isolates in set 3B (5317 
and 5316). Both isolates were PCR negative to all resistance mechanisms studied, 
except mutation of gyrA at Ser-83 (Table 7.10). Isolate 5317 was adeE^ and adeY^ 
while 5316 was only adeE\ The former had elevated MIC (> 4-fold) of gentamicin, 
- a m i k a c i n , tetracycline, chloramphenicol and ethidium bromide, suggesting that adeY 
could possibly function as an RND-type efflux pump with a wide range of substrates. 
.This can be confirmed by further studies, such as target disruption carried out for adeE 
• here. Lee et al, 2000, demonstrated that simultaneous expression of two efflux pumps 
in P. aeruginosa showed an additive effect on drug resistance. Of the 83 GDG 3 
isolates 82% were PCR positive to both adeE and adeY. Together with isolates of set 
3B, they offer an opportunity to study the possible synergistic or additive effects of 
AdeE and AdeY. 
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Isolates of 5 sets (3B, 3C, B12, C5 and EU) showed a difference in ethidium bromide 
(> 4-fold within each set), suggesting that changes in MIC within the sets could be due 
to efflux because ethidium bromide is a common substrate for the pump (Paulsen, 
Brown and Skurray, 1996). In P. aeruginosa, at least 5 efflux systems have been 
identified (see Chapter 1.3.1), and in E. coli, at least 3 efflux proteins, AcrB (Ma et al, 
1993), AcrF (Klein, Henrich and Plapp, 1990; Klein, Henrich and Plapp, 1991) and 
AcrD (Rosenberg, Ma and Nikaido, 2000) have been reported. Also, simultaneous 
expression of 2 efflux systems was shown by Pumbwe and Piddock, 2000 in P. 
aeruginosa. Changes in the activities of the pumps studied here and/or of other 
yet-to-be-known efflux pump(s) may contribute to the changes in susceptibilities in 
these serial isolates. 
Of the adeB女 GDG 2 Acinetobacter (Chapter 7.1.1), more than 70% had low MIC of 
amikacin (< 0.06 - 2 mg/L), netilmicin (< 0.03 — 4 mg/L), imipenem (< 0.03 - 2 mg/L), 
ciprofloxacin (< 0 .015- 0.5 mg/L) and rifampin (< 0.25 — 4 mg/L). Of the 70 adeE" 
and 75 adeY^ blood culture isolates (Chapter 7.1.1), with the exception of ceftazidime 
- and chloramphenicol, over 70% of them had low MIC of amikacin, gentamicin, 
netilmicin (all < 0.06 - 4 mg/L), imipenem (< 0.03 — 2 mg/L), ciprofloxacin (< 0.02 -
1 mg/L), tetracycline ( < 0 . 1 2 5 - 4 mg/L) and rifampin (< 0.25 — 4 mg/L). The data 
‘ sugges t that the presence of adeB, adeE and adeY was not generally associated with 
i " 
clinically significant resistance phenotypes and other resistance mechanism(s) would 
be required for them. 
Nevertheless, the adeB gene was found in 70% of GDG 2, and adeE and adeY'm 84% 
and 90% of GDG 3 isolates respectively (Chapter 7.1.1). Isolates from clinical 
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specimens were significantly more likely to be adeE^ than those from the 
environments, (p = 0.001 Fisher Exact test, Odds Ratio: 5.41 (95% confidence limit, 
1.79 < OR < 16.56)) (Chapter 7.2.3), suggesting AdeE may be a contributing factor to 
the multidrug resistance seen in clinical isolates. In P. aeruginosa, the constitutively 
expressing MexAB-OprM in a wide type strain was identified to contribute to the 
intrinsic resistance (Gotoh et al., 1994; Poole et al., 1993). Also, the overexpression of 
MexAB-OprM, MexCD-OprJ and MexEF-OprN in mutant strains (Poole et al., 1996a; 
Poole et al., 1996b; Kohler et al., 1997b) was shown to be responsible for multidrug 
resistance in P. aeruginosa. Overexpression of one of the three efflux systems 
(MexAB-OprM, MexCD-OprJ and MexEF-OprN) was found in 94% (303/321) of 
isolates exposed to quinolones. The initial preferred resistance mechanism selected in 
response to the exposure of quinolones was through the efflux system(s), not through 
an alternation'in gyrase gene (Kohler et al., 1997a). Although gyrase mutations confer 
a higher level of resistance, they seem to occur less frequently than the efflux-type 
mutations, even in clinical isolates (Jakies et al., 1992). In cases of re-exposure to the 
drug, subsequent mutations, such as those in the gyrase gene, would then appear and 
- contribute to a further increase in resistance levels (Kohler et al., 1997a). Lomovskaya 
et al” 1999, showed that the emergence of a fluoroquinolone-resistant mutant was 
.undetectable in the mutant without the multidrug efflux pumps (MexAB-OprM, 
‘MexCD-OprJ and MexEF-OprN) in P. aeruginosa, indicating that efflux pumps 
played a significant part in the emergence of fluoroquinolone resistance. 
In Chapter 4, the /^fliMP-4 transcript level in the blaiMP-4^  blood culture isolates was 
studied (Table 4.1). There might be a general correlation (Spearman's rho coefficient 
of correlation = 0.627) between the transcript levels and meropenem MIC (Figure 4.3). 
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From the PCR results of adeE and adeY obtained from Chapter 7.1.1, with the 
exception of 4379 and 4431, all bla\y[?.A isolates were adeE^ and 7.11). 
Efflux systems in P. aeruginosa were shown to interplay with P-lactamases (Masuda et 
al； 1999; Nakae et al； 1999) and porin OprD (Kohler et al, 1999) in P-lactam 
resistance. Nakae et al., 1999, concluded that although the efflux pump MexAB-OprM 
contributed significantly to p-lactam resistance, its contribution became relatively 
small when p-lactamase was overexpressed. On the other hand, Kohler et al., 1999, 
demonstrated that none of the resistant mutants were found to have OprD after the 
carbapenem exposure, suggesting that the loss of OprD, resulting in a reduction of 
carbapenem entry into the cell, was the first mechanism of resistance to develop under 
carbapenem exposure. The function of the porin which counteracted the contribution 
of the simultaneous overexpression of two efflux systems (Pumbwe and Piddock, 
2000) makes it difficult to identify the actual role of either the porin and the efflux « 
pump. No similar work on porin has so far been reported in Acinetohacter. 
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CHAPTER 9 CONCLUSION 
9.1 Conclusion 
The prevalence of adeABC (Magnet et al., 2001) was examined in different 
Acinetobacter GDG and in sets of serial isolates from clinical specimens. AdeB was 
found to be closely associated with GDG 2. 
Two RND-type efflux proteins, AdeE (1037 aa) and AdeY (1054 aa), were found in 
GDG 3 Acinetobacter, an important species in Hong Kong (Chu et al., 2001). Target 
disruption of AdeE revealed that it is a multidrug efflux protein and its substrates 
include quinolones, ceftazidime, carbapenem, aminoglycosides, tetracycline and 
rifampin. AdeE and AdeY were closely associated with GDG 3 and coexisted in 82% of 
GDG 3 i so la tes . ‘ 
Real time RT-PCR was used to study mRNA levels of the target genes {adeB and 
blamp-4). Inter- and intra-assay results obtained were reproducible and acceptable. The 
transcript levels of blamp-4 might be moderately associated with meropenem MIC 
(Spearman's rho coefficient of correlation = 0.627). 
To study longitudinally the emergence of multidrug resistance, epidemiologically and 
clonally related sets of serial isolates with different antimicrobial susceptibilities were 
sought from clinical specimens in the laboratory. Isolates within the sets were examined 
for MIC of aminoglycosides, quinolones, capabenems, tetracycline, chloramphenicol, 
rifampin and ethidium bromide, and the presence of the common resistance 
mechanisms {aph(3')-VIa, aac(6’)-Ib, integrase I and arr-aacA4 and the 
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mutation of gyrA and parC). The results support the contention that adeE and adeY 
behave as functional efflux pumps. Nevertheless their contribution to clinically 
significant resistance is likely to be small. Whether their presence would be a 
prerequisite for the emergence of other resistance mechanisms, e.g. quinolone 
resistance in Pseudomonas (Lomovskaya et al.，1999), requires further study. 
9.2 Future plan 
Studies have shown that efflux systems would interplay with each other and contribute 
to the resistance phenotype (Lee et al‘, 2000; Pumbwe and Piddock, 2000). AdeE and 
AdeY were found to co-exist in most GDG 3 Acinetobacter isolates, but only the role of 
AdeE was determined in this project. It is therefore necessary to study the functional 
role of AdeY, in a similar fashion as for AdeE. A study of the transcript levels of both 
adeE and adeYhy real time RT-PCR may help us to understand the interplay and their 
relative importance in GDG 3 Acinetobacter. Isolates with different efflux pump(s) 
conditions {adeE^ and adeY^; adeK and adeY'\ adeE^ and adeY as well as adeK and 
adeY) will be useful for this purpose. 
The deduced product of the putative 7 revealed a high degree of identity with an 
outer membrane protein of A. baumannii (AdeC) (Chapter 6.1.2) (Magnet et al., 2001). 
Sequencing of the upstream and downstream regions of adeE and adeY hy chromosome 
walking should find the operon and perhaps the regulatory genes of the efflux systems. 
This would help to understand the regulation of these efflux systems. 
To get a clearer picture on the interplay between different resistance mechanisms, DNA 
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microarrays (Brown and Botstein, 1999; Duggan et al, 1999) is a promising method 
which allows a large scale analysis of mRNA levels, and many genes can be studied at 
once. Nevertheless, RNA levels may not reflect the protein levels straightforwardly 
(Gygi et al., 1999) and the transcript levels would not indicate the protein activity. 
Additional information such as protein expression and the corresponding activities are 
therefore required for a clear understanding of efflux pump system in Acinetohacter. 
i ‘ 
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APPENDIX 1 
Overview of ARDRA patterns obtained after restriction of the amplified 16S rRNA 
gene with a standard panel of five restriction enzymes from Dijkshoorn et al. (1998) 
Cfo\ 4/1/1 Mbol Rsa\ Msp\ 
M M M M M M 
I I 1 M I I I I I i l 1 1 1 i l l I I I I 
n 1 2 3 4 5 6 7 1 2 3 4 5 1 2 3 1 2 4 1 2 3 1+3 
2+3 
M, molecular size marker (100-bp ladder). Numbers below each lane correspond to ARDRA pattern 
designations for each different enzyme. 
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ARDRA profiles of 202 Acinetohacter reference strains previously identified to genomic species by use of 
D N A - D N A hybridization (Dijkshoorn et al., 1998). 
Strain'' Designation as received Source Restriction Patterns 
and/or other designations'^ 
C/oI Alu\ Mbo\ Rsa\ Msp\ Bfa\ BsmM 
Genomic species 1 (A. calcoaceticus) 
RUH 220r ATCC 23055^ ^ T soil 2 2 1 1 3 
RUH 54 LMD 22.17, 2® soil 2 2 1 1 3 
RUH 583 3® soil 3 2 1 1 3 
RUH 584 4' soil 2 2 1 1 3 
RUH 944 5' i.v.catheter 2 2 1 1 3 
RUH 582 soil 2 2 1 1 3 
RUH 2202 M'^ T wound 2 2 1 1 3 
RUH 2203 132^8' wound 2 2 1 1 3 
Genomic species 2 (A. baumannii) 
RUH 2207 91^9' sputum 1 1 1 2 3 
RUH 112 10' wound 1 1 1 2 3 
RUH 88 " e wound 1 1 1 2 3 
RUH 1147 12® toe web 1 1 1 2 3 • 
RUH 510 13' bronchus 1 1 1 2 1 
RUH 1052 LMD 82.54, 14' not known 1 1 1 2 1+3 
RUH 1063 NCTC 7844, 15® not known 1 1 1 2 1 
RUH 557 16' urine 1 1 1 2 3 
RUH 48 \ T wound 1 1 1 2 3 
RUH 413 19" pus 1 1 1 2 1 
RUH 336 20' sputum 1 1 1 2 3 
RUH 2208 1 4 < 2 P wound 1 1 1 2 3 
RUH 871 I T urine 1 1 1 2 1 
RUH 230 23® wound 1 1 1 2 3 
RUH 872 24' urine 1 1 1 2 1 
RUH 2209 'ATCC 17904^ 25' urine 1 1 1 2 3 
RUH 1019 26' ‘ wound 1 1 1 2 1 
RUH 213 IT sputum 1 1 1 2 1 
RUH 882 28' urine 1 1 1 2 1 
RUH 436 29' sputum 1 1 1 2 1 
RUH 523 30' urine 1 1 1 2 3 
RUH 134 3 r urine 1 1 1 2 3 
RUH 215 32® blood 1 1 1 2 1 
RUH 875 33' urine 1 1 1 2 1 
RUH 150 34' urine 1 1 1 2 3 
RUH3023T CCUG 19096T’d’ urine 1 1 1 2 1 
•  ATCC 19606^35® 
RUH 1093 36' sputum 1 1 1 2 1 
RUH 332 3T blood 1 1 1 2 3 
RUH 210 38' sputum 1 1 1 2 3 
RUH 128 39' sputum 1 1 1 2 3 
RUH 97 40' sputum 1 1 1 2 3 
RUH 447 4 r catheter tip 1 1 1 2 1 
, RUH 414 42' ear 1 1 1 2 1 
RUH 3242 if bum 1 1 1 2 1 
“ RUH 3344 burn 1 1 1 2 1 
RUH 2032 6f sputum 1 1 1 2 1 
RUH 2033 f sputum 1 1 1 2 1 
RUH 3370 16'" resp 1 1 1 2 3 
• 2 4 7 
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APPENDIX 2 
Genomic species 2 (A. baumannii) (continued) C/oI AM Mbo\ Rsal Msp\ Bfal BsmAl 
RUH 3371 丨 / resp 1 1 1 2 3 
. RUH 1752 13g bronchus 1 1 1 2 1 
“ R U H 2180 19« sputum 1 1 1 2 3 
RUH 3238 GNU 1084,7® bum wound 1 1 1 2 1 
RUH 3429 TU 147,24® wound 1 1 1 2 1 
RUH 1486 umbilicus 1 1 1 2 1 
RUH 1907 18g bronchus 1 1 1 2 3 
RUH 2688 22® pharynx 1 1 1 2 1+3 
RUH 3239 GNU 1 0 8 3 , u r i n e 1 1 1 2 1 
RUH 3240 GNU 1 0 8 6 , r e s p . t r a c t 1 1 1 2 3 
RUH 3242 GNU 1082,5® wound 1 1 1 2 1 
RUH 3245 GNU 1080,3® CSU 1 1 1 2 3 
RUH 3247 GNU 1078, rectal mucosa 1 1 1 2 1 
RUH 3281 GNU 1081,4® trach. asp irate 1 1 1 2 1 
RUH 3282 GNU 丨 079,2® trach. site 1 1 1 2 1+3 
RUH 3410 MB 142,29» skin 1 1 1 2 1 
RUH 3413 SJH9/MB 264,30^ skin 1 1 1 2 1 
RUH 3423 PGS 9971,268 urine 1 1 1 2 1 
RUH 3425 PGS 10086,28® urine 1 1 1 2 3 
RUH 3414 SJH 26/MB 228, 3 n a i l fold 1 1 1 2 1 -
RUH 3422 PGS 189, 25« crural ulcer 1 1 1 2 3 
RUH 3424 PGS 10074,27® urine 1 1 1 2 1 
RUH 3428 TU 133,23® wound 1 1 1 2 3 
RUH 3212 04/90 Vllh vlflow 1 1 1 2 1 
RUH 3323 patBh blood 1 1 1 2 1+3 
Genomic species 3 
RUH 2204 102d,43e wound 2 1 3 1 3 
RUH 502 44 ' drain 2 1 3 1 3 
RUH 1163 45 ' toe web 2+3 1 3 1 3 
RUH 2205 丨 62d,46e wound 2 1 3 1 3 
RUH 1020 4 r bronchus 2 1 3 1 3 
RUH 411 ‘ 48' sputum 2 1 3 1 3 
RUH 509 49^ bronchus 2 1 3 1 3 
RUH 37 50 ' blood 2 1 3 1 3 
RUH 408 51' not known 2+3 1 3 1 3 
RUH 468 52 ' urine 2 1 3 1 3 
RUH 56 LMD 79.41,53® not known 2 1 3 1 3 
RUH 532 54' urine 2 1 3 1 3 
RUH 2206 ATCC 19004^ 55' CSF 2 1 3 1 3 
RUH 1942 l l f urine 2 1 3 1 3 
RUH 1944 12^ urine 2 1 3 1 3 
„ RUH 1026 58' urine 2 1 3 1 3 
RUH 1266 19' bronchus 2 1 3 1 3 
RUH 1444 r urine 2 1 3 1 3 
RUH 3330 pat M"^  blood 2 1 3 1 3 
RUH 3353 pat T'^  blood 2 1 3 1 3 
RUH 2783 pat iii'' liquor 2 1 3 1 3 
RUH 3199 patDh tube 2 1 3 1 3 
RUH 3201 08/89 IVh sink 2 1 3 1 3 
‘ RUH 3202 08/89 IV*^  sink 2 1 3 1 3 
, RUH 3321 pat Ah blood 2 1 3 1 3 




Genomic species 4 (A. haemolyticus) Cfol Alul Mbol Rsal Mspl Bfal BsmAl 
RUH 2213 197^ 56' wound 1 4 1 2 2 1 
. R U H 415 5T pus 1 4 1 2 2 1 
RUH 55 LMD 70.9,58® not known 1 4 1 2 2 1 
RUH 406 Gilardi 2890,59® not known 1 4 1 2 2 1 
RUH2215T ATCC 17906T,d，60e sputum 1 4 1 2 2 1 
RUH 44 61' air 丨 4 1 2 2 1 
RUH 2214 6ld, 62e not known 1 4 1 2 2 1 
Genomic species 5 (A.junii) 
RUH 2228^ ATCC 17908T’d,63e urine 1 2 1 2 3 3 
RUH 204 64' blood 1 2 1 2 3 3 
RUH 383 65' not known 1 2 1 2 3 3 
RUH 2229 丨 24d, 66e surgical gown 1 2 1 2 3 3 
RUH 2230 178^ 67' water 1 2 1 2 3 3 
RUH 3198 patch sputum 1 2 1 2 3 3 
Genomic species 6 
RUH 2867 ATCC 17979^ 68' throat 1 1 2 2 2 
LUH 286 MGH 97923,39'' urine 1 1 2 2 2 
Genomic species 7 (A.johnsonii) • 
RUH 223 iT ATCC 17909T’d,69e gut 1 4 1 2 2 2 
RUH 2233 92d，70' urine 1 4 1 2 2 2 
RUH 2855 68d,7r urine 1 4 1 2 2 2 
RUH 2856 9卞,IT urine 1 4 1 2 2 2 
RUH 2857 112^ 73' urine 1 4 1 2 2 2 
RUH 2232 153d，75� faeces 1 4 1 2 2 2 
RUH 2859 137d’76e urine 1 4 1 2 2+3 2 
LUH 540 LMD 90.19，21 OA丨 activated sludge 1 4 1 2 2 2 
RUH 2858 134^ urine 1 4 1 2 2 2 
Genomic species S / 9 {A. Iwoffii) 
RUH2219T NCTC 5866T,d, 77' not known 3 3 2 1 2 
RUH 551 ‘ 78® not known 3 3 2 1 2 
RUH 45 79' ‘ blood 3 3 2 1 2 
RUH 2221 44'', 80® prostate seer. 3 3 2 1 2 
RUH 548 81' eye 3 3 2 1 2 
RUH 74 82' not known 3 3 2 1 2 
RUH 302 83' skin 3 3 2 1 2 
RUH 1104 84^  skin 3 3 2 1 2 
RUH 1115 85® skin 3 3 2 1 2 
RUH 549 86' urine 3 3 2 1 2 
RUH 303 87® door 3 3 2 1 2 
- RUH 709 88' wound 3 3 2 1 2 
RUH 2220 202^ 89' urine 3 3 2 1 2 
LUH 1710 62"\CIP 70.31， gangren.lesion 3 3 2 1 2 
ATCC 9957^ 
LUH 1711 63m，SEIP Ac 84.203 chicken 3 3 2 1 2 
LUH 1712 6 r , SEIP 14.84 sperm culture 3 3 2 1 2 
“LUH 1713 65"", CIPA162, conjunctivitis 3 3 2 1 2 
ATCC 17968d 
‘ L U H 1714 66'", CIP 70.19, not known 3 3 2 1 2 
I ATCC 17984 
‘ LUH 1715 67^ SEIP 4.83 pus 3 3 2 1 2 
Genomic species 10 
RUH 2222 198'', 90' urine 4 2 1 2 3 1 
RUH 2223 113:2'', 91' wound 4 2 1 2 3 1 
RUH 2224 ATCC 17924'', 92' not known 4 2 1 2 3 1 
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Genomic species 11 Cfol Alul Mbol Rsal Mspl Bfa\ BsmAl 
RUH 2234 93 ' contact lens 4 2 1 2 3 2 
. R U H 2861 CIP63 .46^ not known 4 2 1 2 3 2 
ATCC 11171,94 ' 
RUH 1050 L M D S 1.109,95® not known 4 2 1 2 3 2 
RUH 2236 51", 96 ' urine 4 2 1 2 3 2 
RUH 2235 210^ 97 ' wound 4 2 1 2 3 2 
RUH 2860 58bd, 98 ' wound 4 2 1 2 3 2 
LUH 287 MGH 97931,225'' sputum 4 2 1 2 3 2 
Genomic species 12 (A. radioresistens) 
RUH 2225 109^ 99 ' urine 7 3 2 2 1 
RUH 2864 SEIP 12.81'', 100' urine 7 3 2 2 1 
RUH 2226 152'', 101® wound 7 3 2 2 1 
RUH 2862 26^ 102' sputum 7 3 2 2 1+3 
RUH 2865^ FO-lTd，iAM13186T，103c cotton 7 3 2 2 3 
RUH 2863 73^104 ' wound 7 3 2 2 3 
RUH 2227 SO'', 105' urine 7 3 2 2 1+3 
RUH 3517 feather pillow 7 3 2 2 3 
Genomic species 13 sensu Bouvet & Jeanjean / Genomic species 14 sensu Tjernberg & Ursing • 
LUH 1718 134", SEIP 5.84 “ blood 1 4 1 2 2 1+2 
LUH 1719 376", K.Irino 214/84 CSF 1 4 1 2 2+3 5 
LUH 1720 496", SEIP 86.66 skin 1 4 1 2 2 1 
LUH 1721 552", SEIP Ac 86.158 skin 1 4 1 2 2+3 5 
LUH 1722 943", SEIPAc87.315 unknown 1 4 1 2 2+3 5 
human origin 
LUH 1723 1001", SEIP Ac 87.348 skin 1 4 1 2 2+3 5 
LUH 1724 1158", SEIP Ac 88.239 skin 1 4 1 2 2 1 
LUH 1725 1191", P.Osterrieth 190 catheter 1 4 1 2 2+3 5 
RUH 2216 7ld’117e conjunctiva 1 4 1 2 3 1 
RUH 2866 118' CSF 1 4 1 2 3 1 
RUH 2217 , 10ld，119e conjunctiva 1 4 1 2 3 1 
RUH 2218 ATCC 17905d，120� conjunctiva 1 4 1 2 2+3 6 
RUH 3206 pat h'^ sputum 1 4 1 2 3 1 
RUH 3207 pat sputum 1 4 1 2 3 1 
RUH 3211 04/90 VI*^  resp.flow meter 1 4 1 2 3 1 
Genomic species 13 sensu Tjernberg & Ursing 
RUH 2210 ATCC 17903", 106' not known 2 1 1 1 1 
RUH 2624 107' skin forehead 2 1 丨 丨 1+3 
RUH 2285 108' bronchus 2 1 1 1 3 
RUH 2376 109' sputum 2 1 1 1 3 
- RUH 503 110' urine 2 1 1 1 3 
RUH 2041 111® post mortem 2 1 1 1 1+3 
RUH 2284 112' bronchus 2 1 1 1 3 
RUH 2627 113' rectum 2 1 1 1 3 
RUH 412 114® blood 2 1 1 1 1 
RUH 2211 lOO'', 115' gastric fistula 2 1 1 1 3 
RUH 2212 165 ^ 116' urine 2 1 1 1 3 
RUH 3417 2 1 � sputum 2 1 1 1 3 




Genomic species lA sensu Bouvet & Jeanjean Cfo\ Alu\ Mbo\ Rsa\ Msp\ Bfa\ BsmM 
LUH 1087 MGH 9968l,K.irinoi05/85 conjunctiva 5 5 1 2 3 
. L U H 1088 MGH 99871,CCUG14816 wound 5 5 1 2 3 
LUH 1726 382", K. Irino 105/85 conjunctiva 5 5 1 2 3 
LUH 1727 513", CCUG 14816, wound 5 5 1 2 3 
Gilardi GLG 4638 
LUH 1728 743", not known 5 5 1 2 3 
RE Weaver CDC E655 
Genomic species 15 sensu Bouvet & Jeanjean 
LUH 1729 79", “ skin 1 2 1 2 2 2 
M.M.Adam Ac606 180:40 va. 
LUH 1730 81", SEIP 23.78 urine 1 2 1 2 2 
Genomic species 15 sensu Tjernberg & Ursing 
LUH 1090 151ad，rvlGH 98795 urine 6 2 1 1 3 
LUH 1091 118d, MGH 98794 faeces 6 2 1 1 3 
Genomic species 16 
LUH 1731 78", CIP 70.18, urine 1 2 1 4 2 
ATCC 17988 . 
LUH 1732 673",SEIP Ac87.123 urine 1 2 1 . 4 2 
LUH 1733 l O i r skin 1 2 1 4 2 
LUH 1734 1211", P. Osterrieth312 faeces 1 2 1 2+4 2 
Genomic species 17 
LUH 1735 641", SEIP 2/87 wound 1 2 1 2 3 4 
LUH 1736 942",SEIP Ac87.314 leg ulceration 1 2 1 2 3 4 
Unclassified strains 
LUH 1738 631", CCUG 14818 ear 1 2 1 2 2 
LUH 1739 640", SEIP 1/87 wound 1 2 1 2 3 
LUH 1737 80", SEIP 14.83 blood 1 4 1 4 3 
LUH 1740 ‘ 930", SEIP 87.302 trach. exudate 1 4 1 4 3 
LUH 1741 944",'SEIP Ac87.316 wound 1 4 1 4 3 
LUH 1742 1240", RUH 65 clinical spec 1 4 1 4 3 
LUH 1743 1271", RUH 422 urine 1 5 1 2 3 
LUH 1469 MGH 99613, 10095° abscess 3 5 1 1 3 
LUH 1470 MGH 99614, 10169° sputum 3 5 1 1 3 
LUH 1471 MGH 99896,5804° blood 3 1 3 1 3 
LUH 1472 MGH 99685, 10090° ulcer 3 1 1+3 1 3 
RUH 3329 pat K"^  blood 1 4 3 4 3 
RUH 53 ATCC 13809 soil 2 5 1 1 3 
_  RUH 175 blood 1 2 1 4 3 
RUH 203 liquor 1 2 1 2 2 
RUH 581 soil 3 3 1 1 2 
RUH 1139 throat 3 1 1 1 3 
a T, type strain 
b Designations of collection L. Dijkshoorn, RUH=Rotterdam University Hospital, LUH=Leiden University Hospital 
ATCC, American Type Culture Collection, Rockville, Md. USA; LMD, LMD Culture Collection, University of 
, Technology, Delft, The Netherlands, NCTC, National Collection of Type Cultures, London, United Kingdom; 
CCUG, Culture Collection, University of GOteborg, GOteborg, Sweden; CIP, Collection de I'lnstitut Pasteur, Paris, France; 
J. ‘ SEIP, Service des Entdrobacteries de I'lnstitut Pasteur, Paris, France; lAM, Institute of Applied Microbiology, The University 
of Tokyo, Tokyo, Japan, MGH, Collection of Malmoe General Hospital, Malmoe, Sweden, 
d Designation used by Tjernberg & Ursing，APMIS 1989，595-605 
‘ Serial no. used by Dijkshoorn et al., System, Appl. Microbiol. 1990, 338-344 
f Designation used by Dijkshoorn et al., J Clin. Microbiol. 1993, 702-705. 
g Designation used by Dijkshoorn et al, J Clin, Microbiol. 1996, 1519-1525 
" D e s i g n a t i o n used by Horrevorts et al., J Clin. Microbiol, 1995, 1567-1572 
‘ Designation used by Dijkshoorn et al., J Clin. Path. 1993, 46:533 
k Designation used by Gemer-Smidt et al., J Clin, Microbiol. 1991, 277-282 
‘ Designation used by Bonting et al., FEMS Microbiol. Ecol. 1992, 57-64 
. D e s i g n a t i o n used by Bouvet & Grimont，Int. J. System. Bacteriol. 1986, 228-240 
“ Designation used by Bouvet & Jeanjean, Res, Microbiol. 1989, 291-299 




lUB Group Codes for incompletely specified bases 
Code Bases Coded 






‘ Y C, T/U 
M A’C 
K G, T/U 
S G,C 
. W A, T/U 
. H A, T/U, C 
B G, T/U, C 
V G, A, C 
D G, A, T/U 
—— N G, A, T/U, C 
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Alignment of adeB, adeE and adeYsLnd the region of specific primers. 
AdeB - - -ATGTCACMrmTTATTCGTCGTCCCGrmTGOTGGGmTTGCGATCTTCATT 57 
AdeBl ATGTTGTCGAGTTTTnTATTGCACGACCTATmTGCTTGGGTTCTCTCTATTTGTATT 60 
AdeB2 ---ATGGCACMTTTnTATTCATCGCCCCATTTTTGCGTGGGTGATTGCATTAGTCATT 57 
水泳；i； * 华 * 氺 氺 : i c * ^ ^ ^jjc 氺;i： * 氺;i：水 H： * * * 
AdeE-79A 一 
AdeB AmTATTTGGATTGCTGAGCATTCCTAAACTGCCMTTGCACGTnrCCMGTGTGGCC 117 
AdeBl ATGGCATTGGGGACGATTTCGATTTTMCGTTACCCATTGAGOmwrcCrGACATrQCA 120 
AdeB2 A T G T T G G C G G G T A T T C T C A C G C T A A C A M A A T G C C T A T T G C A C A G 〒 A T C C G A C G A T t 6 c a 117 
氺氺 ；ic承 ：！^ ；i； 氺 承 氺 氺 *氺氺氺 氺 氺 氺 氺 氺 氺 氺 氺 
AdeB CCGCCACAGGTGMTAmGTGCGACTTATCCTGGTGCTACAGCTAAMCCATTMCGAT 177 
AdeBl CCACCAGGTGTAAATGTTACTGCAMTTATCCGGGCGCATCGGCCAAMCTGTTGMGAC 180 
AdeB2 CCACCGACAGTTACMTTGCTGCMCTTATCCTGGTGCATCTGCTGAGACTGTTGAMAC 177 . 
氺 氺 氺 氺 ：^ ;* ：^ ：！；^ 水 承 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 * 氺 ’ 氺 氺 氺 氺 
AdeB AGCGTTGTMCCTTMTTGAGCGCGAATTATCGGGTGTAAAAMTCTACTCTAC-TATAG 236 
AdeBl AGTGTTACCCAGATTTTGGAGCMCAMTTMGGGTATTGATGGTCTTCTTTATmTCA 240 
AdeB2 ACTGTMCCCAGATCATAGMCMCAMTGMTGGTCTAGATGGmACGCTACATTTCA 237 
氺氺；！； 氺 ； j c 傘 氺 氺 氺氺；i； 氺 氺 氺 氺 氺 氺 氺 氺 承 • 氺 ； i ： 
AdeE-245A 一 
AdeB TGCGACMCAGATACCTCCGGTACAGCAGAGAmCCOTACGTTTAAACCAGGCACAGA 296 
AdeBl TCGAGTAGTAGTr-CGGCAGGACMGCACGGATMGTCTGAGTTTCGATCAAAATACCAA 299 
AdeB2 TCTMCAGT-GCTGGTMCGGTCAGGCCTCTATTCAATTAMCnTGMCAAGGTATTGA 296 
* * ' * * ** * * *本 * 水氺 * ：): ；！： 氺 ； i ： 
AdeY-343A 一 
AdeB TGTGGAMTGGCTCAGGTTGACGTTCAAMTAAAATCMGGCTGTAGMGCrCGCmCC 356 
AdeBl TCCCGATACTGCGCAGGTACAGGTGCAAMTGCTGTGAATCAGGCACTTAGTCGATTGCC 359 
AdeB2 TCCAGATATTGCACAGGTTCAGGTTCAAMCMATTGCAATCrGCMCTGOGCnTTACC 356 
氺 氺氺译氺氺氺氺氺；！；华 ^ 承;f： ；氺；i；*氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 
AfleB GCAAGTTGTACGTCAGCMGGTTTACAGGTTGAGGCTTCATCGTCCGGATmTAATGCT 416 
AdeBl TCMGAGGTTCAGCAGCMGCKJATCACTGTMCAAMTCACAGGGTGATAGTTTACTGGT 419 
AdeB2 TGMGATGTACAGCGTCMGGTGTMCAGTMCTAMTCTGGTGCMGOTCTTGCAAGT 416 
AdeB GGTCGGGATTMCTCTCCAMTMTCMTATTCCGMGTTGAmGAGTGAmTTTGGT 476 
AdeBl CTTTGCGCnTACGATGMAGTGGGACTAGATCTTCTGTCGACATATCTGACTATATGGT 479 
AdeB2 . TATTGCATTCTACTCACCAGATMCAGCCTTTCTGACTCGGACATrAMGACTACGTAM 476 
1 ； ! ； 氺 ； i ! 系 氺 氺 氺 本氺 ^^ H： ^^ 氺卞 H： 
AdeB TCGAAATGTTGTAGMGAGCTAAMCGTGTCGMGGTGTAGGGMGGTTCMTCnTCGG 536 
AdeBl GAGCACACTTCAAGACCCATTAAGTCGGGTAGATGGAGTAGGTGAMTCACTGCATTTGG 539 
AdeB2 CTCATCMTTAAAGMCCACTTAGCCGTGTTGCTGGTGTGGGTGAGGTACAGGTCTTTGG 536 
_ AdeE-538B 
. AdeB' TGCCGAGAMGCTATGCGTATTTGGGTCGACCCGMTAAGCTTGTTTCTTACGGTTTATC 596 
AdeBl TGCTCMTATGQ^TGCGJAT®pcrTGATCCTCATAAATTAMCAGTTATGGATTAAT 599 
AdeB2 TGGTTCATACGciATGSfAffTcScTTGATCCAGCTMGTTMCCAGTTATCAACTAAC 596 
氺氺 He氺* 氺 氺 * 氺 氺 氺 氺 氺 泳 氺 氺 承 ; i c 氺 氺 *乐;1： ^ 氺氺本 氺氺 
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. AdeE-620B 
AdeB GAmGTGATGTGMTMTGCCATTCGTGAAMTMTGTCGAMTTGCACCCGGCCGACT 656 
AdeBl GCCATCAGATOTTAGMOmATTGAAGCACAAAACACTCAMTTACAGCAGGAGAATT 659 
AdeB2 TCCTAGTGATATTGCGACAGCTmCAAGCGCAAMCTCACAAGTAGCAGTAGGTCAATT 656 
承;！；木雄 水；ic承 =1： 氺 * ^：!： * * * * * 氺氺 * * 
AdeB TGGTGATTTACCAGCTGAMMGGCCAGCTCATTACTATTCCATTGTCTGCTCAAGGGCA 716 
AdeBl GGGCGCATTACCCACGCGTGATGGGCAGGCTCTAMTGCMCAGTMCAGCATTATCTCG 719 
AdeB2 AGGTGGTGCACCAGCTGTACMGGTCMGTGCTTMCGCMCAGTGMTGCACAMGm 716 
氺氺： ^ 氺氺氺 氺 氺 氺 氺 氺 氺 氺；ic 氺 氺 氺 氺 氺 氺 
AdeB ATTGTCTAGTCTCGAGCMTTTAMAATATTAGCTTAAAMGTAAMCTMCGGTAGCGT 776 
AdeBl GCTACAAACCGTGAGCCAATTTGAAMTATTATTTTGCGGAaGAMCAAATGGTGCGGT 779 
AdeB2 GCTGCAAACACCTGMCAGTTTAAMATATCTTCTTAAAGAACACAGCATCTGGTGCTGA 776 
AdeB MTTAAGTTATCTGATGTTGCCMTGTAGAMTAGGCTCACAGGCATATMCnTGCCAT 836 
AdeBl TGTATTACTTAAAGATGTTGCTCGAGTCGAGCGTGGTGCTGAMGTTATCAGACGTCTAC 839 
AdeB2 GGTTCGTTTAAMGATGTTGCGCGTGTAGAGTTAGGCTCTGATMCTATCAGTTTGACTC 836 
氺 氺 氺氺氺氺承氺氺氺 氺氺 氺氺 水;J; ^ ；i；氺氺 氺 
AdeB TTTGGAAAATGGTAAGCCTGCTACCGCGGCAGCMTTCMTTMGCCCGGGTGCTAACGC 896 
AdeBl ACGTCTGMTGGAMGCCAGaTCGGGTATGTCTATTCAGCTTGaTCTGGTGCCMTGC 899 
AdeB2 GMGTTTMCGGTAAACCTGCTGGTGGTCTTGCAATTAAMTTGCMCTGGTGCTMCGC 896 
_ ‘ AdeY-920B 
AdeB CGTGAAMCTGCCGMGTOTTCGAGCAAAMTTGMGAGTTGMGCTAMTTTAC-CGG 955 
AdeBl ATTAGAAACGGCTGAACGAGTTAAAGCTGAGGTCACACGATTAA--CTGCCTCTATGCCA 957 
AdeB2 ACTTGATAOOGCAGAAGGTGTr-GMCATCGTTTATCTGMTTACGTMGAACTAT-CCA 954 
AdeB A - AGGCATGGAGTTTAGTATTCOTACGACACCGCGCCGTTTGTCAAMTTTCMTTGM 1014 
AdeBl GCGGGGCTAMGGTTGCGTACCCACGCGACAGTACTCCATTTGTAGMGCTTCTGTAMT 1017 
Ad eB2 ACAGGTCTTGCAG ATAAACTGGCTTATGACACGACTCCATTTATTCGTCTTTCAATTGM 1014 
AdeB AAGGTMTTCATACATTACTTGMGCaTGGTTCTGGrnTCATTGTGATGTATCTATTT 1074 
AdeBl GGAGTGATTAAMCTmGCTGAAGCMTTGTTCTCGTCATTATTGTCATGTTCTTATTT 1077 
AdeB2 AGTGTTGTACACACATTMTTGMGCGGTAGTTTGGTATTTCATTGTCATGTTCTTGnT 1074 
J ‘ 
AdeB TTACATAATGTCCGCTATACGCTTATTCCAGCGATTGTGGCGCCTATTGCCTTACTCGGT 1134 
AdeBl TTGCAGAGCTGGCGTGCGACTTTMTTCCGGCAATTGCTGTTCCAGTTGTATTGmGGA 1137 
AcleB2 TTACAGMCTGGCGTGCMCGATTATTCCMCACTTGCTGTACCTGTTGTGGTGTTAGGT 1134 
氺 * ^^ 氺 氺氺 氺;Jc 氺 ； J c 氺 氺 ; 氺 氺氺>i： 氺 氺氺 氺氺氺 ；i： 氺 氺 译 
AdeB ACTnTACCGTGATGTTGCTTGCCGGCmTCMTTAACGTACTCACCATGTTCGGTATG 1194 
AdeBl ACATTTGGTGTGTTGAGCGTACTTGGCTATAGCATTMTACACTGACTTTGTTTGCGATG 1197 
AdeB2 ACATTCGCTGTTATTMTATCnTGGCTTCTCMTTAACACCTTAACCATGTTCGCCATG 1194 
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AdeB GTGCTTGCCATCGGGATTATTGTCGACGATGCCATTGTCGTGGTTGAAMCGTCGAMGG 1254 
AdeBl GTACTTGCMTTGGTTTACTGGTAGATGACGCGATTGTCGTTGTAGAAAATGTCGAGCGG 1257 
AdeB2 GTATTGGCMTTGGTCTTCTAGTCGATGACGCCATCGTTCTGGTCGMMCGTCGAACGG 1254 
^^ 氺 氺 冰 傘 氺 氺 ： ^ : 氺 氺 氺 水 水 氺 傘 块 * 氺 * 氺 氺 承 氺 承 ^^ 水 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺氺 
AdeB ATTATGGCGACAGAAGGAmTCGCCTAMGATG-CMCCTCTAMGCMTCAMGAGAT 1313 
AdeBl GmTGC-ATGAGCAAMTCTTGATGCTCGGCMGCCACCCTMTTTCMTGaGGAGAT 1316 
AdeB2 GTTATGA-GCGAAGAGCATACCGATCCGGTCACGGCGACCTCACGATCAATGCAACAGAT 1313 
水氺承承氺 氺 氺 氺 氺 氺 : 氺 氺 : f : 氺 氺 氺 氺 氺氺氺：？： 
AdeB TACCAGCCCGATTATTGGTATTACGCTGGTATTGGCGGCAGTATTnTACCTATGGaTT 1373 
AdeBl ATCGGGTGCGCTCGTGGGTATTGCCATGGTACTCGCAGCGGTmTTTACCTATGGCATT 1376 
八 deB2 TTCTGGCGCGTTAATTGGTATCACAAGCGTATTMCAGCGGTATTCGTACCAATGGCATT 1373 
水 氺 氺 氺 ； 1 ； 氺 ； i c 氺 ; j c 氺 ; 氺 氺氺;5； 氺 氺 氺 氺 ：^;氺氺*氺 氺氺氺氺氺氺：^：承氺：^；氺氺 • 
AdeB TGCGAGTGGTTCTGTAGGGGTMTCTATAAACAGTTTACCTTGACCATGTCGGTATCTAT 1433 
AdeBl TTTTGGTGGTTCCGTCGGGATTATCTATCGCCAGTTCTCGGTMCGCTCGTATCGGCAAT 1436 
AdeB2 CnTGGTGGTACMCTGGTGTAATTTACCGTCAGTTCTCGATTACCCTrGTMCAGCMT 1433 
AdeB TTTATTTTCAGCGCTATTGGCACTTATTTTMCACCGGCACTTTGTGCCACGATTTTMA 1493 
AdeBl GGTACTTTCTGCMTTGTTGCnTMCACTTTCACCTGCGTTATGTGCAACATTACTCM 1496 
AdeB2 GGTTCTATCGTTMTTGTAGCGTTMCATTTACACCGGCACTTTGTGCMCCATnTAM 1493 
•氺 氺 氺 氺 氺 氺 氺 泳 水 氺 水 氺氺氺氺 ^ ^ 氺 氺 氺 氺 氺 氺 氺 氺 氺 承 氺 氺 
AdeB ACCAATCGATGGGCAT----CACCAGAAGAAGG GCTTCnTGCATGGTT 1538 
AdeBl ACCTGCAAATGAAAAA- - - -CATAAGCAGAGAA MTTCTTTACTTGGTT 1541 
AdeB2 ACAGCATGATCCGMCAAAGCACCAAGCMTMTATTnTGCTCGTTTCrTTAGAGGCTT 1553 
* * 5jC 不 ^ ^ ^ 不 5jc jjc 不； j C * 
AdeB TGACCGTAGmCGATAMGTCACTAAAMGTAT-GMTTGATGCTGCTTAAAATCAT-- 1595 
AdeBl CMTCGTAMGTCGMCMGGGCAGTCAGGCTACCGCA-CAMGCTAGTTGCTGTnTAG 1600 
AdeB2 TMCMTGGTmGACCGCATGTCGCATAGCTACCAAMTGGTGTTMCCGCATGC-T-- 1610 
* * * * * * * * * * * 
AdeB -CAMCATACAGTTCCMTGATGGTGATCTITTTAGTAATTACCGGT--ATTACCTTTAC 1652 
AdeBl GTAAACCCAAAGTCTTTATGATCATA- - -TTCGTAGGTATTACAGCTTTGTTAG-GTTGG 1656 
AdeB2 -TMGGGCAAAATCTTCTCTGGCGTGCnTACGCTGTAGTTATTGCTTTATTAGTGTTCT 1669 
JjJJjJ * 5i» JjC ?jC jjc >{« 不 不 不 不 不 
)• “ 
AdeB CGGMTGAMTATTGGCCMCAGCATTTATGCCAGAGGAAGATCAAGGTTGGTTCATGAC 1712 
AdeBl CAATATACGCGTATGAATA - CGOTTTTTTACCACAAGAAGACCAAGGCTCGGTTATGGT 1715 
AdeB2 TGTTCCAAAAACTC--CCATCTTCATTCTTACCAGAAGMGATCAGGGTGTGGTCATGAC 1111 
AdeB TTCGTTCCAGCTACCTTCAGATGCMCCGCTGAGCGTACTCGGAATGTAGTCAAT-CAAT 1771 
AdeBl TCMTTTAGTACGCCTGTAGGCACGACACTAGCTGAMCAGAGCGGGTTGGTAATCAGAT 1775 
AdeB2 GCTTGTTCAATTACCGCCMATGCAACGCTTGACCGTACAGGTAMGTGATTGACACCAT 1787 
承 ；)::：： 氺 承 氺 木 泳 ：！：^： 承 : s i ! * * 
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AdeB TTGAAAATAATT——TGAAAGACAATCCCGATGTAAAAAGTAATACCACCATTTTGGG 1826 
AdeBl TGCAGATTACrmTGACGAAAGMAAGMTAATCTCAATGTGArmTATGGTGATGGG 1835 
AdeB2 GACAAACTTCTTC---ATGAATGAAAAAGATACTGTGGMTCGATTTTCACCGTTTCGGG 1844 
氺 氺 氺 ^^ 氺水 : f ：氺 * 氺氺 氺 氺 承 氺； i： 氺 * 氺氺氺 
AdeB ATGGGGTnTAGTGGCGCAGGACAMATGTAGCTGTGGCmTACGACAOTAMGACTT 1886 
AdeBl TAGAMTAACGCAGGCAGTGGGCAAMTGTGGGAATGGCmTGCCGGACTCAMCATTG 1895 
AdeB2 CTTCTCATTCACGGGTGTGGGTCAAAATGCTGGTATCGGCTTCGTTAMTTGAAAGACTG 1904 
氺氺 ； i ；氺氺氺氺氺氺氺氺 ：^: 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 
AdeB CAMGAGCGGACTAGCTCTGCATCTAAGATGACAAGCGACGTTAATTCTTCTATGGCGM 1946 
AdeBl GGATGACCGAGMGGTAGTGAAMTACAGCCGMGCTGTGATTGCrCGTGCAAATGCACA 1955 
AdeB2 GAGTGAACGTACTTCACCAGAAACTCAAATTGGCGCATTGATTCAGCGTGGTATGGCATT 1964 
； 承 块 氺 ； i；水 氺 氺氺 氺 氺 ； i ： 泳 • 
AdeB CAGTACGG AAGGCG AGACTATGGCCGTGTTACCACCCGCTATTGATGA 1994 
AdeBl TTTTAAGTCACTGCGTAACGCAC---GTGTTCAGGTACTTTCACCCGCTGCTGTAAGAGG 2012 
AdeB2 GMTATGATCGTTAAAGACGCATCTTACATCATGCCnTACAGCTTCCAGCAATGCCTGA 2024 
氺 氺 氺 氺氺 氺 氺 氺 氺 氺 氺 氺 
AdeB GTTAGGTACmTTCAGGTTTCAGTTTACGTTTACAAGACCGCGCTAACTTAGGT-ATGC 2053 
AdeBl CCTTGGGCAATCTAGTGGCnTGMTTTTGGTTGCMGATGCTGAGAATAAAGGACGAGA 2072 
AdeB2 ACTCGGTGTAACAGCCGGATTCAACTTGCMCTTAMGATTCAAGTGGTCMGGCCATGA 2084 
"：^ ；氺 氺 氺 氺 氺 氺氺 氺 ；i；氺氺氺 氺氺氺 ^ 
AdeB CTGCTmCTGGCTGCTCMGATGMCTTATGGCMTGGCAGCCMGAATAAAAAGTTCT 2113 
AdeBl -TGCnTACTCGCAGCACAAMTAATGTGTTAAMGCAAATGCTGATTCTG- - - -GCCTA 2127 
AdeB2 GAAACTTATTG -CTGCACGTMTACGATOTAGGTTTGGCTGCACAAGATAAAC-GTCTT 2142 
* * * 水 氺 承 氺 ： i ： H：承 氺 ： i ： 水 氺 氺 氺 氺 
AdeB ATATGGTTTGGAATGAAGGGTTGCCACAAGGTGAC--AATATTTCTTTAAAAATTGACCG 2171 
AdeBl GCTGCAGTACGmAMTAGCTTAGAAGATAAAGCCCAGTTACAAGTCGATA-TCGATCA 2186 
AdeB2 GTGGGTGTTCGCCCTAATGGTCMGAAGATACACCTCAGTATCAAATTAATG-TAGACCA 2201 
氺 氺 氺 氺 ； i ； 氺 氺 氺 氺 氺 ；i： 氺 氺 承 氺 氺 
AdeB TGAAMGCmGTGCATTTGGTGTTMGTTTTCTGATGTTTCAGACATCATTTCTACATC 2231 
AdeBl AAGAAMGCCAGTGCTCTTGGAmGCCCAAGCAGATAmGTAATACGCTCTaTCGGC 2246 
AdeB2 AGCTCMGCTGGTGCCATGGGTGTGAGTATTGCCGAAATTAACAATACGATGCGTATTGC 2261 
* 不 * * * * * * * * * 
AdeB MTGa}TTCMTGTATATCMTGACTTCCCTAATCAAGGACGTATGCAACAAGTCATTGT 2291 
AdeBl GTGGGGCGGATOTATATTMCGAmCATAGATCAGGGACGTGTTMGCGAGmATTT 2306 
AdeB2 ATGGGGTGGCTCATACATTAACGACTTCGTTGACCGTGGCCGCGTGMAAMGTTTATGT 2321 
泳氺氺 氺 水 氺 氺 氺 氺 ^^ 氺 * j J :氺氺水 ^ 氺 氺承氺 水 氺 
AdeB ACAGGTTGAGGCTAMTCACGTATGCMTTGAMGATATCTTGAATCTGMAGTCATGGG 2351 
AdeBl ACMGGTGAAGCGMCTATCGTTCCTTACCCCMGATATTGGGCAATGGTATGrrCGCGG 2366 
AdeB2 TCMGGTGATGCGGGTAGCCGTATGATGCCTGMGACTTAAACAAGTGGTATGTACGTM 2381 
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AdeB TTCMGCGGTCMmGTCTCGmTCAGMGnGTMCGCCACAATGGAATAAGGCACC 2411 
AdeBl TACTAGTGGTGAGATGACGCCArnTCTAGaTCTCTTCTGTGAAATGGaGATGGGCCC 2426 
AdeB2 TMCAMGGCGAAATGGTACCGTTCTCTGCATTTGCTACTGGCGAATGGACATATGGTTC 2441 
氺 氺 ； i ； 傘 ； | c 承 水 氺 氺 泳 氺 ^ 氺 氺氺氺氺氺 氺 氺 
AdeB ACMCMTATAATCGmTAACGGACGACCATCnTGAGTATTGCTGGTATTCCTAACTT 2471 
AdeBl TCAAATGCTGCMCGCTTTMCGGTCTTTCAGCCGTTCAAATACMGGCTCTGCGGCAGC 2486 
AdeB2 TCCACGTCTTGMCGTTATMCGGCGTGTCATCGGTTMCATTCMGGTACACCTGCACC 2501 
氺； i； 承 承 ; 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺氺 氺氺 氺 
AdeB CGATACGTCATCGGGTGMGCMTGCGTGAMTGGMCMCTGATTGCGAAATTACCGA- 2530 
AdeBl TGGTGAGAGTTCTGGTGGGGCTATGGATMGATGCAGCAGTTAGTTGACCAGCMC- - - - 2542 
AdeB2 TG(K:GTGAGCTCTGGTGACTCMTGAMGCGATGGMGAMmTTGCTAAGTTACCATC 2561 
^ J^i：氺氺氺泳 氺 氺 氺 氺 ；i：*氺 ^ ：^ ^ 泳氺氺 木 氺承 . 
AdeB MGGTATTGGCTACGAGTGGACAGGTAmCCTTACAGGAAAAGCAGTC 2579 
AdeBl MGGTmMTCTTCAGTGGAGTGGGTTGTCrrATCAAGAGAAACTAGC 2591 
AdeB2 TATGGGOTACMGGTTTCGACTATGMTGGACAGGTTTATCACTTGMGAACGTGAGTC 2621 
； i：氺氺氺氺氺 氺 氺 氺 氺 氺 ^ ^ ^ ^^ 氺 氺 水 氺 
AdeB TGMTCACMATGGCCrmTACTTGGTTTATCCATGTTAGTTGTCTTCCTTGTCTTGGC 2639 
AdeBl GGGTGGCCAMCGATCTGGTTATATTmTCTCMTCATCTTTATCrmTATGTTTGGC 2651 
AdeB2 TGGTGCTCAAGCTCCATTCTTATATGCGCnTCATTGTTAATCGTTTTCCnTGCTTGGC 2681 
小 承;}c氺 氺 ；i；氺氺 氺 氺 氺 ; 氺 氺 氺 氺 氺 氺 氺 氺氺氺氺氺 
AdeB TGCACTCTATGAAAGCTGGGCAATTCCACnTCTGTGATGCTAGTTGTGCCACTCGGTAT 2699 
AdeBl AGCACnTATGAMGTTGGTCTATTCCTGTCTCTGTCATGCTAGTGATTCCTTTAGGTCT 2711 
AdeB2 TGCATTGTATGAMGCTGGTCTATTCCGTTCTCGGTTTTACTTGTAGTACCACTCGGTAT 2741 
Jj;?}:氺 ^ 氺 氺 氺 氺 氺 氺 氺 氺 氺 氺 译 氺 氺 氺 氺 氺 氺 氺 氺 ; i ； 氺 氺 氺 氺 氺 氺 氺 氺 * 氺 氺 氺 氺 氺 氺 
AdeB TTTTGGAGCAATC--ATTGCCAT……--TATGTCTA——GGGGGTTAA T 2738 
AdeBl TATTGGCGCTGT- - -AGTGGCTG CAAGTCTG GCAGGTTTTG T 2750 
AdeB2 TATTGGTGCMTCGTATTMCTTACTTGGGTATGATTATTAMGGAGATCCAAATCTCTC 2801 
AdeB GMTGATGTGTTCTTCAAAATCGGGCTAATTACCATTATTGGTCTATCGGCAMGMTGC 2798 
AdeBl TAACGATATTTACnTCAGGTCGCTATGCTTACCACCATTGGGCnTCTGCCAMMTGC 2810 
AdeB2 AAATMCATTTACTTCCAAGTAGCGATGATCGCGGTAATCGGTOTTCTGCAAMMTGC 2861 
氺;i； 氺 氺 氺 氺 氺 ： i ： 氺 氺 * 氺 承 承 * * * * * * 
J- ‘ 
AdeB GATTTTGATTGTTGAATTTGCGAAAATGCTGAAAGMGMGGCATGAGTTTGATTGAAGC 2858 
AdeBl CATTTTGATTGTTGAATTTGCGGCAGCTAAGTTAGAGGCTGGTCAGGCGTTMTGGACGC 2870 
AdeB2 GATCTTGATTGTTGAGTTCGCAAMGAGCTGCAGGAAAMGGTGMGACCTGATTGMC^ 2921 
AdeB CACTGTTGCCGCAGCCMACTTCGCTTACGGCCMTTCTGATGACATCACTTGCATTTAC 2918 
AdeBl CATTATTGMGGTGCGGGTCAGCGATTACGGCCMTTATTATGACATCTCTGGCmTGT 2930 




AdeB GTGTGGTGTMTTCCTTTGGTGATTGCCTCAGGTGCMGTTCAGAMCTCAACATGCT-T 2977 
AdeBl TGCAGGTGTTCTTCCATTAGCTGTATCTACAGGAGCAGGAGCTGTCAGTCGAAAAGAAAT 2990 
AdeB2 TTTCGGTGTACTTCCGCTTGCCCnTCAACAGGTGaGGGGCAGGAMTCACCCTTCTGT 3041 
氺;i：氺氺水 ；氺氺氺 ^ ：^  氺 氺 ^^^^ 水 承 水 氺 氺 * ；！： * 氺 承 
AdeB TAGGCACAGGGGTmTGGCGGCATGATTTCAGCCACCATTCTGCmrnTCnTGTTC 3037 
AdeBl T-GGTATCGCCGTCACTGGTGGGATGATTTCGGGMCATTACTTTCTATTTTCTTTGTGC 3049 
AdeB2 TGGGTAC-GGGGTACCCGGGGGGGT-ACTCCAGGCM-GTTCTAAGGAATCTCnT-TCC 3097 
jjc 冷 氺 木 泳 氺 氺 氺 氺 氺 氺 氺 * 氺 氺 氺 氺 * 氺 氺 氺 承 氺 氺 氺 
AdeB CCGTGTmTTATCTTCATTTTGGG-TGCAGTAGMMGCTATTTTCC- - --TCTAAGAA 3092 
AdeBl CTTTATTTTTTCnTTGGTTCGTCG-TTTMCTMTMGTTAMTACCAM——AAGG 3103 
AdeB2 CCGTATTTCTGGGGGGGATTCCAAAATCmTAGACAAACCAAAACCCAMCCaCCGGG 3157 
氺 氺 * 氺 氺 氺 氺氺 氺 氺 氺 氺 氺 氺 氺 
AdeB AAAAATCTCATCTTAA 3108 ‘ 
AdeBl CAAAATGA 3111 
AdeB2 AATAA——……-3162 




Clustal W multiple aa sequences alignment of AdeE, AdeY and AdeB (Magnet et al., 2001) from A. 
baumannii, AcrB (Ma et al., 1993) and AcrD (Rosenberg et al., 2000) from E.coli, MexB (Poole et al., 
1993a), MexD (Poole et al., 1996b) and MexY (Mine et al., 1999) from P. aeruginosa, MtrD 
(Hagman et al., 1997) from Neisseria gonorrhoeae’ AmrB (Moore et al., 1999) from Burkholdeha 
pseudomallei. 
MexD -MSEFFIKRPNFAWWALFISLGGLLVISKLPVAQYPNVAPPQITITAT--YPGASAKVL 57 
AdeB -MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISAT--YPGATAKTI 57 
Mt i-D -MAKFFIDRPIFAWVISIFIlAAGIFGIKSLPVSQYPSVAAPTITLHAI--YPGASAQVM 57 
AmrB -MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPWNVSAS--YPGASAKW 57 
MexY -MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPWNVSAT--YPGASAKW 57 
AcrB -MPNFFIDRPIFAWVIAlIIMLAGGLAILKLPVAQYPTIAPPAVTIFTSASYPGADAKTV 59 
MexB -MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVS--YPGASAETV 57 
Ac i-D -MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTAN--YPGASAQTL 57 
AdeY -MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIMT--YPGASAETV 57 
AdeE MLSSFFIARPIFAWVLSICIMALGTISILTLPIEQYPDIAPPGVNVTAN--YPGASAKTV 58 . 
• 氺 氺 氺 氺 ：？;译;J: ；^; • • • • 氺 • • •氺• ••氺 • 氺 氺 • • 氺氺氺氺 ^ • • 
MexD VDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIWTFEPGTDPDLAQ--VDVQNRLKKAE 115 
AdeB NDSWTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQ--VDVQNKIKAVE 115 
Mt rD EGSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQ--VEVQNKLSEVL 115 
AmrB EEAVTAI lEREMNGAPGLLYTKATS-STGQASLTLTFRQGVNADLAA--VEVQNRLKIVE 114 
MexY EEAVTAIlEREMNGAPGLLYTKATS-STGQASLTLTFRQGVNANLAA--VEVQNRLKIVE 114 
AcrB QDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQFTVQVQNKLQLAM 119 
MexB QDTWQVIEQQMNGIDNLR YIS SESNSDGSMTTTVTFEQGTDPDIAQ --VQVQNKLQLAT 115 
Ac i-D . ENTVTQVIEQNNTTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAV--QQVQNQLQSAM 115 
AdeY ENTVTQIlEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGIDPDIAQ--VQVQNKLQSAT 115 
AdeE EDSVTQILEC^IKGIDGLLYFSSSSSSAGQARISLSFDQNTNPDTAQ--VQVQNAVNQAL 116 
MexD ARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNIN--NELRRLPG 173 
AdeB ARLPQVVRQQGLQVEASSSGFLMI.VG INSPN --NQYSEVDLSDYLVRNW--EELKRVEG 171 
Mt rD RTLPATVQQYGVTVSKARSNFLMIVMLSSDV----QSTEEMNDYAQRNW--PELQRIEG 169 
AmrB SRLPESVRRDGIYVEKAADSIQLIVTLTSSS--GRYDAMELGEIASSNVL--QALRRVEG 170 
- M e x Y SRLPESVRRDGIYVEKAADSIQLIVTLTSSS--GRYDAMELGEIASSNVL--QALRRVEG 170 
AcrB PLLPQEVQQQGVSVEKSSSSFLMWGVINTD--GTMTQEDISDYVAANMKFTDAISRTSG 177 
MexB PLLPQEVQRQGIRVTKAVKNFLMWGWSTD--GSMTKEDLSNYIVSNIQ--DPLSRTKG 171 
AcrD “ RKLPQAVQNQGVTVRKTGDTNILTIAFVSTD--GSMDKQDIADYVASNIQ--DPLSRVNG 171 
AdeY ALLPEDVQRQGVTVTKSGASFLQVIAFYSPD--NSLSDSDIKDYVNSSIK--EPLSRVAG 171 
AdeE SRLPQEVQQQGITVTKSQGDSLLVFALYDES--GTRSSVDISDYMVSTLQ--DPLSRVDG 172 
MexD VGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGS--APGSSAQE 231 
AdeB VGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGD--LPAEKGQL 229 
Mt rD VGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNIQISAGSIGS--LPAVRGQT 227 
AmrB VGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGN--LGVPDSAP 228 
MexY VGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGN--LGVPDSAP 228 
Ac rB VGDVQLFGSQYAMRIWMNPNELNKFaTPVDVITAIKAQNAQVMGQLGGTFTPPVKGQQ 237 
MexB VGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGG--LPAVKGQQ 229 
AcrD VGDIDAYGSQYSMRIWLDPAKLNSFQ^fTAKDVTDAIESQNAQIAVGQLGG--TPSVDKQA 229 
AdeY VGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGG--APAVQGQV 229 
AdeE VGEITAFGAQYAMRIWLDPHKLNSYGLMPSDVRTAIEAQNTQITAGELGA--LPTRDGQA 230 
承氺 • •；jC來•；；！ •氺 •傘 . 氺. 氺. •水 . ^ . 
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A P P E N D I X 5 
MexD LTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLAT--ERHAHR 289 
AdeB ITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILE--NGKPAT 287 
MtrD VTATVTAQGQLGTAEEFGNVILRANTDGSNIYLKDVAKVGLGMEDYSSSTRL--NGVNTT 285 
AmrB ISATVKVDDTLVTPEQFGEIPLRIRADGGAIRLRDVARVEFGQSEYGFVSRV--NQl^AT 286 
MexY ISATVKVDDTLVTPEQFGEIPLAHPRIX]GAIRLRDVARVEFGQSEYGFVSRV--NQMTAT 286 
Aci-B LNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIlAEFFTNGQPAS 297 
MexB LNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQF--NGSPAS 287 
AcrD LNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRF--NGKPAS 287 
AdeY LNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKF--NGKPAG 287 
AdeE LNATVTALSRLQTVSQFENIILRTETNGAWLLKDVARVERGAESYQTSTRL--NGKPAS 288 
• • 氺 •氺 • 氺 氺 • • 
» » • • • » • • « • • • 
MexD GRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKV--IHTLI 347 
AdeB AAAIQLSPGANAVKTAEWRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKV--IHTLL 345-
Mt rD GMAVMLSNSGNAMTAKAVKERLAVLEKYFP(^MSWKTPYDTSKFVEISIEKV--IHTLI 343 
AmrB GLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKV--VSTLL 344 
MexY GLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKV--VSTLL 344 
AcrB GLGIKLATGANALDTAMIRAELAKMEPFFPSGLKIVYPYmTPFVKISIHEVFTVKTLV 357 
MexB GIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKWYPYDTTPWSASIHEV--VKTLG 345 
Ac rD GLGWLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDV--VKTLL 345 
AdeY GLAIKIATGANALDTAEAVEHRLSELRKNYPTGLADKLAYDTTPFIRLSIESV--VHTLI 345 
AdeE GMSIQLASGANALETAERVKAEVTRLTASMPAGLKVAYPRDSTPFVEASVNGV--IKTLA 346 
MexD EAlv{VLVFLVMFLFLE_YTLIPSIVVPVaLGTLMVMYLLGFSVNMm¥FGMV--LAIG 405 
AdeB EAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMV--LAIG 403 
Mt rD EAMVLWVWLFLQNIRYTLIPTIVWISLLGGFAFISYMGMSINVLTMFAMI --LVIG 401 
AmrB EAMLLWAWLFMQNFRATLIPTLVWVALLGTFTVl^GLGFSINVLTMFGMV--LAIG 402 
MexY EAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVL™FGMV--LAIG 402 
AcrB EAIILVFLVMYLFLQNFRATLIPTIAVPWLLGTFAVLAAFGFSINTLTMFGMVFTLAIG 417 
MexB EAILLWLWLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMV--LAIG 403 
„ AcrD EAIALWLWLFLQNFRATLIPTIAVPVVLMGTFSVLYDFGYSVNTLTMFAMV--LAIG 403 
AdeY EAWWYFIVMFLFLQNWRATIIPTLAVPVWLGTFAVINIFGFSINTLTMFAMV- -LAIG 403 
AdeE EAIVLVIIVMFLFLQSWRATLIPAIAVPWLLGTFGVLSVLGYSINTLTLFAMV--LAIG 404 
MexD ILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFM--AG 463 
, A d e B IIVDDAIVWENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFA- -SG 461 
MtrD IVVDDAIVVVENVERIMAGEGLPPmTKKAMGQISGAVIGITAVLISVFVPLAMF--SG 459 
AmrB ILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFF--SG 460 
MexY ILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFF--SG 460 
Ac rB LLVDDAIVWENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFTFGG 477 
MexB LLVDDAIVWENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFF--GG 461 
A c r D L L V D D A I V V V E N V E R I M S E E G L T P R E A T R K S M G Q I O J A L V G I A M V L S A W V P M A F F - - G G 461 
AdeY LLVDDAIWVENVERVMSEEHTDPVTATSRSMQQISGALIGITSVLTAVFVPMAFF--GG 461 
AdeE LLVDDAIVWENVERVMHEQNLDARQATLISMQEISGALVGIAMVLAAVFLPMAFF--GG 462 
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APPENDIX 4 
MexD SVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIP---EGHHE-KRGFFGAFN-- 517 
AdeB SVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPI----DGHHQ-KKGFFAWFD-- 514 
Mt rD AAGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIP---KGHHEEKKGFFGWFN-- 514 
AmrB AVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPID---ADHHE-KRGFFGWFN-- 514 
MexY AVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPID---ADHHE-KRGFFGWFN-- 514 
AcrB STGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIA--KGDHGEGKKGFFGWFNFT 535 
MexB STGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIE--KGDHGEHKGGFFGWFN-- 517 
AcrD TTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLK--KGEH-HGQKGFFAWFN-- 516 
AdeY TTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKAPSNNIFARFFRGFN-- 519 
AdeE SVGIlYRQFSVTLVSAMVLSAIVALTLSPALCATLLKPAN……EKHKQRKFFTWFN-- 515 
• 氺 氺 氺 • 氺 氺 • • • • •• •氺 ••氺• ••氺氺氺氺本氺••• 氺氺 氺 . 
MexD RGFARVTERYSLLNSKLVAIMGRFMLWAGLVAMLGYFYLR1JPEAFWAEDLGYMVVDVQ 577 
AdeB RSFDKVTKKYELMLLKI IKHTWMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFNfrSFQ 574. 
MtrD KKFDSWTHGYEGRVAKVLRKTFRMMWYIGLAWGVFLFMRLPTSFiiTEDQGFVMVSVQ 574 
AmrB RAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGWALLFVRLPQAFLPEEDQGDFMI_ 574 
MexY RAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGWALLFVRLPQAFLPEEDQGDFMI_ 574 
Ac rB RMFEKSTHHYTDSVGGILRSTGRYLVLYLIIWGMAYLFVRLPSSFLPDEDQGVFMTMVF 595 
MexB RMFLSTTHGYERGVASILKHRAPYLLIYWIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQ 577 
Ac rD QMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMWLFLRLPTSFLPLEDRGMFTTSVQ 576 
AdeY NGFDRMSHSYQNGTO^KGKIFSGVLYAWIALLWLFQKLPSSFLPEEDQGVVMTLVQ 579 
AdeE RKVEQGQSGYRTKLVAVLGKPKVFMIIFVGITALLGWQYTRMNTGFLPQEDQGSVMVQFS 575 
MexD L--PPGASRVRTDATGEELERFLKS--REAVASVFLISGFSFSGQGDNAALAFPTFKDWS 633 
AdeB L--PSDATAERTRNWNQFENNLKD- -NPDVKSNTTILGWGFSGAGQNVAVAFITLKDFK 630 
Mt rD L--PAGATKERTDATLAQVTQLAKS--IPEIENIITVSGFSFSGSGQNMAMGFAIFKDWN 630 
AmrB Q--PEGTPMAETMANVGDVERYLAE--HEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWS 630 
MexY Q--PEGTPMAETMANVGDVERYLAE--HEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWS 630 
AcrB TQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWA 655 
MexB T--PPGSSAERTQVVVDSMREYLLEKESSSVSSVFIVrGFNFAGRGQSSGMAFIMLKPWE 635 
AcrD L--PSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWS 634 
AdeY L--PPNATLDRTGKVIDTMTNFFMN-EKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWS 636 
AdeE T--PVGTTLAETERVGNQIADYFLTKEKNNLNVIF_G_AGSGQNVGMAFAGLKHWD 633 
• * * * 
MexD --ERGAEQSSAAEIAALNEHFALP--DDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGR 689 
. A d e B --ER--TSSASKMTSDVNSSMANS--TEGETMAVLPPAIDELGTFSGFSLRLQDRANLGM 684 
Mt rD --ERTASGSDAVAVAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGH 688 
」 AmrB - -ERREASQHVGAIVERINQRFAG-LPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGY 687 
MexY --ERREASQHVGAIVERINQRFAG-LPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGY 687 
AcrB FTDRPGEENKVEAITMRATRAFSQIKDA-MVFAFNLPAIVELGTATGFDFELIDQAGLGH 714 
MexB --ERPGGENSWELAmQMHFFSFKDA-MVFAFAPPSVLELGNATGFDLFLQDQAGVGH 692 
AcrD --ERDSKTGTSFAIlERATKAFNQIKEA-RVIASSPPAISGLGSSAGFDMELQDHAGAGH 691 
AdeY --ERTSPETQIGALIQRGMALNMIVKDASYIMPLQLPAMPELGVTAGFNLQLKDSSGQGH 694 
AdeE --DREGSENTAEAVIARANAHFKSLRNA-RVQVLSPMVRGLGQSSGFEFWLQDAENKGR 690 
‘ •氺 * * . * ^ ^ 
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MexD E--ALLQARDTLLGEIQTNP-KFL--YAMMEGLAEAPQLRLLIDREKARALGVSFETISG 744 
AdeB P--ALLAAQDELMAMAAKNK-KFY--MVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSD 739 
Mt i-D T--GIAGEGNELIQKMRASG-LFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRT 745 
AmrB E--ALVKARDQLLARAAEDP-RLAN--VMFAGQGEAPQIRLDIDRRKAETLGVSMDEINT 742 
MexY E--ALVKARDQLLARAAEDP-RLAN--VMFAGQGEAPQIRLDIDRRKAETLGVSMDEINT 742 
AcrB EKFrLTQARNQLLAEAAKHPDMLTS--VRPNGLEDTPQFKIDIDQEKAQALGVSINDINT 772 
MexB E--VLLQARNKFLMLAAQNP-ALQR--VRPNGMSDEPQYKLEIDDEKASALGVSLADINS 747 
AcrD D--ALMAARNQLLALAAENP-ELTR--VRHNGLDDSPQLQIDIDQRKAQALGVAIDDIND 746 
AdeY E--KLIAARNTILGLAAQDK-RLVG--VRPNGQEDTPQYQINVDQAQAGAMGVSIAEINN 749 
AdeE D--ALLAAQNNVLKANADSG--LAA--VRLNSLEDKAQLQVDIDQRKASALGLAQADISN 744 
MexD TLS- _AAFGSEVINDFTNAGRQQRWIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVS 802. 
AdeB IIS--TSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEWT 797 
MtrD ALA--SALSSSYVSDFPN(XJRLQRWQADEDARMQPADILNLTVPNKSGVAVPLSTIAT 803 
AmrB TLA--VMFGSDYIGDFMHGSQVRKVWQADGAKRLGIDDIGRLHVRNEQGEMVPLATFAK 800 
MexY TLA--VMFGSDYIGDFMHGSQVRKVWQADRRKRLGIDDIGRLHVRNEQGEMGMGDVRQ 800 
AcrB TLGMFTWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRMDGQMVPFSAFSS 832 
MexB TV--SIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFAT 805 
Ac rD TL--QTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFAT 804 
AdeY TMR_-IAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFAT 807 
AdeE TLS--SAWGGSYINDFIDQGRVKRVYLQGEANYRSLPQDIGQWYVRGTSGEMTPFSSFSS 802 
MexD VKWEEG--PVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLP----AGIGYE\\T 856 
AdeB PQWNKA--PQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLP- - --KGIGYE\\T 851 
MtrD VSWENG--TEQSVRFNGYPSMKLSASPATGVSTGQAMEAVQKMVDELG----GGYSFEWG 857 
AmrB AAWLG- -PPQLTRYNGYPSFNLEGQAAPGYSSGEAMQAMEQLMQGLP- - --EGIAHEWS 854 
MexY GRLDPR--PAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTA----RGIRPRW 854 
Ac rB SRWEYGFTSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLP- • - -TGVGYDFT 888 
„ MexB GKWEYG- -SPKLERYNGVPAMEILGEPAPGLSSGDAMMVEEIVKQLP- - --KGVGYSWT 859 
AcrD SRWETG--SPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLP----NGFGIOT 858 
AdeY G E m G - -SPRLERYNGVSSVNIQGTPAPGVSSGDSMKAMEEIlAKLPSMGLQGFDYEWT 865 
AdeE •  WWQMG- -PQMLQRFNGLSAVQIQGSAAAGESSGGAMDKMQQLVDQQQ GFNLQWS 855 
, M e x D GLSYQEK-VSA--GQATSLFALAILWFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVM 913 
AdeB GISLQEK-QSE--SQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIM 908 
’ MtrD GQSSEEA-KGG--SQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVT 914 
AmrB GQSFEER-LSG--AQAPALFALSVLIVFLALAALYESWSIPLAVILWPLGVLGALLGVS 911 
MexY RPVLRRTPVAG--AQAPALFALSVLIVFLALAALYESWSIPUVILWPLGVLGALLGVS 912 
AcrB GMSYQER-LSGNFTQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAAT 947 
MexB GLSYEER-LSG- -SQAPALYALSLLWFLCLAALYESWSIPFSVMLWPLGVIGALLATS 916 
AcrD AMSYQER-LSG--AQAPALYAISLLWFLCLAALYESWSVPFSVMLWPLGVIGALLATW 915 
AdeY GLSLEER-ESG--AQAPFLYALSLLIVFLaAALYESWSIPFSVLLWPLGIIGAIVLTY 922 
"AdeE GLSYQEK-LAG--GQTIWLYFFSIIFIFLCLAALYESWSIPVSVMLVIPLGLIGAWAAS 912 
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APPENDIX 5 
• MexD VS GMSNDVYFKVG- -LITIIGLSAKNAILIVEFAKELWE-QGHSLRDAA 959 
AdeB SR GLMNDVFFKIG- -LITI IGLSAKNAILIVEFAKMLKE-EGMSLIEAT 954 
Mt i-D GRNLFEGLLGSVPSFANDIYFQVG--FVTVMGLSAKNAILI lEFAKDLQA-QGKSAVEAA 971 
AmrB LR GLPNDIYFKVG--LITIIGLSAKNAILI lEVAKDHYQ-EGMSLLQAT 957 
MexY LR GLPNDIYFKVG--LITI IGLSAKNAILI lEVAKDHYQ-EGMSLLQAT 958 
AcrB F----RG LTNDVYFQVGFTLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEAT 996 
MexB M----RG LSNDVFFQVG--LLTTIGLSAKNAILIVEFAKELHE-QGKGIVEAA 962 
AcrD M-- --RG LENDVYFQVG--LLTVIGLSAKNAILIVEFANEMNQ-KGHDLFEAT 961 
AdeY LGMIIKGD----PNLSNNIYFQVA--MIAVIGLSAKNAILIVEFAKELQE-KGEDLIEAT 975 
AdeE L----AG FVNDIYFQVA--MLTTIGLSAKNAILIVEFAAAKLE-AGQALMDAI 958 
MexD lEAARLRFRPIIMTSMAFILGVIPLA--LASGAGAASQRAIGTGVIGGMLSATFLGVLFV 1017 
AdeB VAAAKLRLRPILMTSLAFTCGVIPLV--lASGASSETQHALGTGVFGGMISATILAIFFV 1012 
Mt rD LEAARLRFRPI IMTSFAFILGWPLY--lAAGASSASQRAIGTTVFWGMLVGTLLSVFLV 1029 
AmrB LEAARLRLRPIVMTSLAFGFGWPLA--LSSGAGSGAQVAIGTGVLGGIVTATVLAVFLV 1015 
MexY LEAARLRLRPIVMTSLAFGFGWPLA--LSSGAGIRAQVAIGTGVLGGIVTATVLAVFLV 1016 
AcrB LDAVRMRLRPILMTSLAFILGVMPLFTVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFV 1056 
MexB lEACRMRLRPIVMTSLAFILGWPLA--ISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV 1020 
AcrD LHACRQRLRPILMTSLAFIFGVLPMA--TSTGAGSGGQHAVGTGVMGGMISATILAIYFV 1019 
AdeY LHAAKMRLRPIIMTTLAFGFGVLPLA--LSTGAGAGNHPSVGYGVPGGVLQASSKESLFP 1033 
AdeE lEGAGQRLRPIIMTSLAFVAGVLPLA--VSTGAGAVSRKEIGIAVTGGMISGTLLSIFFV 1016 
MexD ‘ PICFVWLLSLLRSKPAPIEQAASAGE----……---1043 
AdeB PVFFIFILGAVEKLFSSKKKISS 1035 
MtrD PLFYVWRKFFKETAHEHEMAVRHASKAGITGSDDKQY 1067 
AmrB PLFFLWGRLFRLRKAPRTGNSPQIPTEQA 1045 
MexY PLFFLWGRLFRLRKAPRTGNSPQIPTEQA 1046 
AcrB PVFFVWRRRFSRKNEDIEHSHTVDHFTH 1085 
MexB PLFYVAVSTLF- -KDEASKQQASVEKGQ 1046 
AcrD PLFFVLVRRRFPLKPRPE 1037 
, A d e Y -VFLGGIPKSFRQTKTQTLRE 1053 
AdeE PLFFLLVRRLTNKLNTKKAK 1036 
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